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ABSTRACT
An Investigation of Alkylboron Transmetallation in Palladium-Catalyzed Suzuki Reactions
By
Benjamin Murray

Advisor: Prof. Mark R. Biscoe
Through the past 40 years, carbon-carbon cross-coupling reactions have greatly enhanced the
ability of chemists to synthesize C(sp2)-C(sp2) bonds and more recently C(sp2)-C(sp3) bonds. In
particular, the Suzuki reaction has proven to be invaluable with its high yields, good functional
group tolerance, and low toxicity of reagents. One of the component steps of the catalytic cycle
of this reaction is transmetallation, in which the nucleophilic species transfers its organic
component to the metal center (generally palladium). The mechanism of transfer from primary
alkylboron nucleophiles was studied in the 1990's via use of deuterium-labeled probes and
analysis by NMR, giving evidence to this being a stereoretentive SE2 mechanism. Subsequent
work on secondary systems has highlighted the plausibility of both retentive and invertive
mechanisms of transmetallation in Suzuki reactions. More recent research highlighted that the
enantiospecificity of such C(sp2)-C(sp3) reactions is not reliant solely upon the nucelophilic
species. The selectivity is influenced by multiple factors including the ligand electronics, ligand
sterics, electrophile electronics, as well as the inclusion of exogenous additives. Herein, we
described the development of a stereodivergent Suzuki reaction using optically active secondary
alkylboron nucleophiles, in which the stereoselective pathway of transmetallation is controlled
purely by ligand selection. A wide substrate scope of aryl halides and secondary alkylboron
nucleophiles is displayed for this work. Secondly, we will describe our investigation into the
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mechanism of transmetallation for primary alkylboron systems. One drive for this research was
the apparent incompatability of results between our stereoinvertive inactivated secondary
alkylboron work and the mechanistic work in the 1990’s (that displayed complete stereoretention
of primary alkylboron nucleophiles). In particular, the potential flaws may have been present in
previous studies, and how well our stereodivergent ligand-controled Susuki system (for
secondary alkylborons) translates to primary alkylboron systems.
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1. General Introduction
1.1 The History of Metal-Catalyzed Carbon-Carbon Cross-Coupling Reactions

The search for greater control and manipulation of carbon-carbon bond forming reactions is at
the heart of organic chemistry. This is not surprising due to its importance in synthesizing
molecules of value to society, such as pharmaceuticals, agrochemicals, cosmetics, natural
products, and more.
The discovery of a new class of reactions in the 1970s would ultimately lead to the 2010 Nobel
Prize in Chemistry being awarded to Richard Heck, Ei-ichi Negishi, and Akira Suzuki for their
significant contributions to the field in their discovery of cross-coupling reactions. The transition
metal-catalyzed C-C bond-forming reactions they discovered did not only improve our
understanding of organometallic chemistry, but also added an incredibly useful reaction to the
chemistry toolbox of organic synthesis. The Royal Swedish Academy of Sciences’ 2010 Nobel
Prize announcement cited the use of cross-coupling reactions in the synthesis of the anti-cancer
drugs Taxol and (+)-dynemicin A (Figure 1.1).1

Figure 1.1: Structures of Dynemicin A and Taxol.
1

Cross-coupling reactions are traditionally described as the creation of a C-C bond between a
carbon electrophile and a main group organic nucleophile via a metal catalyst.

Figure 1.2: General catalytic cycle for cross-coupling reactions.
The general mechanism for most cross-coupling reactions follows three main steps, as depicted
in Figure 1.2. Firstly, the low-valent metal complex undergoes oxidative addition into the
electrophile (typically an aryl halide). Secondly, this oxidative addition intermediate will
encounter the nucleophilic component of the reaction (M’R1) which will transmetallate the
attached organic group onto the catalytic metal center, simultaneously releasing a metal halide
byproduct (M’X). The third and final step occurs since both groups are now bound to the catalyst
and are able to move into a cis-configuration, which allows reductive elimination to take place jettisoning the product while also reactivating the catalyst to its initial oxidation state. Most
common systems usually occur with the catalytic metal undergoing the cycle by transitioning
between a 0 oxidation state and a +2 oxidation state,2 but there are exceptions to this.3
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Arguably, the main group metals that have had the most success as nucleophiles in coupling
reactions have been based on boron or tin. This is due to their high stability (compared to the
other possible reagents) (Figure 1.3), while still maintaining enough nucleophilicity to undergo
the reaction. These features paired with their propensity to react with a high selectivity and
functional group tolerance has made them attractive. Traditionally, boron has been the element
of choice for the pharmaceutical industry due to its low toxicity levels. However, recently it is
being realized that tin’s toxicity is often related to its volatility and that the toxicity of heavier
stannanes is also low.

Figure 1.3: Relationship between metal’s stability and nucleophilicity.4 Configurational stability
refers to the compound’s ability to retain the stereochemical information over time (i.e. how fast
does an enantioenriched sample become a racemic sample?).
Defining cross-coupling reactions is generally dependant on the type of nucleophile used (Figure
1.2 lists the names associated with the different nucleophile classes). All closely follow the
mechanistic steps described previously. The Heck reaction is a similar reaction (unlisted in
Figure 1.2) that follows a mechanistically unique mechanism involving migratory insertion of an
olefin in place of transmetallation.
Additional variations to the system are the catalytic metal used, the ligand system on said
catalyst, and the structure of the electrophile (in regards to if X is a halide or sulfonate) (Figure
1.4).
3

Figure 1.4: Variations of the components of cross-coupling reactions.
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1.2 The History and Development of the Suzuki Reaction
The Suzuki reaction (also known as the Suzuki-Miyaura reaction) was first reported by Akira
Suzuki in 1979 as a C(sp2)-C(sp2) cross-coupling reaction. He demonstrated the ability to couple
vinyl boron complexes with vinyl halides via a palladium catalyst system5 (Figure 1.5).

Figure 1.5: First Suzuki reaction.5
In a subsequent paper in the same year, Suzuki also made use of aryl halides as the electrophilic
component of his cross-coupling reactions.6 These papers were the initial creation of the Suzuki
reaction, which has become a staple reaction of the organic chemistry community. Using these
palladium catalyzed systems allowed for easy C(sp2)-C(sp2) bond formation which was
previously more difficult to accomplish.
Particularly, organoboron reagents attracted interest due to their low toxicity, ease of access and
their stability to moisture, air, and heat. Organoboron moieties are often unreactive, but with the
coordination of a base to the boron atom to create the “ate” complex greatly increases its
nucleophilicity. This has proven to be vastly useful in facilitating transmetallation of boronic
acids and esters.2
Although Suzuki reactions primarily make use of palladium as the catalytic metal, it should be
noted that other metals can undergo the required steps for the cross coupling to take place. These
include nickel,3 iron,7 platinum,8 cobalt,9 copper,10 and a variety of nanoparticles (usually made
5

from the previously listed metals).11,12 Nickel is of interest as it is often more electron rich than
equivalent palladium systems and can therefore oxidatively add into more difficult electrophiles
more easily (such as aryl chlorides and aryl halides with deactivating substituents)13 and at a
lower cost than palladium.
The progression of ligand design has also increased the efficiency and scope of cross-coupling
reactions. The ligand(s) of the catalytic system are of great importance as they must encourage
the following traits in the catalyst: an electron-rich metal center, to allow oxidative addition;
appropriate steric size, to allow coupling groups onto the metal while also being large enough to
facilitate rapid reductive elimination; and to maintain catalyst stability, so that the transition
metal undergo many catalytic cycles without decomposition, therefore enabling low catalyst
loading and full conversion of starting materials. Originally the ligands used were simple
monodentate phosphines such as triphenylphosphine,5 but it did not take a long time until
researchers began manipulating ligand designs to seek improvement. The use of alkylphosphines
rather than arylphosphines showed promise, as these electron-rich ligands increased the catalytic
metal’s election density (a key feature required to assist oxidative addition).14,15 Other groups
had success with further variations such as bidentate ligands,16 non-phosphine type ligands,17
Buchwald ligands,18 and others.

Figure 1.6: Examples of different ligand types used in Suzuki reactions.
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The expansion of metal types, ligands and organoborons has greatly increased the variety of
possible Suzuki type reactions. From the original C(sp2)-C(sp2) cross-coupling reaction, there are
now C(sp2)-C(sp3) couplings,19 C(sp3)-C(sp3) couplings,20 and enantioselective C(sp2)-C(sp3)
couplings.21
Not only have new ligand types increased the scope of possible product formed, they have also
expanded the assortment of starting materials that can be used. For instance, aryl chlorides are
now utilized often as the electrophile in cross-coupling reactions (these are generally cheaper
than the bromide and iodide equivalents)(Figure 1.7 (a)).

Figure 1.7: (a) Relationship of cost and stability of aryl halides. (b) Examples of boron reagents
used in Suzuki reactions.

Additionally, the variety in organoboron nucleophiles has also increased, giving greater
variances in stability and nucleophilicity – a few select examples are shown in (Figure 1.7 (b)).

7

The main side products produced in Suzuki reactions tend to arise from homocoupling,
protodeboronation or oxidation.22 Reactions systems that are able to mitigate the production of
these products tend to facilitate high product yields.

8

1.2.1 The Advancement from C(sp2)-C(sp2) Suzuki Reactions to C(sp2)-C(sp3) Suzuki
Reactions

The ability to do any type of carbon-carbon bond formation through cross-coupling reactions
was indeed useful, but due to the prevalence of bonds between other carbon hybridizations in
nature, natural products, bioactive molecules and others, it is important to expand to other
coupling types. The next step would be that researchers would instigate in developing new
systems to allow compatibility with C(sp3) moieties. C(sp2)-C(sp3) cross-coupling reactions face
additional challenges, particularly the side-reaction of -hydride elimination, which can create
incorrect side products. Dissociation after -hydride elimination can lead to an unwanted olefin,
whereas reinsertion after -hydride elimination can lead to an incorrect regioisomer (Figure 1.8).

Figure 1.8: Suzuki catalytic cycle with explanation of -hydride elimination.
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In 1986 Suzuki published his first reaction to successfully couple C(sp2)-C(sp3) carbons.23 He
made use of aryl/vinyl halides (iodides and bromides) to couple with alkyl-9-BBN nucleophiles
in the presence of base (NaOMe or NaOH) via a palladium catalyst. Zero percent yield was
reported for any example that attempted to make use of s-butyl boron reagents. Suzuki expanded
on this initial work in a 1989 paper (Figure 1.9).19

Figure 1.9: Suzuki’s 1989 paper’s substrate table.19
This paper largely focuses on the coupling of vinyl halides with terminal olefins and the
cyclization of similar species in an intramolecular fashion, as well as some expansion to the
C(sp2)-C(sp3) bond forming reactions. They manage to achieve 40% yield of the sec-butyl
boronic ester, which the group had previously struggled with.

10

An alternative way to achieve similar results is to swap the synthetic handles of the desired
coupling groups. Fu’s group did this using a nickel catalyst system, with aryl-boronic acid
nucleophiles and inactivated secondary alkyl electrophiles (Figure 1.10).24

Figure 1.10: Fu’s nickel catalyzed Suzuki reaction with alkyl halides.24
They mainly used cyclic alkyl bromides but when using alkyl iodides they were able to use secbutyl groups (and other non-cyclic alkanes) to couple with aryl/vinyl boronic acids. These gave
moderate to good yields. Nickel catalysts are generally more active to oxidative addition,
therefore allowing chemists to more easily use alkyl electrophiles than they would with
palladium systems.

The first example of using secondary alkyl potassium trifluoroborates as nucleophiles in Suzuki
reactions was reported in 2008 by the Hoogenband group.25 Their use of the Buchwald ligand
RuPhos enabled them to couple s-butyltrifluroborate (and cyclopentyltrifluoroborate) with aryl
bromides. They struggled with b-hydride elimination and increased temperatures increased this
issue. Overall, their yields were low to moderate but showed promise in the development of this
research area.
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Advancements have been made in using Suzuki reactions to generate C(sp2)-C(sp3) bonds, with
more options available to chemists in substrate scope, catalytic conditions and types of
organoborons used. Figure 1.11 highlights the diversity of Suzuki reactions available with a
small sampling of examples with C(sp2)-C(sp3) bond formation.

Figure 1.11: (a) Molander Suzuki coupling of aminomethyltrifluoroborates with aryl meslates.26
(b) Suzuki’s cyclization via intramolecular Suzuki cross coupling.27 (c) Molander’s coupling of
alkyl trifluoroborates with aryl triflates.28 (d) Occhiato’s Suzuki coupling of vinyl trifliates (on
lactams) with boronic acids.29
Figure 1.11, line (a) depicts Molander’s groups coupling of aminomethyltrifluoroborates with
aryl and heteroaryl mesylates.26 Starting materials with heteroatoms are generally more difficult
to couple do to their propensity to coordinate to the catalytic transition metal. Line (b) shows
Suzuki’s palladium-catalyzed cyclization via generation of the organoborane in-situ with 9BBN-H.27 Line (c) displays Molander’s reported coupling of alkyl trifluoroborates with alkenyl
and aryl trifluoromethanesulfonates via a palladium-catalyzed Suzuki reaction.28 Line (d)
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highlights Occhiato’s work in the Suzuki coupling of vinyl trifluoromethanesulfonates on
lactams with alkyl boronic acids (and esters).29
Figure 1.11 gives a sampling of how the scope of Suzuki reactions has broadened. Although the
products and substrates are varied - often the conditions used need to be altered to the extent that
one configuration that is feasible for a certain reaction may be inadequate for another.

13

1.2.2 The History of Harnessing the Suzuki Reaction for the Generation and Proliferation
of Enantiomeric Centers

The desire to undergo enantioselective cross-coupling reactions is predictable due to the
prominent number of chiral centers in pharmaceuticals and natural products. Figure 1.12 displays
some of the many molecules of interest that contain chiral centers and that having enantiopure
samples are desired.

Figure 1.12: Structures of kendomycin, (+)-discodermolide and epothilone A.
Synthesizing a racemic product is at best wasteful and inefficient (e.g. chiral resolution), and at
worst potentially harmful and dangerous (toxicity of undesired enantiomer e.g. thalidomide
scandal). Therefore, it is unsurprising that due to successful C(sp2)-C(sp3) cross couplings, there
was much enthusiasm to investigate reactions that that may allow the selective generation of
enantioenriched products.
Synthetic approaches towards the selective production of single-enantiomer products using
Suzuki reactions can be subdivided into two categories: 1) use of racemic or achiral substrates to
generate single-enantiomer products directly through a cross-coupling reaction using a chiral
ligand (asymmetric cross-couplings), and 2) use of an enantioenriched starting material whose
stereochemistry is retrained through the cross-coupling process (stereospecific cross-couplings).
14

In the following sections asymmetric Suzuki reactions will be discussed, followed by
stereoselective Suzuki couplings using optically active organoboron nucleophiles. It should be
noted that similar results can be achieved by use of optically active electrophiles. However, these
generally require nickel catalysis to achieve oxidative addition and are mainly limited to benzylic
electrophiles.30,31

There are two commonly used terms in this field: enantiomeric excess (e.e.) and enantiomeric
selectivity (e.s.). The calculation of each is shown below:
e.e. = % of major enantiomer - % of minor enantiomer
e.g. : Product is 80% R and 20% S, e.e. = 80-20 = 60% e.e.

e.s. = (e.e. of the product / e.e. of the starting material) x100%
e.g. : Starting material had e.e. = 80% and product had e.e. = 40%, e.s. = (40/80)x100 = 50% e.s.
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1.2.2.1 Generation of Enantioenriched Products via Asymmetric Suzuki Reactions

The asymmetric synthetic method generally involves the uses of an enantioenriched ligand as
part of the catalytic metal system, thus influencing the product’s outcome and hopefully
selectively inducing some enantioenrichment. Some examples are between C(sp2)-C(sp2)
couplings that create axial chirality, whereas the examples most pertinent to this manuscript
involve the creation of an enantioenriched chiral C(sp3) center. What follows are examples of
each.

In 2000, Buchwald’s group generated axial-chiral biaryls (Figure 1.13) through an asymmetric
C(sp2)-C(sp2) coupling between an aryl boronic acid and an aryl halide.32

Figure 1.13: Buchwald’s asymmetric coupling of aryl bromides and aryl boronic acids, creating
optically active products.32
This reaction made use of mono and biaryl boronic acids with substituents in the para and ortho
position. Electron-rich and electron-neutral variants were observed to undergo conversion. Mono
and biaryl electrophiles were also utilized almost all of which contained an ortho phosphonate
group. Yields were generally high and created products of moderate to good e.e. This chemistry
was done primarily in hope of being able to access new optically active biaryl ligands.
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The first example of an asymmetric enantioselective Suzuki reaction that could create C(sp3)
centers was not reported until 2008 by the Fu group. This made use of chiral ligands in a nickel
catalyzed system to synthesize C(sp3)-C(sp3) bonds (Figure 1.14).20

Figure 1.14: Fu’s nickel catalyzed asymmetric Suzuki coupling of two alkyl moieties.20
This alkylboron cross-coupling system gave moderate to good e.e. and yields. Some of its
limitations were that it only used electrophiles with a homobenzylic bromide and there were no
aryl nucleophiles presented. “Alkyl1” was either a methyl, iso-propyl, n-butyl or primary
ethylbenzene group. “Alkyl2” was generally a linear carbon chain (length of 3-6 carbons) with a
group attached to its terminal end, including examples such as benzene, silyl protected alcohol
and methyl ester. Aryl groups utilized were mainly unsubstituted benzene but there were also
examples that included furan and a 1,3-benzodioxole.
Following this paper Fu investigated a range of expansions on this asymmetric coupling work.
Between 2010 and 2012 Fu employed a wider range of organoboron nucleophiles including an
arylboronic ester.33,34 During this time Fu’s group focused on increasing the reaction scope of the
electrophiles. They successfully developed method to utilize -haloamides,33 protected haloalcohols,35 -haloamides,34 -haloamides,36 -haloamides protected with carbamates or
sulfonates, and -halosulfones.37 The reaction’s conditions have slowly evolved but are not too
different from the initial conditions in Figure 1.14, and still make use of the same ligand system
(or slight variants of said system).
17

The Morken group was able to generate enantioenriched organoboranes from achiral geminal
bis(pinacolboronates) via palladium-catalyzed Suzuki coupling with aryl halides (Figure 1.15).38

Figure 1.15: (a) Morken’s asymmetric synthesis of secondary benzylic Bpin molecules. (b)
Morken’s labeled boron experiment to investigate the transmetallation mechanism.38
By use of an optically active ligand, the Morken group achieved good yields with moderate e.e.
values. The aryl electrophiles (Ar) used in this work included some variation in electronics by
use of electron-rich, electron-neutral, and somewhat electron-poor aryl halides. A few of these
electrophiles contained an oxygen atom but they were all off from the primary ring of the aryl
halide. The nucleophilic scope of the reaction (R group) was less vast and mainly made use of
linear alkanes, sometimes capped at the terminal end with a phenyl group. However there was a
single example of a protected alcohol capping the terminal end of the alkyl chain.
Morken then used 10B-labeling experiments to elucidate the mechanism. The results showed that
the mechanism of transmetallation proceeded via a stereoinvertive pathway (Figure 1.15 (b)).
Using nearly identical conditions to those described by Morken, the Hall group was
simultaneously (but independently) working on the same chemistry. Through use of similar
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ligands, they too developed a palladium-catalyzed Suzuki reaction to produce enantioenriched
secondary alkylboronic esters from achiral geminal bis(pinacolboronates) (Figure 1.16).39

Figure 1.16: Hall’s asymmetric synthesis of secondary benzylic Bpin molecules.39
Hall’s group had similar results in terms of e.e. and yields. They had an even narrower scope of
nucleophiles used in this reaction, with all examples being a linear alkane (2-4 carbons long)
capped with a phenyl group. They used electron-rich and electron-neutral electrophiles with no
heteroatoms present in the aromatic rings.

A more recent example of an asymmetric enantioselective Suzuki reaction was published in 2017
by the Fletcher group. In the creation of C(sp2)-C(sp3) bonds, they shifted to using a rhodium
catalyzed system with a chiral ligand - opposed to Fu’s nickel based reactions (Figure 1.17).40

Figure 1.17: Fletcher’s rhodium-catalyzed asymmetric synthesis of optically active cyclic allylic
systems.40
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Fletcher’s conditions suffer from a limited electrophile scope – as they can only be coupled at the
allylic position and all are cyclic, with no linear moieties displayed so far. However, the
electrophiles used include vinyl chlorides and some contain heteroatoms. The scope of
nucleophiles is more substantial - they include vinyl and aromatic boronic acids but also more
interesting aromatic heterocycles seem to work well.

These examples of asymmetric synthesis can be powerful tools and can be mechanistically
interesting. Unfortunately, new reactions often struggle to produce results similar to what is
reported – particularly when small electronic or steric differences in substrates are required. A
minor change to the system can drastically reduce the selectivity of the reaction.4 The next
section attempts to overcome some of these downfalls by having a configurationally stable
stereocenter pre-formed in the organoboron nucleophile.

20

1.2.2.2 Generation of Enantioenriched Products via Stereospecific Transmetallation of
Optically Active Secondary Organoborons in Suzuki Reactions

Synthesizing enantioenriched products by starting with optically active substrates eliminates the
issue of needing effective generation of selective chirality by specialized ligands. Instead a new
challenge emerges where existing stereochemistry of an enantioenriched nucleophile must be
retained throughout a cross-coupling reactions. In asymmetric catalysis the selectivity may be
eroded by substrates coordinating incorrectly to the catalyst-ligand system. In this alternative
method, the main cause for loss of e.e. is -hydride elimination. It is then useful to use systems
with ligands that facilitate rapid transmetallation and reductive elimination (therefore reducing
the available time for -hydride elimination to take place).

Cyclopropyl organoborons compounds had been shown to work well in Suzuki cross-coupling
reactions due to the simpler transmetallation enabled by the increased s character of their
exocyclic bonds. These substrates tend to undergo fewer side reactions and are resistant to hydride elimination.41 In 1998 the Deng group reported the first stereospecific C(sp2)-C(sp3)
Suzuki reaction using the cyclopropyl organoborons (Figure 1.18).42

21

Figure 1.18: Deng’s uses of cyclopropyl boronic acids to undergo stereoselective Suzuki cross
coupling.42
These reactions occurred with good to high yields and with very high e.s. values. The substrate
scope was somewhat limited, with no heteroatoms tolerated in any of the aromatic ring systems,
and with the presence of only one R group tolerated on the cyclopropyl boron nucleophile.
Additionally, this R group was exclusively a phenyl or n-hexyl group. This reaction can make
use of electron-neutral and electron-withdrawing electrophiles. Work on cyclopropyl
organoboranes continued under Deng (expansion of electrophile scope to include vinyl triflates
and benzylic bromides),43,44 and Gevorgyan (stereospecific coupling of trisubstituted optically
active cyclopropyl organoborons).45
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The Crudden research group successfully overcame the obstacles of non-cyclopropyl secondary
systems in 2009 with the first stereoselective C(sp2)-C(sp3) coupling of secondary benzylic
boronic esters. This process used aryl iodides via a cationic palladium-catalyzed Suzuki reaction
(Figure 1.19).21

Figure 1.19: Crudden’s stereoretentive Suzuki coupling with benzylic boronic esters.21
This coupling gave moderate to good yields with net retention of the stereocenter (upper e.s. of
89%).4 The nucleophilic scope was limited to electron-neutral benzylic moieties that had no
heteroatoms. Electron-deficient and electron-neutral aryl iodides were tolerated, but they also
contained no heteroatoms.
In 2014 Crudden’s group expanded upon this initial work by using dibenzylic organoboronic
esters to couple with aryl iodides.46 The substrate scope was still limited to non-heteroaromatic
cycles, and did not include any electron-rich electrophiles. The stereoselectivity was still a
retentive process but with slightly improved e.s. (consistent values between 80% - 100%).4
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In 2010, the Molander group published results on the stereoselective cross-coupling of nonbenzylic secondary alkyl -trifluoroboratoamides with aryl halides via a palladium-catalyzed
system (Figure 1.20 (a)).47

Figure 1.20: (a) Molander’s stereoinvertive coupling of secondary potassium trifluoroborates. (b)
Molander's rationale of stability and mechanistic pathway in relation to coordinating carbonyl.47
This reaction made use of aryl bromides and chlorides that contained electron-withdrawing and
electron-neutral substituents. Converse to Crudden’s work, transmetallation proceeded with net
stereoinversion. High yields and high e.s. values were obtained in these reactions. Molander
proposed that the carbonyl group may coordinate to the palladium metal center, therefore
assisting transmetallation while simultaneously hindering -hydride elimination.47 Their
hypothesis involves oxygen-ligation to the metal (Figure 1.20 (b)), which occupies a vacant
coordination site on the palladium thereby inhibiting -hydride elimination.
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Suginome and Ohmura coupled -(acylamino)benzyboronic esters with aryl halides. These
nucleophiles had a similarly positioned carbonyl to Molander’s alkyl -trifluoroboratoamides
and like Molander’s work they also have net inversion of the stereocenter (Figure 1.21 (a)).48

Figure 1.21: (a) Suginome and Ohmura’s Suzuki reaction with secondary boronic esters.48 (b)
Suginome and Ohmura’s work on the effects of additives on the mechanism of
transmetallation.49
This is particularly interesting as their conditions are similar and use the same ligand.
Subsequently, they produced a paper in 2011 that highlighted the ability to change their system’s
enantioselectivity by adding additives (Figure 1.21 (b)). Using PhOH (2.5 equiv) helped
facilitate an invertive mechanism, whereas using the lewis acid Zr(Oi-Pr)4.i-PrOH made the
system stereoretentive.49 The suspected reasoning for this switch in stereoselectivity is that the

25

lewis acid may disrupt the coordination of the carbonyl to the boron, therefore making it more
electrophilic and more likely to go via a 4-membered transition state. However, these variations
did not give high enough e.s. values to be truly useful.

In 2011, Hall’s research group reported the stereoselective cross-coupling of optically active 3,3diboronyl carboxyesters with aryl (or vinyl) bromides (Figure 1.22).50

Figure 1.22: Hall’s stereoinvertive Suzuki reaction with diboronyl carboxyesters.50
These reactions proceeded with moderate to good yields and with very high e.s. values. Although
the reaction scope only varied the electrophile, electron-rich, electron-neutral and electrondeficient aryl bromides all worked well. There was one example that successfully used 2bromothiophene with only a minor decrease in yield. Additionally, vinyl bromides were applied
with varying success. This reaction has the added interest of orthogonality as the B(dan) handle
is unaffected and could be used for further transformations. Hall reports two such examples, by
further coupling to different electrophiles (enantioselectively), after having converted the B(dan)
to a more active boron species (potassium trifluoroborate). Hall’s Suzuki system proceeds with
stereoinversion. Hall suggests that the -carbonyl assists the invertive pathway (as has been
suggested in previous examples listed above) and stabilizes the system to prevent -hydride
elimination. Hall also suggests the B(dan) has a stabilizing effect on the system but it is unclear
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how large an effect this has as the coupling reaction using the monoboron nucleophile (as proof
of orthogonality) also proceeds with very high selectivity without such stabilization.

In 2012, Aggarwal’s group investigated the use of optically active propargylic boronic esters in
the preparation of optically active allenes. The reaction proceeded in good yield and excellent e.s
(Figure 1.23).51

Figure 1.23: Aggarwal’s stereoselective Suzuki type reaction with propargylic boronic esters.51
This reaction utilized electron-rich, electron-neutral and electron-deficient aryl iodides but none
contained any heteroatoms. A variety of alkyl and aryl substituted propargylic boronic esters
were used. It is apparent that this Suzuki reaction does not undergo the general mechanism
proposed for such chemistry; Aggarwal proposes the mechanism displayed in Figure 1.24.
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Figure 1.24: Aggarwal’s proposal for the catalytic cycle of his couplings between propargylic
boronic esters and allenes.51
The mechanism begins with the traditional oxidative addition of the aryl iodide, followed by
silver oxides extraction of the halide, thereby forming a palladium-hydroxy species. It is this
palladium-hydroxy species that Aggarwal suggested would allow the six-membered transition
state to form, therefore explaining the regiochemistry seen in the results. From that point the
reductive elimination takes place, producing the tetrasubstitued allene. Three of the coupling
examples given in the paper had some issue with correct transfer of the aryl group and gave a
proportion of the product with a proton in place of the aryl group (between 5% and 20%). The
other examples showed no production of this side product. This type of transformation goes from
point chirality to axial chirality, therefore it is unsurprising that the mechanism is unrelated to the
general stereoretentive or stereoinvertive pathways mentioned so far.
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Molander returned to his stereospecific Suzuki work with alkyltrifluoroborates in 2012, using a
system without the carbonyl group on the organoboron nucleophile (Figure 1.25).52

Figure 1.25: (a) Molander’s stereoretentive Suzuki reaction with alkyltrifluoroborates. (b)
Molander’s rationale of the synthetic assistance from coordinating benzyl system.52
Using 1-(benzyloxy)alkyltrifluoroborates, Molander successfully coupled these nucleophiles to
aryl and heteroaryl chlorides, with moderate to good yields and high enantioselectivity. They are
able to utilize electron-rich, electron-neutral and electron-deficient electrophiles. The nucleophile
scope is more limited with mainly simple, linear alkane moieties with terminal phenyl groups.
This work goes via a stereoretentive mechanism with excellent e.s. values, which is opposite of
his previous alkyltrifluoroborate studies shown in Figure 1.2. Molander suggests that the reason
for this mechanism is the lack of a strong intramolecular carbonyl coordinating group to the
boron, therefore reducing its propensity to undergo invertive transmetallation. This is in line with
the rationale of the Suginome and Ohmura work mentioned previously, where they believed the
addition of a lewis acid disrupted the carbonyl coordination.49 He suggests that the complexation
of the benzyl group still exists and assists the substrate from undergoing -hydride elimination –
by the same reasoning previously discussed (Figure 1.25 (b)).47
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The Yun research group published a paper in early 2013 which mainly discussed a copper
catalyzed method of synthesizing optically active diborons (one being a B(dan) and the other a
B(pin)).53 In order to show the utility to their main body of work, they converted one of their
products to an enantioenriched trifluoroborate so they could use it in a stereoselective Suzuki
reaction (Figure 1.26).

Figure 1.26: Yun’s example of a stereoretentive Suzuki reaction with a secondary diboron
system.53
This reaction was of low yield (15%) and had an e.s. of 86%, but is the first example of using
1,1-diboraalkanes in an enantioselective cross-coupling reaction with no assistance from a
coordinating group. This system went with retention of the stereocenter, which they suggest
gives further credibility to the idea that a strong coordinating group is required in the boron
moiety to increase its nucleophilicity and to facilitate the alternative invertive mechanism.
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A Crudden and Aggarwal collaboration, published in 2013, reported the cross couplings of
optically active allylic boronic esters with aryl iodides (Figure 1.27).54

Figure 1.27: Crudden and Aggarwal’s use of optically active boronic esters in a Suzuki type
reaction.54
Moderate to good yields were reported with excellent e.s. values. Primarily the -product was
produced in high quantities (/ between 83:17 to 94:6) with high E-alkene selectivity (E/Z often
99:1). Some select substrates had poor E/Z ratios. Electron-poor and electron-neutral
electrophiles were tolerated. The scope of R groups on the nucleophile was not expansive as they
were either small alkyl groups (Me or n-Pr) or hydrogen. A similar mechanism to the previous
Aggarwal coupling discussed (coupling of propargylic boronic esters) was invoked for the
production of the -product. That is the use of Ag2O to generate a palladium-hydroxy species
which can then form a six-membered transition state with the nucleophile, therefore explaining
the alteration in regiochemistry. Aggarwal recently expanded on this work to generate orthosubstituted 1,1-diarylalkanes.55
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In 2014, the Biscoe group published the first palladium-catalyzed cross-coupling reaction using
an inactivated, enantioenriched, secondary alkylboron nucleophile (Figure 1.28).56

Figure 1.28: Biscoe’s stereoinvertive Suzuki reaction with inactivated secondary boron
nucleophiles.56
The reactions proceeded with net inversion of configuration, and in good yields with high
enantioselectivity. Previously, inversion of configuration was only shown in Suzuki crosscoupling reactions using an alkylboron nucleophile that contained a carbonyl group capable of
remote coordination to palladium. Thus, this paper demonstrated that remote coordination was
not essential, and that other reaction conditions could be altered to facilitate the invertive
mechanistic pathway. The nucleophilic scope of the enantiospecific examples of this reaction
was narrow as only two variants of inactivated nucleophiles were demonstrated. The
electrophilic scope enabled use of the more difficult aryl chlorides and enjoyed the ability to
work with a variety of aromatic heterocycles (although no heteroatoms on the ring containing the
carbon-chloride bond). Additionally, electron-rich, electron-neutral and electron-poor aryl
chlorides seemed to work effectively in this reaction system.

32

In 2014 the Hall research group reported on the Suzuki cross-coupling reaction that was
enantioselective but also allowed regioselective control by ligand selection. This was the
coupling of activated cyclic vinyl boronic esters and aryl (or vinyl) bromides (Figure 1.29).57

Figure 1.29: Hall’s enantio- and regioselective Suzuki cross-coupling reactions.57
The regioselectivity was generally higher when producing the -products, but both reactions had
variations in regiocontrol based upon the electrophile used. The e.s. values were consistently
excellent and yields ranged from moderate to excellent. Only the two nucleophiles shown in
Figure 1.29 were used, but the range of electrophiles was broader. Electron-rich, electron-neutral
and electron-deficient aryl bromides were successfully used in each reaction variation. Two
heteroaromatic halides were used, as were two vinyl bromide systems. Hall proposes a similar
mechanistic hypothesis to Aggarwal (Figure 1.24) to account for the abnormal regioselectivity of
the -products (i.e. palladium-hydroxy complex forms a six-membered ring with the boron
nucleophile allowing the transition metal to access the -position). Hall suggests that this is
facilitated by using triarylphosphines, whereas the -product is generated when using
alkylphosphines.
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1.2.3 Details of the Mechanism of Transmetallation in Palladium-Catalyzed Suzuki CrossCoupling Reactions with Alkylboron Nucleophiles

The Suzuki reaction is comprised of three main steps: oxidative addition, transmetallation and
reductive elimination. The first and last steps are relatively well understood mechanistically, but
research on transmetallation is less mechanistically clear due to its high dependence upon
reagents and reaction conditions.2 This is arguably the most important step to thoroughly
understand in the context to stereospecific cross-coupling as this is the step that transfers the
chiral C(sp3) center to the catalytic metal.
Due to the low nucleophilicity of organoboron species it is unlikely that they are able to undergo
transmetallation without in situ activation. It has been shown that Suzuki reactions require base,
as organoboron compounds generally do not react with organopalladium(II) halides (such as
PhPdI(PPh3)2). Organoboron reagents readily undergo transmetallation to transition metals when
in the presence of base and a suitable ligand. There have been mixed opinions on the role of
hydroxide in Suzuki reactions, as it may facilitate transmetallation via coordination to the boron
to make the borate or if it replaces the halide of the oxidative addition palladium intermediate.2,58
Soderquist attempted to elucidate the mechanism of alkylboron transmetallation in his 1998
paper.59 He begins by analyzing the effect of adding base to different reaction substituents while checking for any variance in NMR results (Figure 1.30).
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Figure 1.30: Soderquist’s 11B and 31P NMR experiments.59
In example Figure 1.30 (a), base readily coordinates to the boron and causes a chemical shift in
the boron NMR. A similar effect is not observed when using the derivative in example Figure
1.30 (b), possibly due to electron donation by oxygen into the vacant p orbital of boron. A
separate experiment Figure 1.30 (c) highlights the role of base with the palladium catalyst,
showing that it will displace the halide and form the palladium-hydroxy compound. From these
experiments it is clear that base could influence transmetallation in at least two ways.
Soderquist’s use of direct competition reactions between 9-BBN moieties and the oxygenimplanted derivative (OBBD) resulted in selective consumption of the 9-BBN species. Thus
suggesting that the boron-oxygen bond is not activating enough compared to the higher reaction
rate of the hydroxyl coordinated 9-BBN compound. Through further experiments, he deduces
that the cause for this is likely that the rate determining steps are at different points in the
catalytic cycles for these moieties (Figure 1.31). The rate determining step for the 9-BBN species
is oxidative addition (RDS2), whereas for OBBD species the rate determining step is the
production of the palladium-hydroxy complex (RDS1). This explains the selectivity seen for the
9-BBN species in competitive reactions, as the rate determining step comes earlier in the
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catalytic cycle for that compound, therefore allowing it to consume the organopalladium halide
species before it has time to be converted to the palladium-hydroxy complex.59

Figure 1.31: Soderquist’s proposed catalytic cycles for 9BBN and OBBD nucleophiles.41
Soderquist proposes some other curious features of base in the Suzuki reaction that are less
related to transmetallation, including production of a bihydroxyboron byproduct (top right corner
of Figure 1.31) (hence the general requirement of excess base), catalyst regeneration and
accelerated rates of coupling using the OBBD moieties (even with no direct evidence of a boron
ate formed with base). In regards to transmetallation, it seems clear that the base may be active in
coordination to the boron and/or palladium compounds. The role of base is an interesting feature,
but it may be less mechanistically relevant to what is discussed in this manuscript, as both borate
and palladium-hydroxy routes are likely compatible of supporting stereoinvertive and
stereoretentive transmetallation mechanisms.
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Mechanistic studies suggest that aryl boron nucleophiles favor a transmetallation pathway is via
a palladium-hydroxy species and that a system where both components are coordinated by OH- is
disfavored. Reports suggest that for C(sp2) boron nucleophiles, transmetallation will not occur
between the halide-palladium complex and the borate species.60,61 It is unclear if these results
directly correlate to C(sp3) boron nucleophiles.
Soderquist and Woerple independently proposed a mechanism for transmetallation of primary
alkylboron compounds (Figure 1.32).16,59

Figure 1.32: Soderquist and Woerpel's strategies to deduce transmetallation pathway using
coupling constants of vicinal protons.16,59
They both showed that transmetallation goes with retention of stereochemistry for primary
Suzuki reactions (Figure 1.32), leading both to propose the stereoretentive mechanism (Figure
1.33), as this would be consistent with selectivity observed in his deuterium probe coupling
experiment.
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Figure 1.33: Soderquist's transition state proposal with two possible routes to this alignment.59
Figure 1.33 shows a mechanism for stereoretentive alkyl transfer in which both hydroxyl
complexes could possibly lead to the transition state. In 1998, Soderquist thought both these
routes as viable, but if alkyl systems transmetallate similarly to C(sp2) systems, then more recent
evidence (previously mentioned) suggests the palladium-hydroxy species to be the more active
reagent.
Following Soderquist’s and Woerpel's work, it was generally accepted that alkylboron Suzuki
reactions went via a retentive mechanism. There were few exceptions to this and the few that did
occur via an invertive pathway were usually explained by reasoning of a nearby coordinating
carbonyl (Figure 1.34).47,48,50 These proposals were further supported when certain additives
(that disrupted this coordination) caused the system to revert to a retentive mechanism.49

Figure 1.34: Stereoinversion assisted by coordinating carbonyl.47,48,50
This mechanism was not questioned until the Biscoe group reported a general cross-coupling
method using inactivated organoboron nucleophiles where the stereogenic C-B center
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consistently underwent stereoinvertive transmetallation.56 This suggests the possibility that
alkylboron transmetallations could proceed via two distinct, competing pathways (Figure 1.35).
It should be noted that potassium trifluoroborates (as seen in work by Biscoe56 and
Molander26,28,47,52) are thought to first convert to the boronic acid/boronate form before
undergoing any transmetallation process.22

Figure 1.35: The proposed mechanisms for invertive and retentive mechanistic pathways.
Stereoretentive and stereoinvertive transmetallation both occur via SE2 pathways, the bottom
route of Figure 1.35 shows Soderquist’s proposed 4-member cyclic (metathesis-like) transition
state resulting in retention of the stereocenter.59 The top route shows nucleophilic attack from the
minor lobe of the bonding orbital of the carbon, going through the depicted planar transition
state, therefore inverting the stereochemistry of the molecule. It is possible that the erosion of
e.e. that is often seen (to varying degrees in all stereoselective coupling reactions) comes from
these two path ways being in competition. The closer the activation energies of these two
pathways, the more likely the system will display low stereoselectivity. Additionally, (as
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mentioned earlier) it seems that both of these pathways would be compatible with either the
creation of a borate complex (if an extra Y moiety was attached to boron in Figure 1.35 and Y =
OH) or a palladium-hydroxy complex. However, the invertive pathway would not require a
Suzuki intermediate containing a B-O-Pd bonded system, as proposed by Denmark.62 However,
this was only demonstrated for C(sp2) systems, and thus may have less relevance to C(sp3)
systems.

40

2. Enantiodivergent Pd-Catalyzed C-C Bond-Forming Suzuki Reactions Enabled via
Ligand Parameterization

After our group’s 2014 publication describing the first stereoselective cross coupling of
inactivated enantioenriched alkylborons, we proceeded to investigate this area more deeply.
Transmetallation in our system showed a propensity to proceed via an invertive pathway, which
was contrary to the expected findings in the literature. The literature suggests that invertive
pathways only occur when there is a -carbonyl coordinating group.47,48,50 The only previous
exception to this was Morken’s boron labeled experiments which also went via an invertive
mechanism without carbonyl activation.38 Therefore, it is unclear which features control the
stereoselectivity transmetallation in our system. Much of the reported work in regards to
transmetallation of boron nucleophiles in the Suzuki reaction has focused on C(sp2)-boron
moieties60–64 or primary alkylborons (as discussed in the previous chapter).16,59 These may help
focus our thoughts to the correct direction when considering transmetallation of secondary
systems, but the level of knowledge in this area is certainly low. Our 2014 system is
advantageous for such an investigation since we use inactivated alkyl nucleophiles – this
removes a possible source of electronic interference in our research.
While we investigated the synthetic expansion of the 2014 work, we also initiated a collaboration
with the Sigman group to statistically analyze our results and model the correlation between
ligand properties and stereoselectivity.65 Stereoselection produced using our previous ligand
system (PtBu3), as well as others, was investigated using predictive statistical models. The goal
was to relate the properties of the phosphine ligand systems to the enantiospecificity of the
reaction. In the initial step of this process, the products from reactions with different aryl
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chlorides were evaluated with respect to e.e. (Figure 2.1). It was discovered that there is a
selectivity variance in regards to the para-substituent on the aryl chloride (Figure 2.1).

Figure 2.1: Investigation of substrate and ligand effects on stereoselectivity. Positive e.e. value =
retention. Negative e.e. value = inversion. *stereocenter. L = ligand.
The electronically distinct aryl halides indicated that the more electron-deficient aryl chlorides
caused an erosion in stereoinversion and thereby allowing greater access to the retentive product.
This gave an indication that even subtle differences in the reaction can influence transmetallation
and stereoselectivity. When Shibin Zhao screened a range of phosphine ligands (while using only
one electrophile) the resulting enantioselectivity varied dramatically, with no obvious correlation
in ligand solid angle to stereoselectivity. The absence of a clear relationship between ligand
properties and the transmetallation pathway suggested the use of statistical analysis via ligand
parameterization, a technique pioneered by the Sigman group.
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The Sigman group correlated stereochemical outcome with phosphine properties (steric and
electronic) and the branched:linear ratio of the products. Their workflow began with molecular
mechanics (MM) analysis to determine the low energy conformations of the ligands. This was
then followed by density functional theory calculations to optimize the geometry (Figure 2.2).

Figure 2.2: Adapted from published Science paper.65 (A) Workflow design of Sigman’s group’s
analysis of ligands. G‡ = relative free energy of activation, f(xi) = function of parameter xi.
(B) Phosphine parameterization and ligand analysis. b:l = branched:linear ratio. Positive e.e. =
retention. Negative e.e. = inversion.
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Sigman’s group used the generated electronic and steric data to select four specific descriptor
subsets. Using these descriptors, they could then try to fit to a correlation with our empirical
stereochemical results. With each parameter - they recorded the mathematical minimum values,
the mathematical maximum values, the lowest energy conformer values, and the Boltzmann
weighted averages. This range of values was used to better capture the properties of flexible
ligands, thereby enabling a better correlation to the experimental evidence.
Before they were able to undergo a useful multivariate regression analysis with the data, it was
important to first consider the branched:linear ratios and the relationship to the ligand. Figure 2.2
(B)

highlights

the

relationship

between

ligand,

stereoselectivity,

and

-hydride

elimination/isomerisation. As discussed in the previous chapter, an alkyl group attached to the
catalytic metal can undergo -hydride elimination and create the corresponding internal or
terminal alkene. This alkene may reinsert onto the palladium center – potentially causing a
regioselective or stereoselective alteration, therefore creating undesired byproducts (Figure 2.3).
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Figure 2.3: Catalytic cycle with explanations of the scrambling of stereo- and regio-control due
to -hydride elimination.
The regioisomers created in the top left of Figure 2.3 will have a 50% probability of appearing as
the opposite enantiomer (rather than a distinct product) due to the symmetry of the sec-butyl
nucleophile we are using. So in total, -hydride elimination for the system can: 1) form the
terminal alkyl-palladium complex to produce the linear product; 2) reinsert onto the same carbon
giving a 1:1 ratio of desired enantiomer vs. undesired enantiomer; 3) reinsert on the neighboring
internal carbon, which in the case of our s-butyl nucleophile will also produce a 1:1 ratio of R:S
products. For these reasons, it is apparent that -hydride elimination can convolute the data and
is not relevant to the mechanism of transmetallation. There appeared to be a small correlation
between ligand size B1 (Figure 2.2 (B)) and propensity to -hydride eliminate (this is supported
by research suggesting larger ligands promote fast reductive elimination, therefore minimize hydride elimination).66 Due to the interference from the -hydride elimination/isomerization, any
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ligands that produced e.e. of <30% were eliminated from the data to be analyzed (Figure 2.2
(B)).
Tolman electronic parameters are a useful descriptor with relation to ligand electronics. Sigman
utilized this documented correlation to the electrostatic potential minimum (Vmin)67 and using
their calculated Vmin values with the reduced data set revealed connection between ligand
electronics and transmetallation pathway. Stereoinvertive reactions were promoted by electronrich alkyl phosphines (good -donors), and electron-poorer arylphosphines helped facilitate
stereoretentive reactions (good -backbonding acceptors).
During our synthetic studies, we found that use of bulky and very electron-rich PAd3 resulted in
an improvement in the stereoinvertive selectivity compared to P(t-Bu)3. However, in the initial
ligands screened in this set (1-9 (Figure 2.2 (B))) none were equally as effective for the
stereoretentive pathway. Based upon the electronic trends established using the Tolman
electronic parameters, we predicted that a ligand that was sufficiently bulky (to reduce but also
-hydride elimination) and had electron-withdrawing substituents affixed to the aryl moieties (to
promote the retentive pathway) might effectively fill this stereoretentive ligand void. Buchwaldtype ligands (10-15) were proposed, and all showed improvement upon the initial ligand screen
(1-9) in their stereoretentive selectivity and linear to branched ratios. Ligands 11 and 14 were
particularly effective, providing 90% e.e. with minimal isomerization. This highlighted the
effectiveness of Sigman’s ligand parameterization statistical analysis.
Now armed with an excellent ligand for stereoinversion (9) and two for stereoretention (11 and
14) we proceeded to investigate the scope of the reaction (Figure 2.4). Conditions for our
invertive and retentive protocols are nearly identical and can both work well with electron-rich
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and electron-deficient aryl electrophiles. Due to some slower oxidative addition of aryl halides
using the electron-poor ligand system, aryl bromides and trifluoromethanesulfonates were also
examined. High stereoselectivity was achieved for all reactions, including some examples with
heteroaryl halides. Both diastereoisomers (17a and 17b) were produced from a single
trifluoroborate diastereoisomer with a diasteromeric ratio of 30:1 for retention and 5:1 for
inversion (a 3.6 kcal/mol free energy of activation difference) purely by ligand control. This
substrate scope also highlights an advantage compared to our previously published work with
PtBu356 in that more diverse nucleophiles are tolerated (16j and 16k). Substrate 18 was used as a
probe to confirm our mechanistic hypothesis, as an invertive pathway should be severely
hindered by the sterics of this molecule. Consistent with this prediction, only the stereoretentive
conditions generated significant product.
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Figure 2.4: Substrate table for stereodivergent cross-coupling reactions. †44% yield and 84% e.e.
(86% e.s.) when run at 60oC.
Further statistical analysis was used by Sigman’s group to investigate transmetallation (Figure
2.5). A modified version of our original nucleophile was employed in this work, in which the
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alkyl group of the organoboron nucleophile containing a terminal phenyl group (20). This was
selected due to its lack of symmetry compared to the sec-butyl nucleophile previously used;
therefore regioisomers would not affect e.e. results.

Figure 2.5: adapted from published Science paper.65
With a single electrophile, 24 ligands were examined. Sigman’s multivariate linear regression
highlighted the correlation of four values to the effectiveness of a system to go via
stereoretention or stereoinversion (Figure 2.5 (B)). These are two electronic parameters and two
steric parameters (Figure 2.5 (C)). The first electronic parameter is the E*(P-C) (this describes the
propensity to allow -backbonding) and the second is ELP(P) (this describes the energy of the lone
pair orbital of the phosphorus – therefore correlating to the ligand’s ability to -donate). The
steric parameters (the minimum width (B1Boltz) and minimum length (Lminconf)), helped depict the
correlation that large steric bulk helps to promote reductive elimination and reduce -hydride
elimination. It becomes even clearer that the steric descriptors are strongly related to these
effects, as when they remove the four smallest ligands are removed from the dataset, excellent fit
is obtained using only the two electronic parameters (Figure 2.5 (D)). This suggests that strong
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-donor ligands may support the stability of a two-coordinate cationic palladium complex and backbonding may help stabilize formation of palladium hydroxide complex necessary for the 4center transition state of stereoretentive transmetallation.
We have shown that rational ligand development has enabled expansion of the synthetic range of
substrates we can now couple stereoselectively. Equipped with these ligands, we can now
synthesize an R or S product with little regard to the enantiomer we are starting with, therefore,
greatly increasing the value of our chemistry. Additionally, this work has demonstrated the
effectiveness of multivariate regression analysis in ligand design and mechanistic investigations.

50

3. Investigation of the Transmetallation Mechanism of Primary Alkyl Trifluoroborate
Nucleophiles in the Suzuki Reaction

In chapter 2, we showed that the mechanism of transmetallation can vary based on ligand65 (and
chapter 1.2.2.2 highlighted variances based on substrates and reaction conditions), which caused
us to question the universal validity of the mechanistic work of Soderquist59 and Woerpel16
(discussed in chapter 1.3). Both studies indicated retention of configuration through the
transmetallation process of primary alkylborons. This was demonstrated using stereospecifically
deuterated alkylboron nucleophiles in coupling reactions, followed by analysis of the coupling
constants of the vicinal protons (Karplus Equation) (Figure 3.1 (a)). Previously, this was held as
fact for boron systems, as the only real exceptions came from systems with mitigating factors
(those with an intramolecular coordinating group).47,48,50 Upon publication of our group’s
inactivated examples in 201456 it became clear that this may not be as concrete a rule as once
thought. This could potentially result from a number of factors including: different boron
moieties used, different reaction conditions, primary systems having higher rate of
transmetallation (compared to secondary systems)19 that may intrinsically prefer the retentive
mechanism. Additionally, as we discussed in chapter 2, a more sterically crowded nucleophile
site may reduce its ability to undergo inversion (18 - Figure 2.4, chapter 2). If we consider the
Newman projection representations of Soderquist’s and Woerpel’s nucleophiles, it becomes
apparent that their results may arise due to the steric influence of the large R group required for
the Karplus relationship to be used as a mechanistic probe, which may hinder the invertive
pathway (Figure 3.1 (b)).
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Figure 3.1: (a) Soderquist: R = t-butyl, R’ = phenyl. Woerpel: R = CH2OTBDPS or
CH2OTBDMS, R’ = 2-iodocyclohex-2-enone. S = small J value, L = large J value. (b) Invertive
transition state blocked by large R group. Retentive transition state permitted with large R group.
As we have seen that the activation energy gap between the retentive or invertive mechanism can
be small, we thought that this possible steric interference from the large R group could have
potentially biased the system towards the retentive mechanism. In order to test this hypothesis,
we decided to produce the same mechanistic probe they used, but utilize our trifluoroborate
conditions and a smaller R group. The smaller R group would hopefully interfere less sterically
with the transmetallation transition states (Figure 3.2 (c)). We could then replace our smaller R
group with a large R group thus allowing us to determine the J value of the vicinal protons (a
large R group is required to determine coupling constants as it reduces the free bond rotation
between the -carbon and -carbon).
Initially, the synthetic plan was to emulate Woerpel’s synthesis of these probes. We would
deuterate the terminal end of a silyl-protected propargyl alcohol (Figure 3.2 (a), step i), then
utilize deuterated-Schwartz reagent to create the alkene with trans deuterium atoms (Figure 3.2
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(a), step ii). We could then install a boronic ester via a syn-selective hydroboration of the olefin
(Figure 3.2 (a), step iii), which could then be deprotected (Figure 3.2 (a), step iv). Re-protection
of the alcohol with a MOM group would provide the smaller R group that we proposed (Figure
3.2 (a), step v). This would then be converted to a potassium trifluoroborate (Figure 3.2 (a), step
vi), this could then be used in our coupling reaction and the product could be de-protected and reprotected with a large R group (Figure 3.2 (a), steps vii to ix), thus enabling us to see the
coupling constants clearly (in order to determine the syn:anti configuration of the product).
The opposite configuration of probe would be synthesized by deuteration with D2 gas in the
presence of Linlard’s catalyst, therefore giving the cis-deuterated alkene (Figure 3.2 (b), step i).
This could then undergo the same syn-hydroboration as before but instead giving the syn-product
(Figure 3.2 (b), step ii). We would then be able to change the alcohol protecting group to a MOM
group (Figure 3.2 (b), step iii). Following the cross-coupling reaction, the product would then be
re-protected with the large silyl group in order to analyze the coupling constants of the vicinal
protons (Figure 3.2 (b), steps iv to viii). In addition to this we would repeat the procedures
(Figure 3.2 (a) and (b)) (excluding steps related to the protecting groups) using the t-butyl R
group as Soderquist and Woerpel did (starting with 3,3-dimethylbut-1-yne). This would give
further evidence of steric bias if this caused our system to proceed via stereoretention, while the
smaller R group probe went via stereoinversion.
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Figure 3.2 (a): Synthetic route to anti-nucleophile. i: n-BuLi quenched with D2O. ii: Cp2ZrDCl
quenched with HCl. iii: syn-hydroboration. iv: deprotect alcohol. v: protection with MOM-Cl. vi:
conversion to trifluoroborate. vii: cross-coupling reaction using our Suzuki conditions.56,65 viii:
deprotect alcohol. ix: protection with TBDPS-Cl. (b) Synthetic route to syn-nucleophile. i: D2
with Lindlar’s catalyst. ii: H2 with Pd/C. iii: deprotect alcohol. iv: protection with MOM-Cl. v:
conversion to trifluoroborate. vi: cross-coupling reaction using our Suzuki conditions.56,65 vii:
deprotect alcohol. vii: protection with TBDPS-Cl. (c): Transition state of invertive
transmetallation, Woerple and Soderquist (RL = large R group) (left), our system (RS = small R
group) (right).
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We encountered multiple issues with route (a) (Figure 3.2 (a)). In particular, the ability to acquire
the deuterated Schwartz reagent used in Woerpel’s protocol (Figure 3.2 (a), step ii) was not
readily available. This commercial unavailability was further hindered by the unavailability of
LiAlD4, which is required to combine with zirconocene dichloride to produce deuterated
Schwartz reagent.68 Eventually, we were able to obtain the LiAlD4 by synthesis from
combination of LiD and AlCl3.69 Synthesis of the alkene with trans-deuteriums was completed
(Figure 3.2, step ii) but further difficulties were encountered when trying to hydroborate this
alkene (Figure 3.2 (a) step iii). Using Miyaura’s iridium catalyzed method70 to introduce a B(pin)
onto the alkene was unsuccessful. Brown’s method71 to attach 9-BBN to the molecule, which
can then be converted to a boronic acid (and then to the desired boronic ester or trifluoroborate)
was also unsuccessful. Miyaura’s hydroboration via a rhodium catalyst72 was also inadequate.
Additionally, Fernandez’s rhodium-catalyzed hydroboration73 did not produce product either.
Due to these difficulties, we rethought our synthetic approach and decided to make use of our
substrate’s increased flexibility versus Woerpel’s/Soderquist’s substrate (as they required
addition of the boron moiety during the final synthetic step due to its highly reactive nature,
where as we were using boronic esters/trifluoroborates which are more stable and tolerate further
modification while affixed to the substrate). The new synthetic protocol would involve attaching
a B(pin) prior to installing the deuterium atoms (Figure 3.3).
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Figure 3.3 (a): Revised synthetic route to anti-nucleophile. i: hydroboration of alkene. ii: D2 with
Pd/C. iii: deprotect alcohol. iv: protection with MOM-Cl. v: conversion to trifluoroborate. vi:
cross-coupling reaction using our Suzuki conditions.65 vii: deprotect alcohol. viii: protection with
TBDPS-Cl. (b) Synthetic route to syn-nucleophile. i: boration of terminal alkyne. ii: H2 with
Lindlar’s catalyst. iii: D2 with Pd/C. iv: deprotect alcohol. v: protection with MOM-Cl. vi:
conversion to trifluoroborate. vii: cross-coupling reaction using our Suzuki conditions.65 vii:
deprotect alcohol. vii: protection with TBDPS-Cl.
This synthetic route worked well for producing the syn-nucleophile (Figure 3.4, 25), but making
the anti-nucleophile was unsuccessful. The issue was (Figure 3.3 (b), step i) that no product was
formed. This was due to the requirement of a low reaction temperature (-78 oC) which was
incompatible with the substrate (often causing it to solidify), we were unable to successfully
produce this compound by dilution of the reaction or by raising the temperature.
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Figure 3.4: Synthesis of syn-nucleophile with small R group. i: HBpin (1.05 equiv), Cp2ZrHCl (5
mol %), DCM, rt, 24 h.74 ii: D2 (100psi), Pd/C (1 equiv), MeCN, rt, 24 h.75 iii: AcCl (0.15
equiv), MeOH, 0oC to rt, 18 h.76 iv: MOM-Cl (2 equiv), i-Pr2NEt (3 equiv), DCE, 80oC, 24 h.77
v: KHF2 (4.5 equiv), MeOH, H2O, rt, 18 h.56
Based upon synthetic route of Figure 3.3, we devised a new route to create the t-butyl variant of
our nucleophile (Figure 3.5). t-Butyl substrate 29, successfully underwent the transformation that
failed for the silyl-protected substrate (Figure 3.3 (b), step ii). This suggesting that the slight
difference in the R group (t-butyl or CH2OTBDPS) altered the ability to smoothly undergo this
transformation.
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Figure 3.5: (a) i: HBpin (1.05 equiv), Cp2ZrHCl (5 mol %), DCM, rt, 24 h.74 ii: D2 (100psi),
Pd/C (1 equiv), MeCN, rt, 24 h.75 iii: KHF2 (4.5 equiv), MeOH, H2O, rt, 18 h.56 (b) i: n-BuLi (1.2
equiv), 2-isopropoxy-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1 equiv), Et2O, -78oC, 6 h,
(quench with HCl.Et2O).78 ii: Cp2ZrHCl (1.2 equiv), THF, rt, 0.5 h, (quench with H2O).79 iii: D2
(100psi), Pd/C (1 equiv), MeCN, rt, 24 h.75 iv: KHF2 (4.5 equiv), MeOH, H2O, rt, 18 h.56
The next step was to synthesize the fourth and final nucleophile. The main target was primarily
the cis-alkene (cis-variant of 21) as we were confident we could then use the standard
deuteration (with D2 gas and Pd/C catalyst) to produce anti-variant of 22. We conceived
numerous plans to synthesize this (and also the terminal alkyne precursor) – including: Chirik’s
cobalt catalyzed Z-selective hydroboration of alkenes80 (our lab is not equipped with the
appropriate air-free/cooling apparatus to successfully generate the cobalt catalyst used),
Miyaura’s Z-selective hydroboration with rhodium72 (didn’t convert starting material to any
significant degree and created a multitude of side products), Hoveyda’s Z-selective crossmetathesis81 (no product produced), Hu’s silver catalyzed borylation of terminal alkynes82 (no
product produced), and the creation of a trans-alkene (containing trans-bromide instead of
B(pin)) to attempt to undergo an invertive Miyaura borylation83 after deuterating alkene (vinyl
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halides are not stable under hydrogenation conditions). It was at this point we decided we would
proceed with only the three nucleophiles we had synthesized.
Once having converted these pinacolboron nucleophiles to the potassium trifluoroborates, we
then used them in Suzuki coupling reactions. We opted to use two bulky ligands, one (electrondeficient, that we had discovered in chapter 2 (14)) that should favor the retentive pathway, and
the other (electron-rich PtBu3) that should favor the invertive pathway. PAd3 was also tested in
one case but showed no difference in results vs. PtBu3, hence this study was continued using the
more accessible PtBu3 ligand system (Figure 3.6).

Figure 3.6: 1H NMR spectra comparing a reaction using PtBu3 and PAd3. Spectra are aligned on
top of one another to confirm negligible difference in results.
We deemed it useful to attempt to estimate how pure our nucleophiles were in terms of syn vs.
anti (as the fictionalization with D2 gas and Pd/C does not always proceed with 100% syn59

selectively). Using the vicinal coupling constants (as in Soderquist’s and Woerpel’s work)16,59
and the de-convolution software (via TopSpin program) we were able to confirm our
nucleophiles were purely one confirmer and this is explained in the following section.
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Defining Syn:Anti Ratios by NMR and TopSpin’s Deconvolution Software
The doublets of the vicinal protons in many of our compounds are not fully separated, therefore
calculating syn:anti ratios can be complex and is explained below. Additional peak impurities are
present in small amounts while can further complicate the data (this may be partly from
hydrogen contamination in the D2 gas). Note: all spectra that are laid on top of each other for
comparison are calibrated to the solvent peak (CDCl3 at 7.26 ppm), unless otherwise noted.
Nucleophiles with t-butyl Group:

Figure 3.7: Compound (27) Zoomed in 1.27 ppm region (1H NMR with Deuterium Decoupling –
800MHz NMR).
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Figure 3.7 shows the doublet (J = 5.0 Hz) (related to the -proton) has a contaminant lying on
top of the left doublet peak. This is confirmed by the integrations, which highlight the peak’s
inflated area value. Due to this we will also look at the -proton to discuss the syn:anti ratio.
However, a glancing evaluation of this peak seems to show no anti-configured doublet (which
would have J = 12.4 Hz).

Figure 3.8: Compound (27) Zoomed in 0.68ppm region (1H NMR with Deuterium Decoupling –
800MHz NMR).
Figure 3.8 shows the syn-configured compound (27), zoomed into the region of the -proton. It
is clear here that there are some side products or complexity, perhaps some of this could indicate
presence of the anti-configured nucleophile (31). In order to determine this we will now
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introduce the anti-configure compound (31) and use overlapping spectra’s to identify possible
peaks.

Figure 3.9: Red = Compound (27), Blue = Compound (31). Zoomed into 1.25 ppm (-proton)
(1H NMR with Deuterium Decoupling - 800MHz NMR).
Figure 3.9 shows that compound (31) does not suffer from the same quantity of impurity on top
of the -proton doublet (1.26ppm, J = 12.3 Hz). These spectra highlight that the anti-nucleophile
(31) may have only a small amount of the same impurity that is in the syn-nucleophile (27).
Additionally, it can be seen that it seems that there is almost zero cross-contamination between
the spectra, therefore suggesting they are either purely syn or anti.
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Figure 3.10: Red = Compound (27), Blue = Compound (31). Zoomed into 0.68 ppm (-proton)
(1H NMR with Deuterium Decoupling - 800MHz NMR).
Figure 3.10 (doublet of -proton) shows that it is possible that there is some correlation of peaks
between the syn and anti-nucleophiles (right most peak). It is unlikely that this is the anticompound red spectrum, as only the right side of the anti-doublet (31) correlates to the
compound (27) spectrum. The left side has no corresponding peak, therefore we can conclude
that the evidence shows that these nucleophiles are purely syn or purely anti.
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Nucleophiles with TBDPS-Protected Alcohol Group

Figure 3.11: -proton of compound (22), red = 1H NMR with deuterium decoupling, blue = 1H
NMR with deuterium decoupling and homodecoupling of CH2 at 3.61ppm.
The blue spectrum is the highlighted -proton peak with only deuterium decoupling (this is a
doublet of triplets, but due to overlap appears as a quartet). The red spectrum is deuterium
decoupled and homonuclear decoupled (in regards to the neighboring CH2). This now shows a
doublet with J = 6.1 Hz. Some downfield impurities still remain and there is some shouldering
on the doublet peaks. As homodecoupling can cause some artifacts with peaks (usually based
upon power used) and can potentially have only partial decoupling effects (also dependant on
power), it is unclear if these shoulders are real. If they are real they could potentially be the antinucleophile. If these shoulders on the exterior sides of the doublet were in fact the anti-doublet,
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their coupling constant would be over 10 Hz, which as we will see in the analysis on the
following pages (of the -proton) is probably too large. It is however possible that one of these
shoulders is related to the anti-nucleophile (with the other half of the doublet completely hidden
under the main syn-doublet’s peaks. We will use TopSpin’s deconvolution software to analyze
the possible area of these peaks.

Figure 3.12: Fitted peaks of Spectrum 5 (22, red, dual decoupled) from deconvolution software.
The fitted peaks above have the relative area values of: 0.347, 3.398, 3.640, 0.463 (left to right)
If the left shoulder was part of the anti-nucleophile then we could compare it to the left peak of
the syn doublet:
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Syn:Anti = 3.398:0.347 = 91:9
If the right shoulder was the anti, then we could compare it to the right peak of the syn doublet:
Syn:Anti = 3.640:0.463 = 89:11
Although these peaks are roughly producing the same syn:anti ratio, these two shoulders cannot
be related to each other due to their coupling constant being in excess of 10 Hz (as described in
the following page). From looking solely at the analysis on this page it appears possible that one
of them could be the anti-nucleophile peak (related to one half of its doublet), therefore it would
be approximately 10% anti. It is unclear if this is the case. These shoulders may be unrelated to
the anti, one reason being that we do not see any further disturbance of the syn doublet other than
these two shoulder (as the expected coupling constant would have a peak that falls directly under
(or between) the syn-doublet – this does not seem to be the case in the above spectrum). Further
evidence by comparing to the -proton’s peak will now be shown.
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Figure 3.13: -proton of compound (22), red = 1H NMR with deuterium decoupling and
homodecoupling of CH2 at 3.61ppm, blue = standard 1H NMR.

Figure 3.13 is the analysis of the -proton. As we do not have the anti-compound to compare the
spectrum with, we will try to estimate what the coupling constants of the anti-compound would
likely be and then decipher if any component is represented in Figure 3.13.
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No.

Compound
Reference

1

(27) and (31)

2

Soderquist59

3

4

5

6

Compound

Syn – J value
(Hz)
5.0

Anti – J
value (Hz)
12.3

4.8

12.3

6.1

unknown

4.7

12.9

6.3

9.7

5.8
(TBDMS)

9.1

(22)

(35),(36),(40),(41)

(33D) and (34C)

Woerpel

16

Table 1: List of vicinal proton J values of relevant compounds.
Table 1, (no.1) - the anti-configuration’s J value (12.3 Hz) is smaller than that of the related anticonfigured ethyl benzoate product ((no.4) - 12.9 Hz). It is reasonable then to expect a smaller J
value for OTBDPS anti-nucleophile ((no.3) - unknown J value) compared to its related ester
product ((no.5) - 9.7 Hz). Therefore, the unknown J value of (no.3) will likely be less than 9.7
Hz. It is less clear how to set a lower expected limit but we can say it must be at least greater
than the syn-nucleophile’s J value ((no.3) - 6.1 Hz). Therefore, for the following investigation
we will consider the J-value limit of the unknown to be between 6.1Hz and 9.7Hz. In the
following we will discuss if any peaks adjacent to our syn-compound’s (22) -proton doublet
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could be part of a doublet related to the corresponding anti-compound’s -proton doublet (as in
all examples referenced these doublets overlap).

Figure 3.14: Copy of Figure 3.13 with addition of peak labeling, and range lines inserted (in
relation to A).
Figure 3.14 investigates if peak A is the right half of the anti-nucleophile doublet in question.
Our range (6.1 Hz – 9.7 Hz) would mean that the other part of this peak would fall between the
marked range lines. There appears to be no disturbance (shoulders, extra peak etc.) in that area.
Therefore, it does not seem like this peak will be related to the anti-nucleophile’s doublet
mentioned, as another peak (the size/area of peak A) would disturb the marked area much more
significantly than what is seen here.
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Figure 3.15: Copy of Figure 3.14 with range lines modified in relation to B.
Figure 3.15 will assist checking if peak B is related to the potential anti-compound. As before,
due to our defined coupling constant range, we would expect the other half of B’s doublet to be a
peak inside the marked range lines. (Note: the peak is not expected to be in the downfield
direction - as every other example, in this paper, of these type of vicinal protons always have
some overlap of the (anti/syn) doublets and are never completely separated). As this peak is very
small it is hard to tell if there is a peak somewhere in the selected region. Therefore, let us
assume that there is such a peak under that region.
We can use deconvolution (on TopSpin 4.0.6) to compare the area of peak B vs. peak 1 (area of
the left half of proposed anti-doublet vs. area of left half of actual syn-doublet) (therefore should
be roughly the ratio of syn:anti, if B is indeed the anti-nucleophile’s peak).
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Figure 3.16: Peak fitted deconvolution of Figure 3.15.
Relative area of B (left peak of possible anti-doublet) = 0.055
Relative area of peak 1 (left peak of syn-doublet) = 1.747
Therefore, percentage of anti = 0.055/(0.055+1.747) = 0.0305, multiply by 100 = 3.05 %
Therefore, potential ratio of syn:anti is 97:3.
Peak
1
2
A
B
C
D
E

Relative Area of Peak
1.747
1.690
0.787
0.055
0.355
0.862
0.823

Table 2: Full Deconvolution Results of Spectrum in Figure 3.16.
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Figure 3.17: Copy of Figure 3.14 with range lines modified in relation to C.
If the anti-nucleophile doublet contained peak C, then the other half of it’s doublet would be
within the range lines in spectrum 11 (based on our defined range), therefore directly under peak
1.
Relative area peak 1 = 1.747, Relative area peak 2 = 1.690, Relative area peak C = 0.355
Peak 1 – peak 2 = 0.057
The remaining difference of areas between peaks 1 and 2 is 0.057, which would mean (if the
other half of a doublet is under peak 1) then it is a very uneven doublet with approximately 86%
of the area on the left side of the doublet (peak C). ((0.355/(0.355+0.057))x100=86%)
There doesn’t seem to be any shouldering of peak 1 either.
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Due to the lack of visible evidence plus the low probability of such an uneven doublet we can
rule out peak C as being related to the anti-nucleophile.
The downfield doublet (D and E) are far away and are not affected by the deuterium decoupling therefore they are not related to the anti-nucleophile.
In conclusion, from looking at the -proton it may seem that there could be 10% anti (from the
shoulders in Figure 3.11. However, these shoulders are likely not related to each other (J would
be too large), and they seem to cause zero disturbance in the middle of the syn-doublet (this
would be expected as the other half of the doublet should appear somewhere there) – so it seems
unclear that these are definitely related to the anti-nucleophile. Another piece of evidence to
consider is the lack of correlation with the -proton region in the NMR spectrum. This seems to
show a maximum possible value for the anti-nucleophile at 3%. Deuteration (with D2 gas
(100psi) and Pd/C) seemed to go with full syn-selectivity for the equivalent t-butyl nucleophiles
– so that may infer that the OTBDPS nucleophile is also exclusively syn. Some of the peaks
surrounding the -proton are probably impurities, and the shoulders on the dual decoupled
spectra (of the -proton) could either be effects caused from the homonuclear decoupling or are
also impurities.
It seems from this analysis that we have somewhere between 0-10% of anti-compound impurity
in our nucleophile, we then proceeded with the cross-coupling reactions displayed below in
Figure 3.18.
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Figure 3.18: Cross-coupling reaction results. Note: all t-butyl based compounds showed no
appreciable quantity of the opposite enantiomer. *Coupling constant was determined by
equivalent B(pin) molecule protected with TBDPS. **Coupling constants and syn:anti ratios
were determined with the equivalent TBDPS protected molecule. ***Coupling constant was
determined by equivalent B(pin) molecule
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It can be seen clearly that systems using the t-butyl probe (28 and 32) only react via a
stereoretentive pathway, regardless of electrophile or conditions used. However, the nucleophilic
probe containing the smaller R-group (25) did show some erosion of the -stereocenter. For
conditions A (invertive conditions) we see a 92:8 (syn:anti) ratio and for conditions B (retentive
conditions) we see a 88:12 (syn:anti) ratio. Assignments of syn:anti ratios were assisted by our
synthesis of the syn and anti products by alternate methods, in combination with TopSpins
deconvolution software. Both of which will be described in the following pages.
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Products with t-butyl Group
Products from Coupling with Ethyl 4-chlorobenzoate

Figure 3.19: Zoomed-in on 2.6 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Green = (41), Purple = (42), Red = (35), Blue = (36).
In Figure 3.19, it can be seen clearly that the green and purple spectra (anti-configured products,
J = 12.9 Hz) appear to contain no syn-configured moieties (J = 4.7 Hz).
The red spectrum also seems to show zero contaminates from an anti-configured product,
although there is a slight shouldering on the right side, it seems unrelated as it is in alignment
with the location of the anti-configured peak. Additionally, there is no obvious peak or distortion
on the left side of this doublet (where the left side of the anti-peak doublet would be).
The blue spectrum shows a small peak on the left side and a small peak on the right side of the
main doublet. The J value between these two peaks is only 11.5 Hz, far smaller than the required
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12.9 Hz and the alignment of the right peak is not at the same chemical shift of the related antiproduct.
From this analysis of Figure 3.19 (-proton), I conclude that this shows no appreciable quantity
of contamination in either the syn- or anti-products.

Figure 3.20: Zoomed-in on 1.46 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Green = (41), Purple = (42), Red = (35), Blue = (36).
To confirm my conclusions from Figure 3.19, we can look at Figure 3.20. This is the other
coupled proton (-proton). All peaks in this region seem to clearly show that there is no
significant amount of the opposite configuration product.
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Products from Coupling with 4-Chlorobiphenyl

Figure 3.21: Zoomed-in on 2.6 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Green = (44), Blue = (43), Red = (37), Purple = (38).
In Figure 3.21 it can be seen clearly that the green and blue spectra (anti-configured products, J
= 12.9 Hz) appear to contain no syn-configured moieties (J = 4.7 Hz). The red and purple spectra
also seems to show zero (or very close to zero) contaminates from an anti-configured product.
From this analysis of Figure 3.21 (-proton), I conclude that there is no appreciable quantity of
contamination in either the syn or anti products.
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Figure 3.22: Zoomed-in on 1.51 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Green = (44), Blue = (43), Red = (37), Purple = (38).
To confirm my conclusions from Figure 3.21, we can look at Figure 3.22. This is the other
coupled proton (-proton). All peaks in this region seem to clearly show that there is no
significant amount of the opposite configuration product.
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Products from Coupling with 4-Chloroanisole

Figure 3.23: Zoomed-in on 2.5 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Green = (46), Blue = (45), Purple = (40), Red = (39).
In Figure 3.23, it can be seen clearly that the green and blue spectra (anti-configured products, J
= 12.9 Hz) appear to contain no syn-configured moieties (J = 4.7 Hz).
The red and purple spectra also seems to show zero contaminates from an anti-configured
product, although there is a slight shouldering on the right side of both peaks. It is hard to tell if
this is really a relation to the anti-configured proton. If this indeed was the shoulder of the antipeak, hidden underneath, then its other half of the doublet would likely be the first peak
downfield of the main doublet. This however would lead to a coupling constant in excess of 13
Hz and is therefore unlikely. This leaves no visible peak that would be the corresponding left
half of this supposed doublet and therefore the shoulder can be eliminated as being part of an
anti-configuration product.
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From this analysis of Figure 2.23, I conclude that there is no appreciable quantity of
contamination in the anti-products.
There is some concern in how clean the NMR of the syn-products are and although the coupling
constant mentioned seems likely that it is not the anti product we can look at the analysis of the
following spectrum (Figure 3.24) to confirm our belief that this is purely the uncontaminated
syn-product.

Figure 3.24: Zoomed-in on 1.42ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Green = (46), Blue = (45), Purple = (40), Red = (39).
To confirm my conclusions from Figure 3.23, we can look at Figure 3.24. This is the other
coupled proton (-proton). All peaks in this region seem to clearly show that there is no
significant amount of the opposite configuration product. This aligns with our previous analysis
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and gives further confirmation that there is no anti-product hidden within the syn-peaks for the
red and purple spectra.
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Products with OTBDPS Group

Figure 3.25: Zoomed-in on 2.75 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Blue = (34C), Red = (33D), Green = (34), Purple = (33). Synthesis of products
33D and 34C are shown on pages 90 and 91.
The blue and red spectra are molecules synthesized from the alternate synthetic route (in order to
use as a comparison for this analysis). The blue spectrum shows the syn-molecule (J = 6.3 Hz).
The red spectrum shows the anti-molecule with a (J = 9.7 Hz), this is an uneven doublet and
potentially has an unknown impurity underneath the right half. This is supported by the fact that
in Figure 3.28 we see the coupling constant to be 9.5 Hz.
The green and purple spectra are the cross-coupling products (green = retentive conditions,
purple = invertive conditions). The coupling constant is 6.3 Hz (syn), highlighting that the both
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went via a stereoretentive pathway. However, it is unclear if this was highly selective as there are
some shouldering peaks on the edges of the main doublet (marked 1 and 4) for both spectra.
To confirm how a mix of the syn and anti products would appear on NMR, compounds (34C)
and (33D) were mixed, this is shown in Figure 3.26:

Figure 3.26: Zoomed-in on 2.75 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Purple = syn only (34C), Blue = Syn with small amount of anti, Red = syn with
more anti, Green = syn with even more anti, Yellow = pure anti (33D).
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As we can see in Figure 3.26, it appears a shoulder does indeed grow on the left side of the syn
doublet as more anti-product is introduced. However, this is still not entirely clear and we will
now look at the-proton for clarity in our analysis.

Figure 3.27: Zoomed-in on 1.84 ppm region (-proton, 1H NMR with deuterium decoupling,
800MHz NMR), Blue = (34C), Red = (33D), Green = (34), Purple = (33).
We can see in Figure 3.27, the peak is not a simple doublet due to coupling with the nearby CH2.
Therefore, we did a deuterium-decoupled experiment while simultaneously homonuclear
decoupling said CH2 (Figure 3.28).
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Figure 3.28: Zoomed-in on 1.84 ppm region (-proton, 1H NMR with deuterium decoupling and
CH2 homonuclear decoupling, 800MHz NMR), Blue = (34C), Red = (33D), Green = (34), Purple
= (33).
Figure 3.28 is the results of this dual-decoupling NMR experiment. The blue spectrum (synproduct from non-cross coupling synthetic pathway) has J = 6.3 Hz (as expected from previous
spectra) but the red spectrum has a J = 9.4 Hz (slightly smaller than Figure 3.25, this is likely due
to impurity on previous spectrum as mentioned).
The spectra above are now slightly less complex but we can see there are some peaks of interest
which might be related to an anti-configured compound. Peaks 1 and 4 may be the anti-product
doublet, but the J = 12.3 Hz which is too large, therefore 1 and 4 are not related to each other. If
either of these peaks (1 or 4) are part of the anti-product then they must have the other half of
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their doublet hidden under peaks 2 and 3. We will again look at the spectra from mixing the pure
syn (34C) and pure anti (33D) compounds together (at this ppm).

Figure 3.29: Zoomed-in on 1.84 ppm region (-proton, 1H NMR with deuterium decoupling and
CH2 homonuclear decoupling, 800MHz NMR), Purple = syn only (34C), Blue = Syn with small
amount of anti, Red = syn with more anti, Green = syn with even more anti, Yellow = pure anti
(33D). Peaks have been aligned with each other for easier analysis.
Figure 3.29 shows that there is growth of a peak on the right side of the doublet as we add more
of the anti compound (33D). This correlates well with peak 4 in Figure 3.28 and as shown more
clearly in Figure 3.30.
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Figure 3.30: Zoomed-in on 1.84 ppm region (-proton, 1H NMR with deuterium decoupling and
CH2 homonuclear decoupling, 800MHz NMR), Green = mix of (33D) and (34C), blue = (33)
(invertive conditions), red = (34) (retentive conditions).
So now we know that there is in fact some anti-compound in our sample (peak 4, Figure 3.28),
we can now use TopSpin’s deconvolution software to analyze the relative peak areas (Figure
3.31).
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Figure 3.31: Zoomed-in on 1.84ppm region (-proton, deuterium decoupled, 800MHz NMR),
deconvolution - fitted peaks of Spectrum 21 (purple – invertive conditions product)
Relative peak areas (left to right) = 1.424, 3.798, 4.689, 0.348 (left to right)
Total area for syn-peaks = 3.798 + 4.689 = 8.487
(divide by 2 as we are comparing half vs. half) = 8.487/2 = 4.2435
Peak 4 is anti then syn:anti (purple – invertive conditions, 33) = 4.2435:0.348 = 92:8
We can now undergo the same deconvolution treatment for the green spectrum (Figure 3.28)
Relative peak areas (left to right) = 0.777, 3.367, 3.594, 0.484
Total area for syn-peaks = 3.367 + 3.594 = 6.961
(divide by 2 as we are comparing half vs. half) = 6.961/2 = 3.4805
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Peak 4 is anti then syn:anti (green – retentive conditions, 34) = 3.4805:0.484 = 88:12
From our analysis we can now see that both reactions with compound 25 gave approximately
10% invertive product (within error). This therefore seems as though we do not have any sort of
ligand effect as we had predicted based upon our secondary alkylboron research, as changing the
ligand used did not affect the ratio of inversion:retention product.
In order to have silyl based products for reference in the spectra, they were synthesized using an
alternate method to set the syn/anti configurations.

Figure 3.32: Synthesis of silyl-protected anti-product (33D).
The synthesis of 33A was a straightforward Sonogashira type reaction coupling propyl alcohol
with ethyl 4-iodobenzoate.84 This was then protected with TBDPS to produce 33B. The synthesis
of 33C via reaction with Schwartz reagent was based on the reaction to produce compound 30.79
The yield of this reaction was low and contained a significant amount of starting material, this
was not an issue as deuteration with D2 gas facilitated production of 33D. Any starting material
was deuterated twice and therefore was inconsequential to the 1H NMR results.
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Figure 3.32: Synthesis of silyl-protected syn-product (34C).
(E)-ethyl 4-(3-oxoprop-1-en-1-yl)benzoate was reduced to alcohol 34A by reaction with NaBH4.
This was then protected with TBDPS to produce 34B. Deuteration with D2 gas with Pd/C
enabled synthesis of 34C.
The syn:anti ratio results from our cross-coupling reactions (Figure 3.18) show that all our
reactions go via a stereoretentive pathway. In our analysis of the spectra related to nucleophile
25, we determined that it contained between 0% and 10% of the anti-compound. From our
results giving no difference in syn:anti ratio based upon ligand selection, and that our products
(33 and 34) both contained 10% of the anti-compound, it seems highly likely that our starting
nucleophile (25) contained 10% of the anti-compound and that the reaction proceeded with
complete stereoretention. The resulting syn:anti rations (of 33 and 34) make far less sense if we
begin to indicate that not only do we have absolutely no ligand effect (electronically and
sterically), but also the resulting syn:anti ration (being the same for both reactions) is purely
coincidental. It seems likely that the activation energy gap (between the invertive and retentive
pathways) for primary systems is less similar to the secondary systems than anticipated.

92

Although there is a small difference in syn:anti ratios between conditions A and B for products
(33 and 34), this is likely due to the deconvolution software’s analysis. It can be concluded that
they both approximately contain 10% anti-configured compound. Therefore, it seems that the
ligand system used has no effect on the transmetallation pathway of these primary nucleophiles.
These interesting results led us to brefily consider the use of secondary benzylic nucleophiles
(using our conditions) to see the possibility of an enantioselective coupling. We made an
enantioenriched

(1-phenylethyl)potassium

trifluoroborate

nucleophile.

This

was

most

successfully created via Aggarwal’s chemistry followed by conversion from the boronic ester to
the trifluoroborate (although Crudden’s synthesis and Lee’s synthesis were attempted, they had
more complications, leading to lower yields).88 Overall, we initially screened this optically active
nucleophile (with our 2014 invertive conditions) but unfortunetly this gave an e.e. of only 2% in
the product (from 98% e.e. in the starting material and coupling with 4-chloronitrobenzene), and
therefore this part of the project was halted.
In conclusion, there seems to be no ligand effect in controlling the mechanism of
transmetallation. Additionally, it does not seem as though having a large R group on the
nucleophilic probes resulted in incorrect data and results. However, it is still unclear if this large
R group could potentially bias the reaction if the two pathways were closer in energy. In our
system the retentive mechanistic pathway seems to be far more accessible than the invertive
pathway for primary systems so that any steric influence was inconsequential.
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4. Investigation into the Relative Rates of Transmetallation to Palladium(II)
Complexes in Cross-Coupling Reactions when Varying the Halide of the
Electrophile

As we have discussed in chapter 1, the transmetallation of nucleophiles onto the catalytic
palladium species follows the oxidative addition step. Oxidative addition generates a LPd(Ar)X
species (X = Cl, Br, I). There has been no direct investigation into what effect the affixed halide
species has in regards to transmetallation. This information could be potentially useful when
considering reactions that require a rapid transmetallation step (such as described in chapter 2,
rapid transmetallation helps reduce -hydride elimination and isomerization).
We proposed using a series of direct competition reactions (Figure 4.1) which should reveal
relative rates of transmetallation.

Figure 4.1: Competition reaction between two oxidative addition palladium(II) complexes. R =
alkyl or aryl group, M = B, Sn, Zn or Mg, L = appropriate ligand.
This reaction setup should enable us to discover the relative rates of reaction based solely on the
effect of the halide. The nucleophile (R-M) would be the limiting reagent as to prevent full
conversion of either oxidative addition species. The aryl groups are only slightly different and
should have a minimal effect of the transmetallation rate. However, due to their differences, we
should still be able to find the ratio the products synthesized, therefore producing data correlated
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to the relative rates of transmetallation. To ensure our results reflected the effect of the halide, we
must be sure that there is no halide exchange between the oxidative addition species. We
hypothesized that this may occur by a bridged dimer (Figure 4.2 (a)).

Figure 4.2: (a) Halide transfer through bridging dimer complexes. (b) BrettPhos ligand.

Therefore, it is important that we inhibit the transfer of halides. The BrettPhos ligand (Figure 4.2
(b)) has been shown to be unable to form dimers due to its large steric bulk and hemi-labile
methoxy group.85 We would use this ligand to inhibit the transfer of halides between the
oxidative addition complexes. We could then mix the oxidative addition complexes together and
use phosphine NMR (to identify different complexes the ligand is affixed to) to confirm that
there is no halide transfer.
Another consideration to be made is that we must use a nucleophile that undergoes direct
transmetallation to the halide-palladium species. This would then rule out use of boron
nucleophiles as the effects of base have proven to be complex and may generate active hydroxylpalladium complexes (see chapter 1.2.3). We decided that a good alternative would be to use a
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lithium amide, as these have been previously shown to undergo direct transmetallation to
oxidative addition complexes of Buchwald ligand-palladium species (shown in Figure 4.3).86

Figure 4.3: (a) Transmetallation in regular Buchwald-Hartwig amination (requires deprotonation
by base). (b) Transmetallation with lithium amide (requires no deprotonation by base).
This is also a good reaction proposal as BrettPhos particularly was shown to be a good ligand to
facilitate C-N bond formation in cross-coupling reactions.85 Figure 4.4 shows the oxidative
addition BrettPhos complexes that we synthesized. (TMEDA)PdMe2 was created by a known
literature procedure.86

Figure 4.4: Synthesis of oxidative addition complexes with BrettPhos.
Unfortunately, when analyzing (by 31P-NMR) test mixtures of the oxidative addition complexes,
we observed that the halides readily exchanged at room temperature in solution (Figure 4.5). We
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then tested this further in a variety of solvents but were unable to find any that prohibited this
halide exchange.

Figure 4.5: 31P-NMR of BrettPhos based oxidative addition compounds (red and blue) and when
mixed produced halide exchanged products (green). Green spectra should be only the combined
peaks of red and blue (extra peaks shown indicate other phosphine compounds have formed, i.e.
halides are exchanging).
In order to continue this investigation we began searching for any ligands that would facilitate
the cross-coupling reaction but also potentially prevent the halide exchange seen with the
BrettPhos ligand-complex. We thought perhaps the bidentate ligand DPPF may be in line with
our needs, however this too underwent halide exchange.
In conclusion, it would be useful to have direct evidence of the effect of halides on the rate of
transmetallation but this seems unlikely to be discovered by using competition reactions as
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discussed. It appears that halide transfer occurs readily in solution, suggesting that it may not
need to exchange via a halide-bridging dimer as previously suggested.
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5. Conclusion

This work has expanded the scope of substrates possible in palladium-catalyzed Suzuki reactions
with inactivated secondary boron species and has enabled high enantioselectivity and yields.
Particularly, the ability to start from either enantiomer of nucleophile and with ligand selection,
be able to stereoselectively couple this to give the desired R or S product should be extremely
useful.
Subsequently, our investigation into the transmetallation mechanism of primary alkylboron
systems highlighted the unexpected lack of translation from our work in secondary systems to
that of primary systems (in terms ligand control of mechanistic pathway (stereoretention vs.
stereoinversion)). We also highlighted that our concerns of a steric bias of mechanistic pathways
of transmetallation (when using a large R group) seem to be unfounded. It is however somewhat
unclear that if a primary system exists with the stereoretentive and stereoinvertive pathways
being closer in activation energy, would a steric influence then be possible?
Unfortunately, our investigation seeking direct evidence of the effect of specific halides (in
halide-palladium complexes) on the rate of transmetallation was unsuccessful. We did learn that
halide exchange happens readily when these type of oxidative addition complexes are dissolved
in solvent. Therefore, it is also likely that a bridging dimer complex is unnecessary to facilitate
this exchange.
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7. Supporting Information for Chapter 2
(adapted from Science paper65)

General Information
Commercially available reagents were purchased from Sigma-Aldrich, Alfa-Aesar, and Ark
Pharm, and used as received unless otherwise noted. Anhydrous THF (inhibitor-free), diethyl
ether, dichloromethane, and toluene were purified by passing through two packed columns of
neutral alumina. Water used in Suzuki reactions was distilled and degassed prior to use.
Anhydrous benzene was purchased from Sigma-Aldrich, and degassed by sparging with
nitrogen. Flash chromatography was performed using Silicylcle silica gel (ultra pure grade).
Solvents used for chromatography (ACS grade) were purchased from Fisher, and used as
received.
General Analytical Information
All compounds were characterized by 1H NMR and
and

13

C NMR spectroscopy. Copies of the 1H

13

C spectra for all new compounds can be found at the end of the Supporting Information.

All previously unreported compounds were additionally characterized by high resolution MS.
NMR spectra were recorded on a Bruker 300 MHz or 500 MHz instrument. All 1H NMR
experiments are reported in δ units, parts per million (ppm), and were measured relative to the
signals for residual chloroform (7.26 ppm), DMSO (2.50 ppm), methylene chloride (5.32 ppm)
or acetone (2.05 ppm). All

13

C NMR spectra are reported in ppm relative to deuterochloroform

(77.23 ppm) or DMSO (39.52 ppm), and were obtained with 1H decoupling. High-resolution MS
analyses were performed on an Agilent 6520 Q-TOF instrument. All GC analyses were
performed on a Shimadzu GC- 2010 gas chromatograph with an FID detector using a 25 m x
0.20 mm capillary column with cross-linked methyl siloxane as the stationary phase. All GC
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yields were calibrated using dodecane or m-xylene as an internal standard. Chiral GC analyses
were performed using a 30 m x 0.32 mm chiral column (Rt®-βDEXsm from Restek). Chiral
HPLC analyses were performed on a Shimadzu LC-20AB prominence liquid chromatograph.
Polarimetry measurements were performed using an Anton Paar-MCP 100 modular circular
polarimeter. Absolute configurations for enantioenriched alkylboron compounds were assigned
according to the known stereoselection preferences of (+) or (-) sparteine mediated lithiations.87–
89

Absolution configurations for cross-coupling products were benchmarked against

enantioenriched compounds previously reported by our group or others using reported optical
rotation values and/or by comparison to previously reported HPLC data.
Procedural Information
General procedure for Suzuki cross-coupling reactions with different ligands:

COOEt

BF3K
+

COOEt

Me
0.5 M toluene(with H2O v/v = 2:1)
100 ºC for 24h

Cl
1.0 equiv

10 mol% G3-Pd-L
or 5 mol% G3-Pd dimer + 10 mol% L
3.0 equiv K2CO3

*

Me

1.5 equiv

On the benchtop, either a) 3rd generation Buchwald’s palladium catalyst precursor dimer (1.84
mg, 1.25 μmol, 5 mol %) and selected phosphine ligand (2.5 μmol, 10 mol %), or b) monoligated 3rd generation palladium catalyst precursor (2.5 μmol, 10 mol %) was added to an 8 mL
screw-top glass cultural tube equipped with a stirbar. K2CO3 (20.7 mg, 0.15 mmol, 3 equiv) and
potassium (R)-sec-butyltrifluoroborate (12.3 mg, 0.075 mmol, 1.5 equiv) or potassium (R)-(4phenylbutan-2-yl) trifluoroborate (18 mg, 0.075 mmol, 1.5 equiv) were added to the test tube,
which was sealed with a screw-top septum and electrical tape. Using a needle attached to a
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vacuum manifold, the reaction mixture was evacuated (ca. 100 mtorr) and backfilled with argon
for 3 times. Toluene (0.1 mL) and degassed water (0.05 mL) were then added via syringe. Ethyl
4-chlorobenzoate (7.75 μL, 0.05 mmol) was added to the vessel via syringe. The septum was
then covered with electrical tape, and the vessel was heated to 100 ºC for 24 h. Saturated aqueous
NH4Cl solution (2 mL) was added to quench the reaction, and the mixture was extracted by ethyl
acetate (3 mL x 3). Solvent of the combined extracts was evaporated under reduced pressure, and
the remaining residue was analyzed by GC and/or HPLC. In these reactions, we explored the use
of ligands spanning a wide range of steric and electronic properties (see below). While most of
the phosphine ligands examined could support the formation of cross-coupling product, no
cross-coupling product was observed using phosphite ligands.

Preparation of racemic 4-phenylbut-2-yl pinacolboronate with Wang’s protocol:90

N

Ts
NH
Me

1.0 equiv

1.1 equiv. NaOMe
10 mol% BTMAC
0.125 M Toluene
rt for 1h
3.0 equiv HBPin
110 ºC for 24 h

BPin
Me

On the benchtop, 4-methyl-N'-(4-phenylbutan-2-ylidene)benzene-sulfonohydrazide (6.32 g, 20
mmol) was added into a 500 mL oven-dried round bottom schlenk flask, which was equipped
with stirbar. The flask was taken into glovebox, where sodium methoxide (1.19 g, 22 mmol) and
benzyltrimethylammonium chloride (370 mg, 2 mmol) were added. Outside of the glovebox, the
flask was connected to schlenk line, evacuated (ca. 200 mtorr) and backfilled with argon 3 times.
Anhydrous toluene (160 mL) was injected into the flask via syringe. After 1 hour stirring under
ambient temperature, HBpin (8.7 mL, 60 mmol, 3.0 equiv) was injected into the flask dropwise
and stirred for an additional 15 min. The mixture was then heated to 110 ºC and refluxed for 24
108

h. After the completion of the reaction (confirmed by GC), saturated aqueous NH4Cl solution
(100 mL) was added to quench the reaction. The mixture was extracted with hexane (150 mL x
3), and the combined organic phases were washed with brine (100 mL) and dried over anhydrous
Na2SO4. The solvent was removed under reduced pressure, and a colorless oil (3.08 g, 59%
yield) was isolated following column chromatography (5/95 hexane:ether).

Preparation of potassium secondary alkyltrifluoroborates:
BPin
R

Me

4.5 equiv KHF2 (4.5 M, H2O)
0.5 M MeOH or MeCN
rt, 2-4 h

BF3K
R

Me

The pinacolboronate (10 mmol) was added to a 100 mL round bottom flask equipped with a
stirbar, and MeOH or MeCN (50 mL) was added via a syringe. Pre-prepared KHF2 aqueous
solution (10.0 mL, 4.5 M, 45 mmol) was added to the mixture via pipette. The mixture was
allowed to stirred at room temperature for 2 h, after which time no more boronate was detectable
by GC. The solvent was removed under reduced pressure. The solid residue was extracted with
acetone (20 mL x 3). The combined extracts were filtered through a cotton plug into another
round bottom flask. Acetone was removed under reduced pressure. The remaining residue was
dissolved in ether (0.5-1 mL) and precipitated by addition of hexane. The precipitate was
collected on a fritted filter funnel, and washed with hexane.

Procedure for oxidation of secondary alkyltrifluoroborates to corresponding alcohols:
BF3K
R1

R2

1 eq. oxone (0.2 M, H2O)
0.2 M acetone
rt, 10 mins

OH
R1

R2

1 eq.
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The potassium alkyltrifluoroborate (0.1 mmol) was added to an 8 mL culture tube. Acetone (0.5
mL) was added to the tube via syringe to dissolve the alkyltrifluoroborate. Then, oxone solution
(0.5 mL, 0.2 M in H2O) was added via syringe, and the mixture was allowed to stir at rt for 10
min. HCl (0.3 mL, 0.1 M in H2O) and H2O (0.5 mL) were added to quench the reaction, which
was then extracted with dichloromethane (2 mL x 3). The combined extracts were dried with
anhydrous sodium sulfate and concentrated under reduced pressure.

Potassium (rac)-2-methylcyclopentyl)-trifluoroborate.91
BF3K

and

BF3K

A 100 mL oven-dried 2-neck round bottom flask was fitted with a

condenser and a rubber septum. The apparatus was evacuated (ca. 200 mtorr) and backfilled with
argon 4 times. 2-methylcyclopentene (2.73 g, 33.3 mmol), dichloromethane (20 mL) and HBBr2SMe2 (33.4 mL, 33.3 mmol) were injected via syringe. The reaction mixture was heated to reflux
overnight. The reaction mixture was allowed to cool to rt, then cooled to 0 ºC, at which point,
water (10 mL) and Et2O (20 mL) were injected via syringe. The resulting mixture was then
extracted with Et2O (40 mL x 2). The organic extracts were combined and washed with water
(30 mL). The resulting crude boronic acid was then dissolved in MeOH (67 mL) and cooled to 0
ºC. KHF2 (24 mL 4.5 M in water) was added dropwise, and the reaction mixture was allowed to
warm to rt. After stirring for 1 h, the solution was concentrated in vacuo. The resulting white
solid was then dried under high vacuum overnight. The crude solid was purified by continuous
Soxhlet extraction with acetonitrile (100 mL). The resulting solution was concentrated under
reduced pressure. The solid was recrystallized from ether/hexane, yielding a white crystalline
solid (4.33 g, 22.8 mmol, 68% yield). 1H NMR (300 MHz, DMSO): δ 1.67-1.50 (m, 2H), 1.50-

110

1.15 (m, 4H), 0.89 (d, J = 6.2 Hz, 3H), 0.98-0.78 (m, 1H), 0.00 (br, 1H) ppm.

13

C NMR (75

MHz, DMSO): δ 36.9, 36.6, 29.4, 25.7, 22.1 ppm. 11B NMR (96 MHz, DMSO): δ 5.15 ppm.

OH

trans-2-Methylcyclopentan-1-ol.92 Using the standard procedure for

OH
Me

Me

oxidation of alkyl trifluoroboronates to their corresponding alcohols, a

and

colorless liquid (8.3 mg, 83% yield) was isolated. 1H NMR (300 MHz, CDCl3): δ 3.74 (q, J = 6.1
Hz, 1H), 2.0-1.84 (m, 2H), 1.84-1.45 (m, 5H) 1.27-1.09 (m, 1H), 0.99 (d, J = 6.8 Hz, 3H) ppm.
13

C NMR (75 MHz, CDCl3): δ 80.8, 42.9, 34.3, 31.8, 21.6, 18.4 ppm.

General procedure for the preparation of alkylcarbamates:88,89

O
R

OH

1.0 equiv

+

Cl

N
iPr

iPr

1.1 equiv TEA,
DCM

reflux, overnight

O
R

O

N
iPr

iPr

1.0 equiv

Alkyl alcohol (100 mmol) and N, N-diisopropylcarbamoyl chloride (100 mmol) were added into
a 250 mL round bottom flask containing a stirbar. Dichloromethane (100 mL) and triethylamine
(110 mmol) were injected successively via syringe. The flask was connected to a condenser and
heated to reflux overnight. The cooled solution was filtered by a gravity filtration, and
concentrated under reduced pressure. The alkylcarbamate was additionally purified via column
chromatography.

3-Phenylpropyl diisopropylcarbamate. Using the general procedure
OCb

above, a colorless oil (7.14 g, 90% yield from 30.0 mmol alcohol) was
isolated following column chromatography (95/5 hexane:ether). 1H NMR (300 MHz, CDCl3): δ
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7.37-7.27 (m, 2H), 7.24-7.15 (m, 3H), 4.12 (t, J = 6.5 Hz, 2H), 4.25-3.53 (br, 2H), 2.72 (t, J =
7.44 Hz, 2H), 1.98 (quintet, J = 6.5 Hz, 2H), 1.22 (d, J = 6.8 Hz, 12H) ppm. 13C NMR (75 MHz,
CDCl3): δ 155.9, 141.7, 128.5, 128.5, 126.0, 64.1, 45.9 (br), 32.7, 31.0, 21.2 (br) ppm.

3-(Thiophen-2-yl)propyl

S

diisopropylcarbamate.

Using

the

general

OCb

procedure above, a colorless oil (7.72 g, 87% yield from 33.0 mmol
alcohol) was isolated following column chromatography (95/5 hexane:ether). 1H NMR (300
MHz, CDCl3): δ 7.12 (dd, J1 = 5.1 Hz, J2 = 1.2 Hz, 1H), 6.92 (dd, J1 = 5.1 Hz, J2 = 3.4 Hz, 1H),
6.81 (dd, J1 = 3.4 Hz, J2 = 1.1 Hz, 1H), 4.14 (t, J = 6.4 Hz, 2H), 4.22-3.56 (br, 2H), 2.94 (t, J = 7
Hz, 2H), 2.10-1.97 (m, 2H), 1.22 (d, J = 6.8 Hz, 12H) ppm.

13

C NMR (75 MHz, CDCl3): δ

155.7, 144.2, 126.8, 124.4, 123.2, 63.6, 45.9 (br), 31.2, 26.7, 21.1 (br) ppm. HRMS: Calcd
(M+H+) 270.1528; Found 270.1536.

3-Phenoxypropyl diisopropylcarbamate. Using the general procedure
O

OCb

above, a colorless oil (7.96 g, 86% yield from 33.0 mmol alcohol) was

isolated following column chromatography (95/5 hexane:ether). 1H NMR (300 MHz, CDCl3): δ
7.33-7.22 (m, 2H), 6.98-6.87 (m, 3H), 4.28 (t, J = 6.3 Hz, 2H), 4.07 (J = 6.4 Hz, 2H), 4.04-3.58
(br, 2H), 2.15 (quintet, J = 6.3 Hz, 2H), 1.20 (d, J = 6.8 Hz, 12H) ppm.

13

C NMR (75 MHz,

CDCl3): δ 158.9, 155.6, 129.5, 120.7, 114.5, 64.7, 61.6, 45.8 (br), 29.2, 21.1 (br) ppm. HRMS:
Calcd (M+H+) 280.1913; Found 280.1929.
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α-Methylation of 3-(thiophen-2-yl)propyl diisopropylcarbamate.

S

1.1 equiv nBuLi (1.6 M, hexane)
OCb
1.0 equiv

Me

S

OCb

1.1 equiv MeI
-78 ºC to rt

3-(5-Methylthiophen-2-yl)propyl diisopropylcarbamate. An oven-dried
Me

S

OCb

200 mL round bottom flask containing a stirbar was sealed with a rubber
septum. Using a needle attached to a vacuum line, the flask was evacuated (ca. 150 mtorr) and
backfilled with argon 3 times. 3- (Thiophen-2 yl)propyl diisopropylcarbamate (5.8 mL, 25
mmol) was then injected via syringe, and the flask was cooled to -78 ºC in a dry ice/acetone bath.
To the cooled solution, n-BuLi (16.0 mL, 32.5 mmol, 2.0 M in hexane) was added dropwise via
syringe. The reaction mixture was warmed to rt and stirred for an additional 1 h. MeI (2.4 mL,
37.5 mmol) was then injected via syringe, and the reaction mixture was stirred for an additional 1
h. Saturated aqueous ammonium chloride (50 mL) was added to the flask slowly, and the
resulting solution was transferred to separatory funnel. The mixture was extracted by ether (3 x
100 mL), and the combined extracts were concentrated under reduced pressure. A colorless oil
(4.72 g, 67% yield from 25.0 mmol carbamate) was obtained following purification by column
chromatography (95/5 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 6.60-6.52 (m, 2H), 4.13 (t,
J = 6.4 Hz, 2H), 4.14-3.63 (br, 2H), 2.85 (t, J = 7.4 Hz, 2H), 2.42 (s, 3H), 1.99 (quintet, J = 8.0
Hz, 2H), 1.21 (d, J = 6.8 Hz, 12H) ppm.

13

C NMR (75 MHz, CDCl3): δ 155.8, 142.0, 137.6,

124.8, 124.2, 63.7 (br), 45.7, 31.2, 26.9, 21.1 (br), 15.3 ppm. HRMS: Calcd (M+Na+) 306.1504;
Found 306.1519.
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Preparation of enantioenriched secondary alkyl pinacolboronate via Aggarwal’s Protocol.88,89

R

OCb

1.1 equiv sBuLi (in hexanes),
1.1 equiv (+)-sparteine,
0.18 M Et2O,
1.1 equiv MeBpin (0.6 M in Et2O)

1.0 equiv (2.5 M in Et2O)

- 78 ºC to reflux
24-36 h

BPin
R

Me

An oven-dried 500 mL 3-neck round bottom flask with stirbar was fitted with a condenser and
rubber septum, and connected to a vacuum line. The apparatus was then evacuated (ca. 200
mtorr) and backfilled with argon for 3 times. Et2O (81 mL) and (+)- sparteine (16.5 mmol)
(TMEDA was used when preparing racemic boronate) were injected through the septum. s-BuLi
(16.5 mmol, in THF) was added dropwise over 10 mins. The flask was placed into a -78 ºC dry
ice/acetone bath and the reaction mixture was stirred for 0.5 h. Predissolved carbamate (15
mmol, in 6 mL ether) solution was then injected dropwise into the flask and stirred at -78 ºC for
6 h. With the reaction mixture still at -78 ºC, predissolved R1BPin (16.5 mmol, in 27.5 mL Et2O)
was injected dropwise and stirred for an additional 1 h. With the reaction under a positive
pressure of argon, MgBr2 powder (16.5 mmol) was quickly added to the mixture, which was
stirred for another 0.5 h at -78 ºC, warmed up to room temperature, and additionally heated to
reflux. The mixture was allowed to reflux for an additional 24 h, at which point, GC analysis
showed complete consumption of the carbamate. The mixture was cooled down to 0 ºC in an ice
water bath. At 0 ºC, methanol (10 mL) was added slowly to quench the remaining organolithium.
Aqueous NH4Cl solution (100 mL) was then added slowly to the mixture. The mixture was
transferred to a 500 mL separatory funnel and extracted with ethyl ether (100 mL x 3). The
combined organic layers were washed with brine (100 mL) and dried by Na2SO4. The organic
layer was filtered, concentrated under reduced pressure, and additionally purified by column
chromatography.
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Me
Me
O

B

Me
Me
O

(R)-4,4,5,5-tetramethyl-2-(4-phenylbutan-2-yl)-1,3,2- dioxaborolane.88
Using Aggarwal’s procedure, a colorless oil (2.40 g, 9.23mmol, 46%

Me

yield from 20 mmol carbamate) was isolated following column
chromatography (5/95 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 7.33-7.24 (m, 2H), 7.247.14 (m, 3H), 2.65 (t, J = 8 Hz, 2H), 1.89-1.74 (m, 1H), 1.69-1.54 (m, 1H), 1.27 (s, 12H), 1.161.07 (m, 1H), 1.05 (d, J = 5.5 Hz, 3H) ppm.

13

125.7, 83.1, 35.5, 35.5, 25.0, 24.9, 15.6 ppm.

C NMR (75 MHz, CDCl3): 143.3, 128.6, 128.4,

11

B NMR (96 MHz, CDCl3): 34.9 ppm. Optical

rotation of enantioenriched product [α]25D (c 1.00, CHCl3) = - 6.4 º.

Potassium 4-phenylbutan-2-yl trifluoroborate.56 Using the general
BF3K
Me

procedure for preparing alkyltrifluoroborates, a pale white solid (1.40 g, 62%
from racemic boronate) was isolated.

Potassium (R)- 4-phenylbutan-2-yl trifluoroborate.56 Using the general
BF3K
Me

procedure for preparing alkyltrifluoroborates, a pale white solid (1.44 g, 5.54
mmol, 55% yield from 10 mmol enantioenriched boronate) was isolated. The

corresponding oxidized alcohol was analyzed as 97.0% ee in 1st run (96.3% in 2nd run) by GC.
1

H NMR (300 MHz, DMSO): δ 7.25-7.17 (m, 2H), 7.15-7.05 (m, 3H), 2.64-2.52 (m, 1H), 2.47-

2.37 (m, 1H), 1.64-1.50 (m, 1H), 1.23-1.08 (m, 1H), 0.70 (d, J = 7.2 Hz, 3H), 0.22-0.03 (br, 1H)
ppm. 13C NMR (75 MHz, DMSO): 144.7, 128.2, 127.9, 124.8, 36.3, 35.0, 16.4 ppm.

11

B NMR

(96 MHz, DMSO): 4.8 ppm.
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Me Me
Me
O
O
B

4,4,5,5-tetramethyl-2- (4-(5-methylthiophen-2-yl) butan-2-yl)- 1,3,2-

Me

Me

S

dioxaborolane.88 Using Aggarwal’s procedure, a colorless oil (2.51 g,

Me

60% yield from 15 mmol carbamate) was isolated following column
chromatography (3/97 hexane:ether).

Me Me
Me
O
O
B

(R)-4,4,5,5-tetramethyl-2- (4-(5-methylthiophen-2-yl) butan- 2-yl)-

Me

Me

S

1,3,2-dioxaborolane.88 Using Aggarwal’s procedure, a colorless oil

Me

(2.13 g, 71% yield from 10.6 mmol enantioenriched) was isolated
following column chromatography (3/97 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 6.586.52 (m, 2H), 2.78 (t, J = 7.9 Hz, 2H), 2.43 (s, 3H), 1.91-1.77 (m, 1H), 1.72-1.55 (m, 1H), 1.26
(s, 12H), 1.13 (sextet, J = 7.0 Hz, 1H), 1.03 (d, J = 6.8 Hz, 3H) ppm.

13

C NMR (75 MHz,

CDCl3): δ 143.7, 137.0, 124.6, 123.6, 82.9, 35.4, 29.4, 24.8, 24.7, 16.6(br), 15.4, 15.3 ppm.

11

B

NMR (96 MHz, CDCl3): δ 34.69 ppm. HRMS: Calcd (M+H+) 281.1747; Found 281.1779.
Optical rotation of enantioenriched product [α]25D (c 1.00, CHCl3) = -6.7 º.

Me

S

BF3K
Me

Potassium

4-(5-methylthiophen-2-yl)

butan-2-yl

trifluoroborate.

Using the general procedure for preparing alkyltrifluoroborates, a white-

yellow solid (1.12 g, 54% yield from 8.0 mmol racemic boronate) was obtained.

Potassium (R)-4-(5-methylthiophen-2-yl) butan-2-yl trifluoroborate.
Me

S

BF3K
Me

Using the general procedure for preparing alkyltrifluoroborates, a white-

yellow solid (1.15 g, 62% yield from 7.1 mmol enantioenriched boronate) white-yellow solid
was obtained. The corresponding oxidized alcohol was analyzed as 95.4% e.e by HPLC. 1H
NMR (300 MHz, DMSO): δ 6.54-6.50 (m, 1H), 6.50-6.45 (m, 1H), 2.75-2.53 (m, 2H), 2.35 (s,
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3H), 1.65-1.50 (m, 1H), 1.24-1.13 (m, 1H), 0.68 (d, J = 7.2 Hz, 3H), 0.13 (br, 1H) ppm.

13

C

NMR (75 MHz, DMSO) δ 145.4, 135.4, 124.5, 122.8, 36.6, 29.3, 16.4, 15.0 ppm. 11B NMR (96
MHz, DMSO) δ 4.76 ppm.

4,4,5,5-tetramethyl-2-(4-phenoxybutan-2-yl)-1,3,2-dioxaborolane.88
Using Aggarwal’s procedure, a colorless oil (2.94 g, 41% yield from 26
mmol carbamate) was isolated following column chromatography (95/5
hexane:ether).

(R)-4,4,5,5-tetramethyl-2- (4-phenoxybutan-2-yl)-1,3,2- dioxaborolane.88
Me
Me
O

B

Me
Me
O

Using Aggarwal’s procedure, a colorless oil (3.20 g, 45% yield from 26

Me

O

mmol carbamate) colorless liquid was isolated following column
chromatography (95/5 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 7.32-7.22 (m, 2H), 6.986.87 (m, 3H), 4.00 (dt, J1 = 6.6 Hz, J2 = 1.5 Hz, 2H), 2.04-1.91 (m, 1H), 1.84-1.70 (m, 1H), 1.24
(s, 12H), 1.22-1.17 (m, 1H), 1.04 (d, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 159.3,
129.5, 120.5, 114.8, 83.2, 67.4, 32.6, 24.9, 15.6, 13.7(br) ppm.

11

B NMR (96 MHz, CDCl3): δ

34.52 ppm. HRMS: Calcd (M+H+) 277.1975; Found 277.1961. Optical rotation of
enantioenriched product [α]25D (c 1.00, CHCl3) = -12.6 º.

BF3K
O

Me

Potassium 4-phenoxybutan-2-yl trifluoroborate. Using the general
procedure for preparing alkyltrifluoroborates, a white solid (1.01 g, 44%

yield from 9.0 mmol racemic boronate) was obtained.
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Potassium (R)-4-phenoxybutan-2-yl trifluoroborate. Using the general
procedure for preparing alkyltrifluoroborates, a white solid (1.64 g, 55%
yield from 11.6 mmol enantioenriched boronate) was obtained. The corresponding oxidized
alcohol was analyzed as 97.7% ee by GC. 1H NMR (300 MHz, DMSO-d6): δ 7.28-7.19 (m, 2H),
6.89-6.81 (m, 3H), 3.92 (m, 2H), 1.77-1.61 (m, 1H), 1.41-1.27 (m, 1H), 0.72 (d, J = 7.2 Hz, 3H),
0.31-0.14 (br, 1H) ppm.

13

C NMR (75 MHz, DMSO): δ 159.1, 129.3, 119.7, 114.3, 68.2, 33.3,

19.3(br), 16.9 ppm. 11B NMR (96 MHz, DMSO): δ 4.77 ppm.

4,4,5,5-tetramethyl-2-(1-phenylpentan-3-yl)-1,3,2-dioxaborolane.88
Using Aggarwal’s procedure, a colorless oil (5.70 g, 69% yield, from 30
mmol carbamate) was isolated following column chromatography (98/2
hexane:ether).

(R)-4,4,5,5-tetramethyl-2-(1-phenylpentan-3-yl)-1,3,2dioxaborolane.88 Using Aggarwal’s procedure, a colorless oil (3.32 g, 81
% yield from 15 mmol carbamate) colorless liquid was isolated following
column chromatography (98/2 hexane:ether). 1H NMR (300 MHz, CDCl3): δ 7.33-7.23 (m, 2H),
7.23-7.11 (m, 3H), 2.70-2.53 (m, 2H), 1.88-1.62 (m, 2H), 1.58-1.41 (m, 2H), 1.28 (s, 12H), 1.100.90 (m, 1H), 0.94 (t, J=7.4 Hz, 3H) ppm.

13

125.7, 83.1, 35.8, 33.4, 25.0, 24.3, 13.8 ppm.

C NMR (75 MHz, CDCl3): 143.3, 128.6, 128.4,
11

B NMR (96 MHz, CDCl3): 34.6 ppm. Optical

rotation of enantioenriched product [α]20D (c 1.00, CHCl3) = -7.7 º.
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Potassium

(1-Phenylpentan-3-yl)trifluoroborate.

Using

the

general

procedure for preparing alkyl trifluoroborates, the crude product, obtained
from extraction of acetone, was dissolved in methanol (10 mL), which was then washed by
hexane (10 mL) multiple times, until no pinacol and boronate were detectable in the hexane
eluent. A white creamy solid (1.05 g, 57 % yield) was obtained after overnight evacuation (ca.
150 mtorr).

Potassium (R)-(1-Phenylpentan-3-yl)trifluoroborate. A white creamy solid
(557.0 mg, 34 % yield) was obtained, using the same procedure above. The
product formed from oxidization to the corresponding alcohol was analyzed as 98% ee by GC.
1

H NMR (300 MHz, acetone-D6): δ 7.27-7.11 (m, 4H), 7.11-7.00 (m, 1H), 2.62 (t, J = 8.3 Hz,

2H), 1.74-1.56 (m, 1H), 1.56-1.35 (m, 2H), 1.35-1.19 (m, 1H), 0.88 (t, J=7.3 Hz, 3H), 0.23 (br,
1H) ppm. 13C NMR (75 MHz, acetone-D6): δ 146.6, 129.2, 128.7, 125.5, 36.5, 34.7, 24.6, 14.2
ppm. 11B NMR (96 MHz, acetone-D6): δ 5.46 ppm.
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Preparation of diastereoenriched secondary alkyl pinacolboronates via Aggarwal’s
protocol.87,93

(S)-1-(Trimethylstannyl)ethyl-2,4,6-triisopropylbenzoate. To a round bottom
flask under argon, ethyl 2,4,6-triisopropylbenzoate (1.45 g, 5.85 mmol, 1.0 equiv)
and (-)-sparteine (1.74 mL, 7.6 mmol, 1.3 equiv) were added followed by the addition of Et2O
(28 mL). The solution was cooled and stirred at -78 ºC for 10 min. s-BuLi (5.4 mL 1.4 M in
cyclohexane, 7.6 mmol, 1.3 equiv) was slowly added dropwise. The reaction was stirred at -78
ºC for 4 h. Me3SnCl (7.6 mL, 1.0 M in hexanes, 7.6 mmol, 1.3 equiv) was slowly added
dropwise to the solution. The reaction was stirred at -78 ºC for a further 20 min, warmed to room
temperature, and then stirred for an additional 1 h. The reaction mixture was diluted with H3PO4
(aq. 5%, 100 mL) and stirred for an additional 20 min. The layers were separated and the organic
layer washed with H3PO4 (aq. 5%, 3 x 100 mL). The combined aqueous layers were extracted
with Et2O (3 × 100 mL). The combined organic layers were dried over MgSO4 and concentrated
under reduced pressure to give crude (S)-1- (trimethylstannyl)ethyl 2,4,6-triisopropylbenzoate.
Methanol was added to the flask (3 ml/g) and a heat gun was used to fully dissolve the crude
product in solution. The flask was then placed in an ice bath at 0 ºC, forming white crystals,
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which were then filtered,

and washed

with

cold

MeOH

providing pure (S)-1-

(trimethylstannyl)ethyl-2,4,6- triisopropylbenzoate (1.29 g, 50% yield).

(R)-1-(Trimethylstannyl)ethyl-2,4,6-triisopropylbenzoate. To a round bottom
flask under argon, ethyl 2,4,6-triisopropylbenzoate (2.65 g, 10.65 mmol, 1.0
equiv) and (+)-sparteine (3.17 mL, 13.85 mmol, 1.3 equiv) were added followed by the addition
of Et2O (50 mL). The solution was cooled and stirred at -78 ºC for 10 min. s-BuLi (9.9 mL, 1.4
M in cyclohexane, 13.85 mmol, 1.3 equiv) was slowly added dropwise. The reaction was stirred
at -78 ºC for 4 h. Me3SnCl (13.85 mL, 1.0 M in hexanes, 13.85 mmol, 1.3 equiv) was slowly
added dropwise to the solution. The reaction was stirred at -78 ºC for 20 min, warmed to room
temperature, and then stirred for an additional 1 h. The reaction mixture was diluted with H3PO4
(aq. 5%, 200 mL) and stirred for an additional 20 min. The layers were separated and the organic
layer washed with H3PO4 (aq. 5%, 3 x 150 mL). The combined aqueous layers were extracted
with Et2O (3 x 200 mL). The combined organic layers were dried with MgSO4 and concentrated
under

reduced

pressure

to

provide

crude

(R)-1-

(trimethylstannyl)ethyl-2,4,6-

triisopropylbenzoate. Methanol was added to the flask (3 ml/g) and a heat gun was used to fully
dissolve the crude product in solution. The flask was then placed in an ice bath at 0 ºC, forming
white crystals, which were then filtered and washed with cold methanol to give pure (R)-1
(trimethylstannyl)ethyl-2,4,6-triisopropylbenzoate (2.43 g, 52% yield).

(S)-2-(1-(4-Methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2dioxaborolane.

A

solution

of

(R)-1-(trimethylstannyl)ethyl-2,4,6-

triisopropylbenzoate (2.4 g, 5.5 mmol, 1.3 equiv) in a Schlenk flask was dissolved in anhydrous
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Et2O (27.5 mL) under an atmosphere of argon. The reaction mixture was cooled to –78 °C. nBuLi (2.2 mL, 2.5 M in hexanes, 5.5 mmol, 1.3 equiv) was added dropwise to the reaction
mixture at -78 °C. The reaction mixture was stirred for 1 h at -78 °C. 4-methoxyphenylboronic
acid pinacol ester (0.5 M in anhydrous Et2O, 0.99 g, 4.23 mmol, 1.0 equiv) was then added
dropwise to the reaction mixture at –78 °C. The reaction mixture was stirred at –78 °C for 30
min (the pale-yellow solution loses its color upon addition of the boronate). The reaction mixture
was removed from the cooling bath and stirred at 40 ºC for 2 h. The reaction mixture was filtered
through silica (~10 mm depth, wetted with Et2O) using a filter frit connected directly to an ovendried receiving vessel, to give a colorless to pale yellow translucent solution. The silica was
washed with Et2O, the filter frit was removed, and the solvent was removed under reduced
pressure to give the crude (S)-2-(1-(4 methoxyphenyl)ethyl)-4,4,5,5-tetramethyl-1,3,2dioxaborolane (1.7 g, crude).

(R)-2-(2-(4-Methoxyphenyl)propyl)-4,4,5,5-tetramethyl-1,3,2dioxaborolane. A solution of crude (S)-2-(1-(4-methoxyphenyl)ethyl)4,4,5,5- tetramethyl-1,3,2-dioxaborolane (1.7 g, 4.23 mmol, 1 equiv) and
chloroiodomethane (0.93 ml, 12.7 mmol, 3 equiv) was dissolved in anhydrous Et2O (30 ml)
under argon. The solution was cooled to -95 ºC (MeOH/N2 (l)). n-BuLi (5 mL, 2.5 M in hexanes,
12.5 mmol, 2.95 equiv) was added dropwise and the stirring was continued at -95 ºC for 10 min.
The reaction mixture was removed from the cooling bath and stirred at room temperature for 1 h.
The reaction mixture was filtered through silica (~10 mm depth, wetted with Et2O), using a filter
frit connected directly to an oven-dried receiving vessel, to give a colorless to pale yellow
translucent solution. The silica was washed with Et2O, the filter frit was removed, and the
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solvent

was

removed

under

reduced

pressure

to

give

the

crude

(R)-2-(2-(4-

methoxyphenyl)propyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (1.58 g, crude).

2-((2R,4R)-4-(4-Methoxyphenyl)pentan-2-yl)-4,4,5,5-

tetramethyl-

1,3,2-dioxaborolane. A solution of crude (S)-1 (trimethylstannyl)ethyl2,4,6- triisopropylbenzoate (2.2 g, 0.2 M in ether, 4.97 mmol, 1.3 equiv) was added to a Schlenk
reaction mixture under an atmosphere of argon. The reaction mixture was cooled to - 78 °C. nBuLi (1.5 mL, 2.5 M in hexanes, 3.8 mmol, 1.30 equiv) was added dropwise to the reaction
mixture at -78 °C. The reaction mixture was stirred for 1 h at –78 °C. (R)-2-(2-(4methoxyphenyl)propyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (0.5 M in anhydrous Et2O),
1.58 g, crude (3.8 mmol, 1.0 equiv) was then added dropwise to the reaction mixture at –78 °C.
The reaction mixture was stirred at -78 °C for 30 min (the pale-yellow solution loses its color on
the addition of the boronate). The reaction mixture was removed from the cooling bath and
stirred at room temperature for 2 h. The reaction mixture was filtered through silica (~10 mm
depth, wetted with Et2O), using a filter frit connected directly to an oven-dried receiving vessel.
The silica was washed with Et2O, the filter frit was removed, and the solvent was removed under
reduced pressure to give the crude 2-((2R,4R)-4-(4-methoxyphenyl)pentan-2-yl)-4,4,5,5tetramethyl-1,3,2- dioxaborolane (0.42 g, 1.37 mmol). A colorless oil (420 mg, 1.37 mmol, 33 %
over 3 steps) was isolated following column chromatography (0-5% ether in hexane). 1H NMR
(300 MHz, CDCl3): δ 7.10 (d, J = 8.8 Hz, 2H), 6.82 (d, J = 8.8 Hz, 2H), 3.78 (s, 3H), 2.71 (q, J =
7.3 Hz 1H), 1.69 (m, 1H), 1.45 (m, 1H), 1.27-1.10 (m, 16H), 0.92 (s, 3H) ppm.

13

C NMR (75

MHz, CDCl3): δ 157.8, 140.4, 128.1, 113.8, 83.0, 55.4, 42.6, 38.2, 25.0, 24.9, 22.3, 15.9 ppm.
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11

B NMR (96 MHz, CDCl3): δ 34.79 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3)

= -37.7 º.

Potassium
Me

2-((2R,4R)-4-(4-methoxyphenyl)pentan-2-yl)-

Me
BF3K

trifluoroborate.

Using

the

general

procedure

for

preparing

MeO

alkyltrifluoroborates, a white solid (310 mg, 64% yield from 1.70 mmol
boronate) was obtained. 1H NMR (300 MHz, DMSO-d6): δ 7.05 (d, J = 8.6 Hz, 2H), 6.78 (d, J =
8.6 Hz, 2H), 3.70 (s, 3H), 2.70 (sextet, J = 6.9 Hz, 1.52-1.37 (m, 1H), 1.12-1.00 (m, 1H), 1.02 (d,
J = 6.9 Hz, 3H), 0.60 (d, J = 7.1 Hz, 3H), 0.23-0.08 (br, 1H) ppm. 13C NMR (75 MHz, DMSO):
δ 156.8, 142.2, 127.5, 113. 3, 54.9, 43.4, 36.2, 21.4, 16.3 ppm.

11

B NMR (96 MHz, DMSO): δ

5.03 ppm.

Preparation of diphenylSPhos derivatives.

MeO

OMe

1.1 equiv nBuLi (1.6 M, hexane)
0.43 M THF
1.0 equiv 1-bromo-2-chlorobenzene

MeO

Br
OMe

1.05 equiv nBuLi (1.6 M, hexane)
0.4 M THF
1.0 equiv ClPAr2 (1.0 M, THF)

MeO

Ar
P Ar
OMe

1.1 eq.

2'-Bromo-2, 6-dimethoxy-1, 1'-biphenyl.94 An oven-dried 250 mL 2MeO

Br
OMe

neck round bottom flask was fitted with a rubber septum and connected to
a vacuum line. This apparatus was evacuated (ca. 200 mtorr) and back-

filled with argon for 4 times. 1,3-dimethoxybenzene (2.9 mL, 22.0 mmol, 1.0 equiv) and THF
(51 mL) were injected into the flask. The flask was cooled to 0 ºC in an ice bath. n-BuLi (13.9
mL, 22.0 mmol, 1.58 M in hexane, 1.0 equiv) was injected dropwise over 5 min. The mixture
was allowed to stir at 0 ºC for 5 additional minutes and then stirred at room temperature for
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another 3.5 h. The mixture was then re-cooled to 0 ºC, and 1-bromo-2-chlorobenzene (2.34 mL,
22.0 mmol, 1.0 equiv) was injected via syringe over 15 min. The mixture was allowed to stir at 0
ºC for another 15 min, at which time, methanol (0.5 mL) was added dropwise to quench the
reaction. The crude reaction mixture was poured into a separatory funnel contained water (100
mL) and extracted with ethyl acetate (50 mL x 3). Combined the organic phases were
concentrated under reduced pressure. The crude oil was purified via recrystallization from ethyl
ether/methanol, and washed with methanol (5 mL x 3). A pale yellow crystalline solid (4.43 g,
69% yield) was obtained. 1H NMR (300 MHz, CDCl3): δ 7.70 (dd, J1 = 7.9 Hz, J2 = 0.9 Hz, 1H),
7.43-7.33 (m, 2H), 7.30-7.19 (m, 2H), 6.70 (d, J = 8.4 Hz, 2H), 3.77 (s, 6H) ppm. 13C NMR (75
MHz, CDCl3): δ 157.9, 136.3, 132.5, 132.5, 129.6, 128.8, 127.1, 125.4, 119.1, 104.3, 56.2 ppm.

Diaryl

R

R
P
MeO

OMe

derivatives

of

(2',6'-dimethoxy-[1,1'-biphenyl]-2-yl)

diphenylphosphine. 2'-bromo-2,6-dimethoxy-1,1'-biphenyl (586.0 mg,
2.0 mmol, 1.0 equiv) was added to an oven-dried round bottom flask.

The flask was fitted with a rubber septum and evacuated (ca. 200 mtorr) and back-filled with
argon 4 times. THF (5 mL) was injected into the flask via syringe. The flask was cooled to -78
ºC, and n-BuLi (1.37 mL, 2.1 mmol, 1.52 M in hexane, 1.05 equiv) was added to the mixture
over 10 min. After the preceding mixture had stirred for 30 min, the corresponding
diphenylphosphine chloride derivative (2.0 mmol, dissolved into 2 mL THF, 1.0 equiv) was
injected into the mixture dropwise via syringe. The mixture was allowed to stir at -78 ºC for 1 h,
and then allowed to warm to rt where it was stirred for an additional 1.5 h. The reaction mixture
was then quenched by methanol (0.5 mL) and dissolved into ethyl acetate (10 mL). The solution
was then passed through a pad of silica gel, eluting with ethyl acetate (20 mL). The solvent was
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then removed under reduced pressure, and the white-yellow solid was recrystallized from hot
methanol.

Bis-(3,5-bis(trifluoromethyl)phenyl)(2',6'-dimethoxy-[1,1'F3C

CF3
CF3

biphenyl]-2-yl)phosphine. Using procedure above, a pale yellow

CF3

crystalline solid (899 mg, 67% yield) was isolated after further

P
MeO

OMe

purification by column chromatography (95/5, hexane/ether). 1H NMR
(300 MHz, CDCl3): δ 7.82 (s, 2H), 7.62 (d, J = 6.1 Hz, 4H), 7.52 (t, J = 7.5 Hz, 1H), 7.39-7.27
(m, 3H), 7.05 (dd, J1 = 7.7 Hz, J2 = 4.0 Hz, 1H), 6.56 (d, J = 8.4 Hz, 2H), 3.56 (s, 6H) ppm. 13C
NMR (75 MHz, CDCl3): δ 142.5, 142.0, 141.1, 140.8, 134.3, 133.1, 131.9, 130.7, 128.5, 125.1,
122.7, 121.4, 118.2, 117.8, 103.7, 55.5 ppm. 31P NMR (121 MHz, CDCl3): δ -9.5 ppm. HRMS:
Calcd (M+H+) 671.1009; Found 671.1017.

(2', 6'-Dimethoxy-[1,1'-biphenyl]-2-yl) di-o-tolylphosphine. Using the
Me

procedure above, a white solid (373 mg, 0.88 mmol, 44% yield) was

P
MeO

OMe

Me

obtained. 1H NMR (300 MHz, CDCl3): δ 7.40 (t, J = 7.1 Hz, 1H), 7.14
(m, 10H), 6.82 (m, 2H), 6.48 (d, J = 8.3 Hz, 2H), 3.36 (s, 6H), 2.18 (s, 6H) ppm. 13C NMR (300
MHz, CDCl3): δ 158.1, 143.0, 142.6, 137.0, 134.2, 133.9, 131.2, 131.1, 129.8, 129.74, 129.1,
128.8, 128.2, 127.4, 125.8, 103.4, 55.3, 21.4, 21.1 ppm.
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P NMR (121 MHz, CDCl3): δ -29.3

ppm. HRMS: Calcd (M+H+) 427.1827; Found 427.1830.

(2',6'-Dimethoxy-[1,1'-biphenyl]-2-yl)bis(4-(trifluoromethyl)
F3C

CF3
CF3

phenyl)phosphine. Using the procedure above, a white needle-like

P
MeO

OMe

CF3
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solid (220 mg, 0.41 mmol, 21% yield) was obtained. 1H NMR (300 MHz, CDCl3): δ 7.53 (m,
4H), 7.46 (td, J1 = 7.3 Hz, J2 = 1.0 Hz, 1H), 7.29 (m, 7H), 7.09 (ddd, J1 = 7.4 Hz, J2 = 3.6 Hz, J3
= 1.0 Hz, 1H), 6.53 (d, J = 8.3 Hz, 2H), 3.47 (s, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.9,
142.9, 142.7, 142.2, 141.7, 136.2, 136.0, 134.0, 131.6, 131.5, 130.7, 130.3, 129.8, 129.7, 127.9,
126.1, 125.13, 125.08, 125.05, 124.99, 122.5, 103.7, 55.5 ppm. 31P NMR (121 MHz, CDCl3): δ 12.0 ppm. HRMS: Calcd (M+H+) 535.1262; Found 535.1273.

Preparation of diphenylXPhos derivatives.

Br
iPr

iPr

Br

4 equiv Mg
0.7 M, THF
3 mol %, 1,2-dibromoethane

Cl

2.2 equiv I2 (2.2 M, THF)

+
iPr
1.0 equiv

1.1 equiv

I
iPr

iPr

iPr

Ar
P Ar
iPr

1.05 equiv nBuLi (1.5 M, hexane)
0.4 M THF
1.0 equiv ClPAr2 (1.0 M, THF)

iPr

iPr

2'-Iodo-2, 4, 6-triisopropyl-1, 1'-biphenyl.95 Magnesium turnings (1.92 g,
I
iPr

iPr

iPr

80.0 mmol, 4.0 equiv) were added to a 100 mL 2-neck round bottom flask,
which had been dried overnight in an oven. The flask was equipped with a

condenser and rubber septum, and evacuated (ca. 200 mtorr) and backfilled with argon for 4
times. Dry THF (28 mL) was injected via syringe. 2-Bromo-1,3,5- triisopropylbenzene (7.15 mL,
20.0 mmol, 1.0 equiv) was injected into the mixture via syringe, the flask was heated to 70 ºC,
and 1,2-dibromoethane (50 uL) was added via microsyringe. After 1 hour at reflux, 2bromochlorobenzene (2.58 mL, 22 mmol, 1.1 equiv) was added dropwise via a syringe with a
syringe pump over 0.5 h. And after additional 1 hour at reflux, the mixture was cooled down to
room temperature and a solution of I2 (11.12 g, 44 mmol, in 20 mL THF, 2.2 equiv) was added
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via cannula until a deep purple color persisted. The reaction mixture was then quenched with
methanol (10 mL), dissolved in ethyl acetate (200 mL), and filtered. The filtrate was washed
successively with aqueous Na2S2O3 and brine, and dried over anhydrous Na2SO4. The solution
was filtrated, and then concentrated under reduced pressure. A pale yellow crystalline solid (6.4
g, 15.8 mmol, 79% yield) was obtained following recrystallization from methanol. 1H NMR (300
MHz, CDCl3): δ 7.95 (dd, J1 = 7.9 Hz, J2 = 0.9 Hz, 1H), 7.38 (dt, J1 = 7.4 Hz, J2 = 1.1 Hz, 1H),
7.20 (dd, J1 = 7.5 Hz, J2 = 1.6 Hz, 1H), 7.06 (s, 2H), 7.08-7.00 (m, 1H), 2.96 (septet, J = 6.9 Hz,
1H), 2.40 (septet, J = 6.9 Hz, 2H), 1.32 (d, J = 6.9 Hz, 6H), 1.23 (d, J = 6.9 Hz, 6H), 1.02 (d, J =
6.8 Hz, 6H) ppm. 13C NMR (75 MHz, CDCl3): δ 148.8, 146.1, 145.9, 139.4, 139.0, 130.7, 128.4,
128.0, 121.0, 102.6, 34.4, 30.8, 25.1, 24.3, 23.7 ppm.

Diaryl

derivatives

of

(2',4',6'-triisopropyl-[1,1'-biphenyl]-2-

R

R

yl)phosphine: 2'-Iodo-2,4,6-triisopropyl-1,1'-biphenyl (812 mg, 2.0

P
iPr

iPr

iPr

mmol, 1.0 equiv) was added into an oven-dried 25 mL round bottom
flask. The flask was sealed with a rubber septum and evacuated (ca. 200

mtorr) and backfilled with argon for 4 times. THF (5 mL) was injected, and the flask was cooled
in a -78 ºC dry ice/acetone bath. n-BuLi (1.37 mL, 2.1 mmol, 1.53 M, in hexane, 1.05 equiv) was
injected via syringe dropwise over 15 min. The mixture was stirred at -78 ºC for 30 min. A predissolved solution of diphenylphosphine chloride derivative (2.0 mmol, in 2 mL THF, 1.0 equiv)
was injected via syringe over 15 min. The mixture was stirred at -78 ºC for 1 h, and then was
warmed to rt and stirred for another 1.5 h. The crude mixture was quenched by methanol (0.5
mL) and dissolved by ethyl acetate (10 mL). The solution was filtrated through a pad of silica gel
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and washed with ethyl acetate (20 mL). The solvent was removed under reduced pressure, and an
off-white crystalline solid was isolated following column chromatography.

Bis(3,5-bis(trifluoromethyl)phenyl)(2',4',6'-triisopropyl-[1,1'F3C

CF3
CF3

biphenyl]-2-yl)phosphine (14).96 Using the procedure above, a white

CF3

solid (808 mg, 1.1 mmol, 55% yield) was isolated following column

P
iPr

iPr

iPr

chromatography (100% hexane). 1H NMR (300 MHz, CDCl3): δ 7.86 (s,

2H), 7.57 (d, J = 6.0 Hz, 4H), 7.54 (d, J = 8.0 Hz, 1H), 7.49-7.40 (m, 1H), 7.37-7.29 (m, 1H),
7.19-7.11 (m, 1H), 7.00 (s, 2H), 2.95 (septet, J = 6.9 Hz, 1H), 2.27 (septet, J = 6.8 Hz, 2H), 1.30
(d, J = 6.9 Hz, 6H), 1.00 (d, J = 6.7 Hz, 6H), 0.82 (d, J = 6.9 Hz, 6H) ppm. 13C NMR (75 MHz,
CDCl3): δ 149.2, 148.9, 148.4, (146.4, 146.4) 140.6, 140.3, 135.0, 134.9, (134.7, 134.6), 133.2,
132.9, 132.9, 132.5, 132.4, 132.1, 132.0, 131.9, 131.8, 131.6, 131.5, 130.8, 128.4, 124.9
(quintet), 123.1, 121.3, 120.8, 34.3, 31.0, 25.6, 24.1, (22.3, 22.3) ppm.
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P NMR (121 MHz,

CDCl3): δ -15.8 ppm. HRMS: Calcd (M+Na+) 759.2026; Found 759.2023.

Bis(4-(trifluoromethyl)phenyl)(2',4',6'-triisopropyl- [1,1'- biphenyl]-

CF3

2-yl)phosphine. Using the procedure above, a white solid (270 mg,
P
iPr

iPr

iPr

CF3

0.45 mmol, 45% yield) was isolated following column chromatography
(100% hexane). 1H NMR (300 MHz, CD2Cl2): δ 7.56 (d, J = 7.9 Hz,

4H), 7.51-7.44 (m, 1H), 7.37 (dt, J1 = 7.53 Hz, J2 = 1.4 Hz, 1H), 7.29 (t, J = 6.8 Hz, 4H), 7.267.16 (m, 2H), 7.00 (s, 2H), 2.93 (septet, J = 6.9 Hz, 1H), 2.32 (septet, J = 6.8 Hz, 2H), 1.29 (d, J
= 6.9 Hz, 6H), 0.96 (d, J = 6.8 Hz, 6H), 0.80 (d, J = 6.9 Hz, 6H) ppm.

13

C NMR (300 MHz,

CDCl3): δ 148.7, 148.5, 148.0, 146.5, 146.47, 142.46, 142.3, 135.6, 135.5, 135.3, 135.2, 134.0,
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133.7, 131.5, 131.4, 131.0, 130.6, 129.8, 127.7, 126.0, 125.54, 125.49, 125.44, 125.41, 125.36,
122.4, 120.74, 34.4, 31.0, 25.7, 24.2, 22.44, 22.42 ppm.
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P NMR (121 MHz, CDCl3): δ -17.7

ppm. HRMS: Calcd (M+H+) 601.2459; Found 601.2454.

Preparation of mono-ligated 3rd and 4th generation Buchwald palladium precatalyst.97–99

NH2
Pd

Ligand (1 equiv)
0.625 M THF or DCM,
rt, 2-12 h

O
Me

SO2

NH2
Pd L
OMs

2

0.5-0.65 equiv

Procedure A (for air-sensitive ligands):97 On the bench top, Buchwald’s 3rd generation
palladium dimer (738 mg, 1.0 mmol, 0.5 equiv) was added into an oven-dried 50 mL round
bottom flask, which was equipped with a stirbar. The flask was brought into glovebox, where the
selected ligand (2.0 mmol, 1.0 equiv) was added. Freshly distilled THF (12 mL) was added into
the mixture via syringe outside glovebox. The mixture was stirred under room temperature for 2
to 12 h, until the solid was dissolved. A gravity filtration is required if black Pd(0) particles
precipitate. The filtrate was collected and concentrated via rotary evaporator. The solid catalyst
precursor was obtained via recrystallization in ether/hexane. The yellow/brown solid was washed
with hexane and dried under high vacuum for 24 h.
Procedure B:98,99 On a bench top, Buchwald’s 3rd generation palladium dimer (240 mg, 0.32
mmol, 0.65 equiv), and ligand (0.5 mmol, 1.0 equiv) was added to a 25 mL oven-dried round
bottom flask, which was equipped with a stirbar. The flask was sealed with a rubber septum and
evacuated (ca. 200 mtorr) and back filled with argon 3 times. 8.0 mL freshly distilled
dichloromethane was injected into the mixture via syringe. The mixture was stirred at room
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temperature for 2 h. Diethyl ether (10 mL) was added into the mixture, which was filtered
through a tightly packed cotton plug. The cotton plug was washed with diethyl ether (10 mL x
2). The filtrates were combined, concentrated under reduced pressure, and recrystallized from
ether/hexane. A pale-yellow solid was collected on a fritted funnel, washed with hexane (10 mL
x 3) and dried under vacuum for 24 h.
Procedure C:98,99 On the benchtop, Buchwald’s 4th generation (N-methyl) palladium dimer
(104.6 mg, 0.14 mmol, 0.65 equiv), and ligand (0.21 mmol, 1.0 equiv) were added to a 25 mL
oven-dried round bottom flask, which was equipped with a stirbar. The flask was sealed with
septum, and evacuated (ca. 200 mtorr) and back filled with argon 3 times. Dichloromethane (3.5
mL) was injected into the mixture via syringe. The mixture was stirred at room temperature for 2
h. The solvent (DCM) was removed under reduced pressure. The remaining residue was redissolved in diethyl ether (10 mL), and insoluble particles was filtered using a cotton plug, which
was then washed with ether (5 mL x 2). The combined filtrates were concentrated under reduced
pressure and thoroughly dried under vacuum.

Tri(1-adamantyl)phosphine-ligated100 3rd generation Buchwald
NH2
Pd L
OMs

L = PAd3

palladium precatalyst (G3-Pd-PAd3): Following Procedure A, a
golden yellow powder was obtained (1.54 g, 1.90 mmol, 95% yield).

Note that insoluble yellow solid may precipitate when stirred overnight. In this case,
dichloromethane (5 mL) was added to dissolve the solid (in 0.5 mmol scale reaction). The
solution was then filtrated through a cotton plug. The filtrates were condensed by rotary
evaporator until little liquid was left. Yellow solid was obtained by the addition of hexane. 1H
NMR (300 MHz, CDCl3): δ 7.73-7.52 (br, 1H), 7.50-7.42 (m, 2H), 7.40 (d, J = 7.5 Hz, 1H),
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7.31-7.22 (m, 1H), 7.22- 7.11 (m, 2H), 7.10-6.95 (m, 2H), 3.98 (br, 1H), 2.80 (s, 3H), 2.26 (s,
18H), 1.89 (s, 9H), 1.62 (m, 18H) ppm.

13

C NMR (75 MHz, CDCl3): δ 141.3, 140.1, 139.3,

138.6(d), 137.5, 128.7, 127.1, 126.5, 126.1, 125.7, 124.7, 119.7, 48.7, 48.7, 41.5, 40.3, 36.6,
29.5, 29.4 ppm. 31P NMR (121 MHz, CDCl3): δ 61.21 ppm.

CataCXium® A-ligated 3rd generation Buchwald palladium
NH2
Pd L
OMs

L = nBuPAd2

precatalyst (G3-Pd-nBuPAd2): Following Procedure A, a pale
yellow powder (506 mg, 87% yield from 0.8 mmol starting material)

was obtained. 1H NMR (300 MHz, CDCl3): δ 7.49-7.35 (m, 3H), 7.25-7.10 (m, 4H), 7.10-6.93
(m, 2H), 4.16 (br, 1H), 2.82 (s, 3H), 2.30-2.11 (m, 6H), 2.11-1.94 (m, 9H), 1.90-1.69 (m, 9H),
1.68-1.54 (m, 6H), 1.48-1.32 (m, 1H), 1.16-0.99 (m, 1H), 1.00-0.79 (m, 2H), 0.64-0.45 (m, 4H),
0.41-0.21 (m, 1H) ppm.
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C NMR (75 MHz, CDCl3): δ 146.2, 140.4, 137.7(d), 136.8, 136.8,

128.3, 127.8, 127.8, 127.1, 125.5, 125.5, 124.8, 120.1, 41.6, 41.4, 40.8, 40.6, 40.3, 40.1, 36.9,
36.7, 29.1, 29.0, 28.9, 28.8, 28.8, 27.9, 25.6, 25.5, 17.9, 17.7, 14.0 ppm.
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P NMR (121 MHz,

CDCl3): δ 48.0 ppm.

Di-tertbutylphenylphosphine-ligated 3rd generation Buchwald
NH2
Pd L
OMs

L = PhPtBu2

palladium precatalyst (G3-Pd-tBu2PPh): Following Procedure A,
a brown solid (504 g, 83% yield from 1.0 mmol starting material)

was obtained. 1H NMR (300 MHz, CDCl3): δ 7.72-7.61 (br, 1H), 7.56 (t, J = 8.6 Hz, 2H), 7.527.46 (m, 2H), 7.35- 7.17 (m, 6H), 6.91 (t, J = 7.3 Hz, 1H), 6.75 (dd, J1 = 7.4 Hz, J2 = 4.0 Hz,
1H), 6.54 (t, J = 7.0 Hz, 1H), 4.28 (br, 1H), 2.72 (s, 3H), 1.38 (d, J = 13.6 Hz, 8H), 1.28 (d, J =
13.6 Hz, 2H), 1.19 (d, J = 14.0 Hz, 8H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.3, 140.1, 138.8,
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138.2, 138.1, 138.1, 136.5, 136.4, 135.4, 135.3, 129.8, 129.8, 129.0, 128.6, 128.5, 127.4, 127.3,
127.2, 126.9, 126.9, 126.5, 125.5, 125.3, 120.3, 40.2, 36.9, 36.7, 36.6, 36.4, 30.9, 30.8, 30.2,
30.2, 27.2 ppm. 31P NMR (121 MHz, CDCl3): δ 65.14 ppm.

Di(3,5-di-trifluoromethyl)phenyl-XPhos-ligated
F3C

CF3
NH2
Pd L
OMs

generation Buchwald palladium precatalyst: Following

P

L=
iPr

iPr

CF3

iPr

1

3rd

CF3

Procedure B, a pale yellow solid (430 mg, 0.42 mmol,
84% yield from 0.5 mmol starting material) was obtained.

H NMR (300 MHz, CDCl3): δ 9.40-9.20 (br, 1H), 7.84 (t, J = 7.3, 1H), 7.74 (t, J = 5.8 Hz, 2H),

7.62 (s, 1H), 7.58-7.39 (m, 4H), 7.38-7.30 (m, 2H), 7.26-7.11 (m, 4H), 7.05 (t, J = 5.2 Hz, 1H),
6.60 (s, 3H), 6.42 (s, 1H), 4.72-4.56 (br, 1H), 2.66 (septet, J = 6.7 Hz, 1H), 2.30 (s, 3H), 2.17
(septet, J = 7.2 Hz, 2H), 1.06 (d, J = 4.5 Hz, 6H), 0.80 (d, J = 5.7 Hz, 6H), 0.48 (d, J = 5.8 Hz,
3H), 0.31 (d, J = 6.4 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): 149.4, 145.8, 145.4, 145.2,

140.2, 139.8, 139.3, 138.4, 137.1, 136.9, 135.9, 135.3, 134.6, 133.8, 133.1, 132.3, 131.5, 131.3,
131.0, 130.4, 128.8, 128.3, 128.1, 127.9, 127.9, 127.8, 127.6, 126.5, 126.2, 124.9, 124.5, 124.4,
123.8, 123.2, 121.4, 120.9, 120.7, 120.6, 39.0, 33.4, 30.6, 25.8, 25.5, 23.6, 23.1, 21.5 ppm.
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P

NMR (121 MHz, CDCl3): δ 44.00 ppm.

Di(3,5-di-trifluoromethyl)phenyl-SPhos-ligated
F3C

NH2
Pd L
OMs

3rd

CF3
CF3

generation Buchwald palladium precatalyst: Following

CF3

Procedure B, a pale yellow solid (450 mg, 0.43 mmol,

P

L=
MeO

OMe

86% yield from 0.5 mmol starting material) was obtained.
1

H NMR (300 MHz, CDCl3): δ 8.24 (dd, J1 = 16.7, J2 = 7.6 Hz, 1H), 7.75 (s, 1H), 7.72-7.58 (m,
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4H), 7.57- 7.7.29 (m, 7H), 7.26-7.18 (m, 2H), 7.18-7.11 (m, 1H), 7.05 (t, J = 6.4 Hz, 1H), 6.86
(t, J = 8.4 Hz, 1H), 6.71-6.45 (m, 2H), 6.12 (d, J = 7.2 Hz, 1H), 5.97 (d, J = 7.0 Hz, 1H), 4.55
(br, 1H), 3.46 (s, 3H), 3.32 (s, 3H), 2.34 (s, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 157.3,

141.6, 140.7, 140.7, 139.6, 138.1, 138.0, 137.8, 137.6, 137.2, 135.3, 135.3, 134.8, 134.6, 134.4,
134.4, 132.4, 131.0, 130.6, 128.6, 127.9, 127.9, 127.8, 127.7, 127.7, 127.4, 126.3, 126.1, 124.8,
124.7, 124.0, 121.0, 116.7, 116.7, 103.6, 55.2, 39.2 ppm. 31P NMR (121 MHz, CDCl3): δ 36.74
ppm.

Di(3,5-di-trifluoromethyl)phenyl XPhosligated 4th
F3C

Me
NH
Pd L
OMs

CF3
CF3

generation

CF3

Following Procedure C, a yellow solid (148 mg, 63%

Buchwald

palladium

precatalyst:

P

L=
iPr

iPr

iPr

yield) was obtained. 1H NMR (300 MHz, CDCl3): δ

9.29 (d, J = 12.0 Hz, 1H), 7.87 (t, J = 7.2 Hz, 1H), 7.73 (s, 2H), 7.68-7.40 (m, 5H), 7.40-6.94 (m,
8H), 6.60 (s, 3H), 6.43 (s, 1H), 2.66 (septet, J = 6.8 Hz, 1H), 2.58 (q, J = 2.0 Hz, 3H), 2.28 (s,
3H), 2.16 (septet, J = 6.4 Hz, 2H), 1.05 (dd, J1 = 6.5 Hz, J2 = 4.4 Hz, 6H), 0.80 (t, J = 5.0 Hz,
6H), 0.48 (d, J = 6.5 Hz, 3H), 0.30 (d, J = 6.6 Hz, 3H) ppm.
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C NMR (75 MHz, CDCl3): δ

149.4, 145.8, 145.4, 145.1, 141.6, 141.5, 140.6, 140.2, 139.8, 138.2, 136.5, 136.4, 136.0, 135.9,
135.5 (br), 134.8 (br), 133.8, 133.8, 132.2, 132.2, 131.8 (q), 131.4, 131.4, 131.3, 131.2, 131.0,
130.9, 130.8, 130.8,129.0, 128.6, 128.3, 128.1, 127.7, 127.6, 127.2, 126.3, 124.8 (br), 124.6,
124.4, 124.2 (br), 123.8, 123.3, 121.7, 121.6, 121.4, 120.9, 120.7, 120.6, 40.8, 40.8, 38.9, 33.4,
30.6, 30.5, 25.8, 25.5, 23.6, 23.1, 21.5, 21.4 ppm. 31P NMR (121 MHz, CDCl3): δ 44.31 ppm.
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General Procedures for Suzuki Cross-Coupling Reactions in Figure 2.4.

BF3K
R

Ar
R

Me

BF3K
R

Me
ArX

condition A1/A2
“retentive pathway”

Me

condition B
“invertive pathway”

Ar
R

Me

Note: Similar selectivity for the stereoretentive pathway was observed using Conditions A1 and
A2. However, we observed that Conditions 1 provided a higher yield with electron-deficient aryl
electrophiles, while Conditions 2 provided a higher yield with electron-neutral and electron-rich
electrophiles.

General procedure 1 (conditions A1):
On the bench top, Cs2CO3 (293.2 mg, 0.9 mmol), di(3,5-di-trifluoromethyl)phenyl-SPhos (11)ligated 3rd generation Buchwald palladium precatalyst (9.4 mg, 9.0 μmol), additional 11 (6.0
mg, 9.0 μmol), sec-alkyl trifluoroborate (0.45 mmol) and aryl halide (if solid) (0.3 mmol) were
added to an oven-dried 16 mL screw-top glass culture tube equipped with a stirbar. Then the test
tube was sealed with a screw-top septum and electrical tape. Using a needle attached to a
vacuum manifold, the reaction vessel was evacuated (ca. 100 mtorr) and backfilled with argon
for 3 times. Toluene (0.6 mL) and degassed water (0.6 mL) were then added via syringe. If the
aryl halide were a liquid, it was added to the vessel via syringe at this point. Then the septum
was covered with electrical tape, and the vessel was heated to the specified temperature for 24-72
h. Following reaction, the contents of the cooled reaction mixture was transferred to a separatory
funnel, diluted with saturated NH4Cl solution (10 mL), and extracted with ethyl acetate (3 x 10
mL). The combined organic layers were washed with brine (10 mL) and dried over Na2SO4. The
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organic layer was filtered, concentrated under reduced pressure, and additionally purified by
column chromatography.

General procedure 2 (conditions A2):
On the bench top, K2CO3 (124.2 mg, 0.9 mmol), di(3,5-di-trifluoromethyl)phenyl XPhos (14)ligated 3rd generation Buchwald palladium precatalyst (9.9 mg, 9.0 μmol), additional 14 (6.6
mg, 9.0 μmol), sec-alkyl trifluoroborate (0.45 mmol) and aryl halide (if solid) (0.3 mmol) were
added to an oven-dried 16 mL screw-top glass cultural tube equipped with a stirbar. The test tube
was sealed with a screw-top septum and electrical tape. Using a needle attached to a vacuum
manifold, the reaction vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 times.
Toluene (0.6 mL) and degassed water (0.6 mL) were then added via syringe. If the aryl halide
were a liquid, it was added to the vessel via syringe at this point. Then the septum was covered
with electrical tape, and the vessel was heated to the specified temperature for 24-72 h.
Following reaction, contents of the cooled reaction mixture was transferred to a separatory
funnel, diluted with saturated NH4Cl solution (10 mL), and extracted with ethyl acetate (3 x 10
mL). The combined organic layers were washed with brine (10 mL) and dried over Na2SO4. The
organic layer was filtered, concentrated under reduced pressure, and additionally purified by
column chromatography.

General procedure 3 (conditions B):
On the bench top, K2CO3 (124.2 mg, 0.9 mmol), PAd3 (9)-ligated 3rd generation Buchwald
palladium precatalyst (12 mg, 0.015 mmol), sec-alkyl trifluoroborate (0.45 mmol) and aryl halide
(if solid) (0.3 mmol) were added to an oven-dried 16 mL screwtop glass culture tube equipped
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with a stirbar. The test tube was sealed with a screw-top septum and electrical tape. Using a
needle attached to a vacuum manifold, the reaction vessel was evacuated (ca. 100 mtorr) and
backfilled with argon 3 times. Toluene (0.6 mL) and degassed water (0.3 mL) were then added
via syringe. If the aryl halide were a liquid, it was added to the vessel via syringe at this point.
Then the septum was covered with electrical tape, and the vessel was heated to the specified
temperature (60-100 ºC) for 24 h. Following completion of the reaction, the cooled reaction
mixture was transferred to a separatory funnel, diluted with saturated NH4Cl solution (10 mL),
and extracted with ethyl acetate (3 x 10 mL). The combined organic layers were washed with
brine (10 mL) and dried over Na2SO4. The organic layer was filtered, concentrated under
reduced pressure, and additionally purified by column chromatography.

Compound Characterization (Figure 2.4):

Racemic

OMe

or

(R)-1-(sec-butyl)-4-methoxybenzene

((R)-16a).101

General procedure A2 was employed with 4-methoxyphenyl
or
Me

Et

trifluoromethanesulfonate (55.8 μL, 0.3 mmol, 1.0 equiv), potassium

sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv), precatalyst (16.6 mg, 0.015 mmol, 5
mol %) and additional ligand (11 mg, 0.015 mmol, 5 mol %). The reaction mixture was heated to
100 ºC and stirred for 48 h. A colorless liquid (35 mg, 53% yield) was isolated following column
chromatography (99:1 hexane/ether). For enantioenriched potassium sec-butyltrifluoroborate,
cesium carbonate (293.2 mg, 0.9 mmol, 3.0 equiv) was used alongside 4th generation precatalyst
(33.6 mg, 0.03 mmol, 10 mol %) and additional ligand (22.0 mg, 0.03 mmol, 10 mol %). A
colorless liquid (31.2 mg, 50% yield) was obtained. Enantiopurity of the product was determined
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by chiral GC (89% ee). A duplicate run on 0.05 mmol scale afforded the product with 89% ee.
1

H NMR (300 MHz, CDCl3): δ 7.13-7.06 (m, 2H), 6.87-6.81 (m, 2H), 3.79 (s, 3H), 2.55 (sextet,

J = 7.0 Hz, 1H), 1.56 (quintet, J = 7.3 Hz, 2H), 1.21 (d, J = 6.9 Hz, 3H), 0.81 (t, J = 7.3 Hz, 3H)
ppm. 13C NMR (75 MHz, CDCl3): δ 157.9, 140.0, 128.0, 113.8, 55.4, 41.0, 31.5, 22.2, 12.4 ppm.
Optical rotation of this product [α]25D (c 1.00, CHCl3) = -20.6 º.

Racemic

OMe

or

(S)-1-(sec-butyl)-4-methoxybenzene

((S)-16a).101

General procedure B was employed with 4-chloroanisole (36.7 μL, 0.3
or
Me

Et

mmol, 1.0 equiv) and potassium sec-butyltrifluoroborate or potassium
(R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was
heated to 80 ºC and stirred for 24 h. A colorless liquid (run 1 (racemic): 42.4 mg, 86%; run 2
(enantioenriched): 40.1 mg, 82%, 98% ee) was obtained following column chromatography
(98:2 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded
the product with 96% ee. 1H NMR (300 MHz, CDCl3): δ 7.13-7.06 (m, 2H), 6.87-6.81 (m, 2H),
3.79 (s, 3H), 2.55 (sextet, J = 7.0 Hz, 1H), 1.56 (quintet, J = 7.3 Hz, 2H), 1.21 (d, J = 6.9 Hz,
3H), 0.81 (t, J = 7.3 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 157.9, 140.0, 128.0, 113.8,

55.4, 41.0, 31.5, 22.2, 12.4 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +26.4 º.

S

S
Me

Me
Et

chloro-3-

Me

or

Et

Me

Racemic or (R)-5-(sec-butyl)-3-methylbenzo[b]thiophene
((R)-16b).56 General procedure A2 was employed with 5-

methylbenzo[b]thiophene

(54.6

mg,

0.3

mmol,

1.0

equiv),

potassium

secbutyltrifluoroborate or potassium (R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5
equiv, 98% ee), precatalyst (16.6 mg, 0.015 mmol, 5 mol %) and additional ligand (11.0 mg,
0.015 mmol, 5 mol %). The reaction mixture was heated to 100 ºC for 24 h (48 h for reaction
138

with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 40.4 mg, 66% yield; run
2 (enantioenriched): 33.6 mg, 55% yield, 90% ee) was isolated following column
chromatography (100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol
scale afforded the product with 90% ee. 1H NMR (300 MHz, CDCl3): δ 7.76 (d, J = 8.3 Hz, 1H),
7.50 (s, 1H), 7.20 (dd, J1 = 8.3 Hz, J2 = 1.6 Hz, 1H), 7.04 (s, 1H), 2.74 (sextet, J = 7.1 Hz), 2.44
(d, J = 1.1Hz, 3H), 1.67 (quintet, J = 7.4 Hz, 2H), 1.31 (d, J = 7.0 Hz, 3H), 0.85 (t, J = 7.4 Hz,
3H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.8, 140.0, 138.0, 132.2, 124.0, 122.7, 121.7, 120.0,
42.1, 31.7, 22.5, 14.1, 12.6 ppm. Optical rotation of this product [α] 25D (c 1.00, CHCl3) = -21.1 º.

S

S
Me

Me
Et

Me

or

Et

Me

Racemic or (S)-5-(sec-butyl)-3- methylbenzo[b]thiophene
((S)-16b).56 General procedure B was employed with 5-

chloro-3-methylbenzo[b]thiophene (54.6 mg, 0.3 mmol, 1.0 equiv) and potassium secbutyltrifluoroborate or potassium (R)-secbutyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv,
98% ee). The reaction mixture was heated to 100 ºC for 24 h. A colorless liquid (run 1 (racemic):
53 mg, 87% yield; run 2 (enantioenriched): 51 mg, 83% yield, 97% ee) was isolated following
column chromatography (100 % hexane). A duplicate run of the enantioenriched variant on 0.05
mmol scale afforded the product with 94% ee. 1H NMR (300 MHz, CDCl3): δ 7.76 (d, J = 8.3
Hz, 1H), 7.50 (s, 1H), 7.20 (dd, J1 = 8.3 Hz, J2 = 1.6 Hz, 1H), 7.04 (s, 1H), 2.74 (hex, J = 7.1
Hz), 2.44 (d, J = 1.1Hz, 3H), 1.67 (quintet, J = 7.4 Hz, 2H), 1.31 (d, J = 7.0 Hz, 3H), 0.85 (t, J =
7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 143.8, 140.0, 138.0, 132.2, 124.0, 122.7, 121.7,
120.0, 42.1, 31.7, 22.5, 14.1, 12.6 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) =
+21.7 º.
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Racemic or (R)-4-(sec-butyl)-1,1'-biphenyl ((R)-16c).102 General
procedure A2 was employed with 4-chlorobiphenyl (56.4 mg, 0.3
or
Me

Et

Me

Et

mmol, 1.0 equiv) and potassium secbutyltrifluoroborate or potassium

(R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was
heated to 100 ºC for 24 h. A colorless liquid (run 1 (racemic): 57.8 mg, 92% yield; run 2
(enantioenriched): 55.6 mg, 88% yield, 90% ee) was isolated following column chromatography
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the
product with 90% ee. 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 7.8 Hz, 2H), 7.58 (d, J = 8.2
Hz, 2H), 7.51-7.41 (m, 2H), 7.41-7.34 (m, 1H), 7.31 (d, J = 8.1Hz, 2H), 2.70 (sextet, J = 7.0 Hz,
1H), 1.69 (quintet, J = 7.0 Hz, 2H), 1.33 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H) ppm. 13C
NMR (75 MHz, CDCl3): δ 147.0, 141.4, 138.9, 128.9, 127.7, 127.2, 127.1, 41.6, 31.4, 22.0, 12.5
ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -23.9 º.

Racemic (or (S)-)4-(sec-butyl)-1,1'-biphenyl ((S)-16c).56 General
procedure B was employed with 4-chlorobiphenyl (56.4 mg, 0.3
or
Me

Et

Me

Et

mmol, 1.0 equiv) and potassium sec-butyltrifluoroborate or potassium

(R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was
heated to 80 ºC for 24 h. A colorless liquid (run 1 (racemic): 57.8 mg, 92% yield; run 2
(enantioenriched): 58.4 mg, 93% yield, 96% ee) was isolated following column chromatography
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the
product with 96% ee. 1H NMR (300 MHz, CDCl3): δ 7.65 (d, J = 7.8 Hz, 2H), 7.58 (d, J = 8.2

140

Hz, 2H), 7.51-7.41 (m, 2H), 7.41-7.34 (m, 1H), 7.31 (d, J = 8.1Hz, 2H), 2.70 (sextet, J = 7.0 Hz,
1H), 1.69 (quintet, J = 7.0 Hz, 2H), 1.33 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.3 Hz, 3H) ppm. 13C
NMR (75 MHz, CDCl3): δ 147.0, 141.4, 138.9, 128.9, 127.7, 127.2, 127.1, 41.6, 31.4, 22.0, 12.5
ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +27.9 º.

Racemic
OMe
Me

or

(R)-1-methoxy-2-(4-phenylbutan-2-

yl)benzene ((R)-16d).103 General procedure A2 was

or

employed with 1-chloro- 2-methoxybenzene (38.1 μL, 0.3
mmol, 1.0 equiv) and potassium 4-phenylbut-2-yl trifluoroborate or potassium (R)-4-phenylbut2-yl trifluoroborate (108.0 mg, 0.45 mmol, 96.3% ee). The reaction mixture was heated to 100 ºC
for 36 h (48 h for reaction with enantioenriched nucleophile). A colorless liquid (run 1 (racemic):
62.8 mg, 87 % yield; run 2 (enantioenriched): 61.6 mg, 86% yield, 93% ee) was isolated
following column chromatography (98:2 hexane/ether). A duplicate run of the enantioenriched
variant on 0.05 mmol scale afforded the product with 93% ee. 1H NMR (300 MHz, CDCl3): δ
7.30-7.19 (m, 3H), 7.19-7.11 (m, 4H), 6.94 (dt, J1 = 7.4 Hz, J2 = 1.1 Hz, 1H), 6.87 (dd, J1 = 8.1
Hz, J2 = 0.9 Hz, 1H), 3.81 (s, 3H), 3.25 (sextet, J = 7.2 Hz, 1H), 2.68-2.44 (m, 2H), 2.05-1.91
(m, 1H), 1.91-1.76 (m, 1H), 1.24 (d, J = 7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.2,
143.1, 135.6, 128.5, 128.3, 126.9, 126.8, 125.6, 120.8, 110.6, 55.4, 39.0, 34.2, 32.0, 21.1 ppm.
HRMS: Calcd (M+H+) 241.1592; Found 241.1603. Optical rotation of this product [α]25D (c 1.00,
CHCl3) = +16.6 º.

Racemic
OMe
Me

OMe

or

(S)-1-methoxy-2-(4-phenylbutan-2-

yl)benzene ((S)-16d).103 General procedure B was employed

Me
or
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with 1-chloro-2- methoxybenzene (38.1 μL, 0.3 mmol, 1.0 equiv) and potassium 4-phenylbut-2yl trifluoroborate or potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol,
96.3% ee). The reaction mixture was heated to 100 ºC for 24 h (48 h for reaction with
enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 66.8 mg, 93% yield; run 2
(enantioenriched): 62.3 mg, 87% yield, 94% ee) was isolated following column chromatography
(98:2 hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded
the product with 95% ee. 1H NMR (300 MHz, CDCl3): δ 7.30-7.19 (m, 3H), 7.19-7.11 (m, 4H),
6.94 (dt, J1 = 7.4 Hz, J2 = 1.1 Hz, 1H), 6.87 (dd, J1 = 8.1 Hz, J2 = 0.9 Hz, 1H), 3.81 (s, 3H), 3.25
(sextet, J = 7.2 Hz, 1H), 2.68-2.44 (m, 2H), 2.05-1.91 (m, 1H), 1.91-1.76 (m, 1H), 1.24 (d, J =
7.0 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 157.2, 143.1, 135.6, 128.5, 128.3, 126.9, 126.8,
125.6, 120.8, 110.6, 55.4, 39.0, 34.2, 32.0, 21.1 ppm. HRMS: Calcd (M+H+) 241.1592; Found
241.1603. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -17.8 º.

Racemic or (R)-1-(sec-butyl)-3-methoxybenzene ((R)- 16e).56
OMe

General procedure A1 was employed with 3-bromoanisole (38.1
Me

Et

or

μL, 0.3 mmol, 1.0 equiv) and potassium sec-butyltrifluoroborate
or potassium (R)- sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction
mixture was heated to 100 ºC and stirred for 24 h (30 h with enantioenriched nucleophile). A
colorless liquid (run 1 (racemic): 38.1 mg, 77% yield; run 2 (enantioenriched): 32.5 mg, 66%
yield, 93% ee) was isolated following column chromatography (98:2 hexane/ether). A duplicate
run of the enantioenriched variant on 0.05 mmol scale afforded the product with 93% ee. 1H
NMR (300 MHz, CDCl3): δ 7.23-7.18 (m, 1H), 6.81-6.69 (m, 3H), 3.80 (s, 3H), 2.57 (sextet, J =
7.1 Hz, 1H), 1.58 (m, 2H), 1.23 (d, J = 7.0 Hz, 3H), 0.82 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (75
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MHz, CDCl3): δ 159.8, 149.7, 129.3, 119.7, 113.2, 110.9, 55.3, 42.0, 31.3, 22.0, 12.4 ppm.
Optical rotation of this product [α]25 D (c 1.00, CHCl3) = -18.0 º.

Racemic

OMe

Me

Et

or

(S)-1-(sec-butyl)-3-methoxybenzene

((S)-16e).56

OMe

General procedure B was employed with 3-chloroanisole (36.6 μL,

or
Me

Et

0.3 mmol, 1.0 equiv) and potassium sec-butyltrifluoroborate or
potassium (R)- sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction
mixture was heated to 80 ºC and stirred for 24 h. A colorless liquid (run 1 (racemic): 42.0 mg,
85% yield; run 2 (enantioenriched): 40.2 mg, 82% yield, 95% ee) was isolated following column
chromatography (98:2 hexane/ether). A duplicate run of the enantioenriched variant on 0.05
mmol scale afforded the product with 95% ee. 1H NMR (300 MHz, CDCl3): δ 7.23-7.18 (m, 1H),
6.81-6.76 (m, 1H), 6.74 (d, J = 1.3 Hz, 1H), 6.75-6.69 (m, 1H), 3.80 (s, 3H), 2.57 (sextet, J = 7.1
Hz, 1H), 1.58 (dq, J1 = 7.5 Hz, J2 = 1.1 Hz, 2H), 1.23(d, J = 7.0 Hz, 3H), 0.82 (t, J = 7.4 Hz, 3H)
ppm.

13

C NMR (75 MHz, CDCl3): δ 159.8, 149.7, 129.3, 119.7, 113.2, 110.9, 55.3, 42.0, 31.3,

22.0, 12.4 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +22.6 º.

Racemic or (R)-ethyl 4-(sec-butyl)benzoate ((R)-16f).101 General
COOEt

procedure A1 was employed with (49.0 μL, 0.3 mmol, 1.0 equiv)
or
Me

Et

ethyl 4-bromobenzoate and potassium sec-butyltrifluoroborate or

potassium (R)-secbutyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction
mixture was heated to 100 ºC and stirred for 24 h (36 h with enantioenriched nucleophile). A
colorless liquid (run 1 (racemic): 52.0 mg, 84% yield; run 2 (enantioenriched): 53.5 mg, 87%
yield, 92% ee) was isolated following column chromatography (95:5 hexane/ether). A duplicate
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run of the enantioenriched variant on 0.05 mmol scale afforded the product with 92% ee. 1H
NMR (300 MHz, CDCl3): δ 7.96 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 4.36 (q, J = 7.1
Hz, 2H), 2.66 (sextet, J = 6.9 Hz, 1H), 1.61 (quintet, J = 7.3 Hz, 2H), 1.38 (t, J = 7.1 Hz, 3H),
1.25 (d, J = 6.9 Hz, 3H), 0.81(t, J = 7.4Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 166.8,

153.2, 129.8, 128.4, 127.2, 60.8, 41.9, 31.1, 21.8, 14.5, 12.3 ppm. Optical rotation of this product
[α]25D (c 1.00, CHCl3) = -24.1 º.

Racemic or (S)-ethyl 4-(sec-butyl)benzoate ((S)-16f).101 General

COOEt

procedure B was employed with ethyl 4-chlorobezoate (46.7 μL, 0.3
or
Me

Et

mmol, 1.0 equiv) and potassium secbutyltrifluoroborate or potassium
(R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction mixture was
heated to 60 ºC and stirred for 24 h (30 h with enantioenriched nucleophile). A colorless liquid
(run 1 (racemic): 55.3 mg, 89% yield; run 2 (enantioenriched): 53 mg, 86% yield, 96% ee) was
isolated following column chromatography (95:5 hexane/ether). A duplicate run of the
enantioenriched variant on 0.05 mmol scale afforded the product with 93% ee. 1H NMR (300
MHz, CDCl3): δ 7.96 (d, J = 8.3 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H), 4.36 (q, J = 7.1 Hz, 2H), 2.66
(sextet, J = 6.9 Hz, 1H), 1.61 (quintet, J = 7.3 Hz, 2H), 1.38 (t, J = 7.1 Hz, 3H), 1.25 (d, J = 6.9
Hz, 3H), 0.81(t, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.8, 153.2, 129.8, 128.4,
127.2, 60.8, 41.9, 31.1, 21.8, 14.5, 12.3 ppm. Optical rotation of this product [α]25D (c 1.00,
CHCl3) = +24.1 º.

Racemic or (R)-1-(4-(sec-butyl) phenyl)-1H-pyrrole ((R)- 16g).56
N

General procedure A2 was employed with 1-(4- chlorophenyl)-1HMe

Et

or
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pyrrole (53.3 mg, 0.3 mmol, 1.0 equiv), potassium sec-butyltrifluoroborate or potassium (R)-secbutyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee), precatalyst (16.6 mg, 0.015 mmol,
5 mol %) and additional ligand (11.0 mg, 0.015mmol, 5 mol %). The reaction mixture was
heated to 110 ºC for 24 h. A colorless liquid (run 1 (racemic): 34.0 mg, 57% yield; run 2
(enantioenriched): 31.2 mg, 52% yield, 85% ee) was isolated following column chromatography
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the
product with 85% ee. 1H NMR (300 MHz, CDCl3): δ 7.34-7.28 (m, 2H), 7.24-7.19 (m, 2H), 7.06
(t, J = 2.2 Hz, 2H), 6.32 (t, J = 2.2 Hz, 2H), 2.63 (sextet, J = 7.0 Hz, 1H), 1.61 (quintet, J = 7.3
Hz, 2H), 1.26 (d, J = 7.0 Hz, 3H), 0.84 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ
145.4, 138.9, 128.2, 120.7, 119.6, 110.2, 41.3, 31. 4, 22.0, 12.4 ppm. Optical rotation of this
product [α]25D (c 1.00, CHCl3) = -21.6 º.

Racemic or (S)-1-(4-(sec-butyl) phenyl)-1H-pyrrole ((S)-16g).56
N

N

General procedure B was employed with 1-(4-chlorophenyl)-1Hpyrrole
or
Me

Et

Me

Et

(53.3 mg, 0.3 mmol, 1.0 equiv) and potassium secbutyltrifluoroborate

or potassium (R)-sec-butyltrifluoroborate (73.6 mg, 0.45 mmol, 1.5 equiv, 98% ee). The reaction
mixture was heated to 80 ºC for 24 h (48 h for reaction with enantioenriched nucleophile). A
colorless liquid (run 1 (racemic): 47.9 mg, 80% yield; run 2 (enantioenriched): 38.5 mg, 64%
yield, 95% ee) was isolated following column chromatography (100% hexane). A duplicate run
of the enantioenriched variant on 0.05 mmol scale afforded the product with 95% ee. 1H NMR
(300 MHz, CDCl3): δ 7.34-7.28 (m, 2H), 7.24-7.19 (m, 2H), 7.06 (t, J = 2.2 Hz, 2H), 6.32 (t, J =
2.2 Hz, 2H), 2.63 (hex, J = 7.0 Hz, 1H), 1.61 (quintet, J = 7.3 Hz, 2H), 1.26 (d, J = 7.0 Hz, 3H),
0.84 (t, J = 7.4 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 145.4, 138.9, 128.2, 120.7, 119.6,
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110.2, 41.3, 31.4, 22.0, 12.4 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +26.8
º.
Racemic

CF3

or

(R)-1-(4-phenylbutan-2-yl)-4-

(trifluoromethyl)benzene ((R)-16h).104 General procedure
or
Me

A1 was employed with 4- bromobenzotrifluoride (42.0 μL,

0.3 mmol, 1.0 equiv) and potassium 4-phenylbut-2-yl trifluoroborate or potassium (R)-4phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 96.3% ee). The reaction mixture was
heated to 100 ºC and stirred for 30 h (48 h with enantioenriched nucleophile). A colorless liquid
(run 1 (racemic): 72.3 mg, 87% yield; run 2 (enantioenriched): 62.7 mg, 75% yield, 91% ee) was
isolated following column chromatography (100% hexane). A duplicate run of the
enantioenriched variant on 0.05 mmol scale afforded the product with 91% ee. 1H NMR (300
MHz, CDCl3): δ 7.56 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H), 7.26-7.22 (m, 2H), 7.21-7.16
(m, 1H), 7.15-7.08 (m, 2H), 2.79 (sextet, J = 7.0 Hz, 1H), 2.55-2.46 (m, 2H), 1.93 (q, J = 7.8 Hz,
2H), 1.29 (d, J = 6.9 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 151.2, 142.3, 128.6, 128.6,

127.6, 126.0, 125.6(q), 39.9, 39.6, 34.0, 22.4 ppm. Optical rotation of this product [α]25D (c 1.00,
CHCl3) = -16.1 º.

Racemic
CF3

or

(S)-1-(4-phenylbutan-2-yl)-4-

CF3

(trifluoromethyl)benzene
or
Me

Me

procedure

B

was

((S)-16h).104
employed

General
with

4-

chlorobenzotrifluoride (40.0 μL, 0.3 mmol, 1.0 equiv)
and potassium 4-phenylbut-2-yl trifluoroborate or potassium (R)-4-phenylbut-2-yl trifluoroborate
(108.0 mg, 0.45 mmol, 96.3% ee). The reaction mixture was heated to 60 ºC and stirred for 24 h.
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A colorless liquid (run 1 (racemic): 73.7 mg, 88% yield; run 2 (enantioenriched): 67 mg, 80%
yield, 87% ee) was isolated following column chromatography (hexane). A duplicate run of the
enantioenriched variant on 0.05 mmol scale afforded the product with 86% ee. 1H NMR (300
MHz, CDCl3): δ 7.56 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.6 Hz, 2H), 7.26-7.22 (m, 2H), 7.21-7.16
(m, 1H), 7.15-7.08 (m, 2H), 2.79 (sextet, J = 7.0 Hz, 1H), 2.55-2.46 (m, 2H), 1.93 (q, J = 7.8 Hz,
2H), 1.29 (d, J = 6.9 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 151.2, 142.3, 128.6, 128.6,

127.6, 126.0, 125.6(q), 39.9, 39.6, 34.0, 22.4 ppm. Optical rotation of this product [α]25D (c 1.00,
CHCl3) = +15.4 º.

Racemic or (R)-4-(1-phenylpentan-3-yl)-1,1'- biphenyl ((R)16i). General procedure A2 was employed with ethyl 4chlorobiphenyl (18.9 mg, 0.1 mmol, 1.0 equiv), potassium 1phenypentan-3-yl trifluoroborate potassium or (R)-1-phenypentan-3-yl trifluoroborate (38.0 mg,
0.15 mmol, 0.15 equiv, 98% ee), precatalyst (5.54 mg, 0.05 mmol, 5 mol %), additional ligand
(3.68 mg, 5 mol %) and toluene/water (200 uL/ 200 uL). The reaction mixture was heated to 100
ºC for 24 h. A colorless oil (run 1 (racemic): 23.7 mg, 79% yield; run 2 (enantioenriched): 22.6
mg, 75% yield, 97% ee) was isolated following column chromatography (99:1 hexane/ether). A
duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the product with 97%
ee. 1H NMR (300 MHz, CD2Cl2): δ 7.67-7.61 (m, 2H), 7.58 (d, J=8.2 Hz, 2H), 7.45 (t, J=7.2 Hz,
2H), 7.38-7.31 (m, 1H), 7.26 (t, J=8.0 Hz, 4H), 7.20-7.12 (m, 3H), 2.58-2.45 (m, 1H), 2.50 (t,
J=7.8 Hz, 2H), 2.09-1.85 (m, 2H), 1.85-1.57 (m, 2H), 0.82 (t, J=7.3 Hz, 3H) ppm. 13C NMR (75
MHz, CD2Cl2): δ 145.2, 143.2, 141.5, 139.1, 129.1, 128.8, 128.7, 128.6, 127.4, 127.3, 127.2,
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126.0, 47.5, 38.6, 34.2, 30.2, 12.3 ppm. Calcd (M+Na+) 323.1776; Found 323.1776. Optical
rotation of this product [α]20D (c 1.00, CHCl3) = -13.2 º.

Racemic or (S)-4-(1-phenylpentan-3-yl)-1,1'- biphenyl ((S)16i). General procedure B was employed with ethyl 4chlorobiphenyl (18.9 mg, 0.1 mmol, 1.0 equiv), potassium 1phenypentan-3-yl trifluoroborate or potassium (R)-1-phenypentan-3-yl trifluoroborate (38.0 mg,
0.15 mmol, 0.15 equiv, 98% ee), precatalyst (4.02 mg, 0.05 mmol, 5 mol %), and toluene/water
(200 uL/ 100 uL). The reaction mixture was heated to 80 ºC for 24 h. A colorless oil (run 1
(racemic): 22.4 mg, 75 % yield; run 2 (enantioenriched): 23.9 mg, 80% yield, 75% ee) was
isolated following column chromatography (99:1 hexane/ether). A duplicate run of the
enantioenriched variant on 0.05 mmol scale afforded the product with 75% ee. 1H NMR (300
MHz, CD2Cl2): δ 7.67- 7.61 (m, 2H), 7.58 (d, J=8.2 Hz, 2H), 7.45 (t, J=7.2 Hz, 2H), 7.38-7.31
(m, 1H), 7.26 (t, J=8.0 Hz, 4H), 7.20-7.12 (m, 3H), 2.58-2.45 (m, 1H), 2.50 (t, J=7.8 Hz, 2H),
2.09-1.85 (m, 2H), 1.85-1.57 (m, 2H), 0.82 (t, J=7.3 Hz, 3H) ppm. 13C NMR (75 MHz, CD2Cl2):
δ 145.2, 143.2, 141.5, 139.1, 129.1, 128.8, 128.7, 128.6, 127.4, 127.3, 127.2, 126.0, 47.5, 38.6,
34.2, 30.2, 12.3 ppm. Calcd (M+Na+) 323.1776; Found 323.1776. Optical rotation of this product
[α]20D (c 1.00, CHCl3) = +10.8 º.

CF3

Me

S

Me
Me
or

CF3

S

Racemic

or

(R)-2-methyl-5-(3-(4-

(trifluoromethyl)phenyl)butyl)thiophene

((R)-16j).

General

with

Me

procedure

A1

was

employed

4-

bromobenzotrifluoride (14.0 μL, 0.1 mmol, 1.0 equiv), potassium 4-(5-methylthiophen-2-yl)but2-yl trifluoroborate or potassium (R)-4- (5-methylthiophen-2-yl)but-2-yl trifluoroborate (39.0
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mg, 0.15 mmol, 1.5 equiv, 95% ee), precatalyst (5.2 mg, 0.005 mmol, 5 mol %), additional
ligand (3.4 mg, 0.005 mmol, 5 mol %), and toluene/ water (200 uL/200uL). The reaction mixture
was heated to 100 ºC for 24 h (48 h for reaction with enantioenriched nucleophile). A colorless
liquid (run 1 (racemic): 13.9 mg, 47% yield; run 2 (enantioenriched): 13.5 mg, 45% yield, 94%
ee) was isolated following column chromatography (100% hexane). A duplicate run of the
enantioenriched variant on 0.05 mmol scale afforded the product with 94% ee. 1H NMR (300
MHz, CDCl3): δ 7.57 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.56-6.52 (m, 1H), 6.50 (d, J
= 3.3 Hz, 1H), 2.85 (sextet, J = 7.11 Hz, 1H), 2.64 (t, J = 7.3 Hz, 2H), 2.44 (s, 3H), 1.96 (q, J =
7.7 Hz, 2H), 1.29 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 151.2, 142.7, 137.5,
127.6, 125.5, 124.7, 124.0, 39.9, 39.2, 28.1, 22.2, 15.4 ppm. HRMS: Calcd (M+Na+) 321.0901;
Found 321.0906. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -29.8 º.

CF3

CF3

Racemic

or

(S)-2-methyl-5-(3-(4-

(trifluoromethyl)phenyl)butyl)thiophene
Me

S

Me
or

Me

S

((S)-

16j).

Me

General

procedure

B

was

employed

with

4-

chlorobenzotrifluoride (13.3 μL, 0.1 mmol, 1.0 equiv), potassium 4-(5-methylthiophen-2- yl)but2-yl trifluoroborates or potassium (R)-4-(5-methylthiophen-2-yl)but-2-yl trifluoroborate (39.0
mg, 0.15 mmol, 1.5 equiv, 95% ee), precatalyst (8 mg, 0.01 mmol, 10 mol %) and toluene/ water
(200 uL/200uL). The vessel was heated to 60 ºC for 24 h (48 h for reaction with enantioenriched
nucleophile). A colorless liquid (run 1 (racemic): 17.8 mg, 60% yield; run 2 (enantioenriched):
15.7 mg, 53% yield, 90% ee) was isolated following column chromatography (100% hexane). A
duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the product with 90%
ee. 1H NMR (300 MHz, CDCl3): δ 7.57 (d, J = 8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 6.56-6.52
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(m, 1H), 6.50 (d, J = 3.3 Hz, 1H), 2.85 (sextet, J = 7.1 Hz, 1H), 2.64 (t, J = 7.3 Hz, 2H), 2.44 (s,
3H), 1.96 (q, J = 7.7 Hz, 2H), 1.29 (d, J = 6.9 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ

151.2, 142.7, 137.5, 127.6, 125.5, 124.7, 124.0, 39.9, 39.2, 28.1, 22.2, 15.4 ppm. HRMS: Calcd
(M+Na+) 321.0901; Found 321.0906. Optical rotation of this product [α]25D (c 1.00, CHCl3) =
+26.9 º.

Racemic
COOEt

or

(R)-ethyl-4-(4-phenoxybutan-2-

COOEt

yl)benzoate ((R)-16k). General procedure A1 was
or
O

Me

O

Me

employed with ethyl 4- bromobenzoate (16.3 μL, 0.1

mmol, 1.0 equiv), potassium 4-phenoxybut-2-yl trifluoroborate or potassium (R)-4-phenoxybut2-yl trifluoroborate (38.4 mg, 0.15 mmol, 1.5 equiv, 98% ee), precatalyst (5.2 mg, 0.005 mmol, 5
mol %), additional ligand (3.4 mg, 0.005 mmol, 5 mol %), and toluene/ water (200 uL/ 200uL).
The reaction mixture was heated to 100 ºC for 24 h (48 h for reaction with enantioenriched
nucleophile). A colorless liquid (run 1 (racemic): 13.2 mg, 44% yield; run 2 (enantioenriched):
15.2 mg, 51% yield, 95% ee) was isolated following column chromatography (95:5
hexane/ether). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the
product with 96% ee. 1H NMR (300 MHz, CDCl3): δ 7.98 (td, J1 = 8.3 Hz, J2 = 1.5 Hz, 2H),
7.32-7.21 (m, 4H), 7.25 (d, J = 1.3 Hz, 1H), 7.24-7.21 (m, 2H), 6.92 (tt, J1 = 7.4 Hz, J2 = 1.0 Hz,
1H), 6.86-680 (m, 2H), 4.37 (q, J = 7.1 Hz, 2H), 3.92-3.73 (m, 2H), 3.10 (sextet, J = 6.9 Hz,
1H), 2.20-1.98 (m, 2H), 1.39 (t, J = 7.1 Hz, 3H), 1.34 (d, J = 7.0 Hz, 3H). 13C NMR (75 MHz,
CDCl3): δ 166.7, 159.0, 152.0, 130.0, 129.5, 128.7, 127.2, 120.8, 114.6, 65.7, 60.9, 37.5, 36.6,
22.2, 14.5 ppm. HRMS: Calcd (M+Na+) 321.1467; Found 321.1461. Optical rotation of this
product [α]25D (c 1.00, CHCl3) = -90.2 º.

150

Racemic or (S)-ethyl-4-(4-phenoxybutan-2-yl)benzoate
COOEt

COOEt

((S)-16k). General procedure B was employed with ethyl 4or

O

Me

O

Me

chlorobenzoate (15.5 μL, 0.1 mmol, 1.0 equiv), potassium 4-

phenoxybut-2-yl trifluoroborate potassium or (R)-4-phenoxybut-2-yl trifluoroborate (38.4 mg,
0.15 mmol, 0.15 equiv, 98% ee), precatalyst (12 mg, 0.015 mmol, 15 mol %) and toluene/water
(200 uL/200 uL). The reaction mixture was heated to 60 ºC for 48 h. A colorless liquid (run 1
(racemic): 16.1 mg, 54% yield; run 2 (enantioenriched): 15.8 mg, 53% yield, 71% ee) was
isolated following column chromatography (95:5 hexane/ether). A duplicate run of the
enantioenriched variant on 0.05 mmol scale afforded the product with 75% ee. 1H NMR (300
MHz, CDCl3): δ 7.98 (td, J1 = 8.3 Hz, J2 = 1.5 Hz, 2H), 7.32-7.21 (m, 4H), 7.25 (d, J = 1.3 Hz,
1H), 7.24-7.21 (m, 2H), 6.92 (tt, J1 = 7.4 Hz, J2 = 1.0 Hz, 1H), 6.86-680 (m, 2H), 4.37 (q, J = 7.1
Hz, 2H), 3.92-3.73 (m, 2H), 3.10 (sextet, J = 6.9 Hz, 1H), 2.20-1.98 (m, 2H), 1.39 (t, J = 7.1 Hz,
3H), 1.34 (d, J = 7.0 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ 166.7, 159.0, 152.0, 130.0, 129.5,
128.7, 127.2, 120.8, 114.6, 65.7, 60.9, 37.5, 36.6, 22.2, 14.5 ppm. HRMS: Calcd (M+Na+)
321.1467; Found 321.1461. Optical rotation of this product [α]25D (c 1.00,CHCl3) = +63.9 º.

Me

5-((2R,4R)-4-(4-methoxyphenyl)pentan-2-yl)-3-

Me

MeO

S

methylbenzo[b]thiophene (17a). General procedure A2 was employed

Me

with 5-chloro-3- methylbenzo[b]thiophene (18.2 mg, 0.1 mmol, 1.0
equiv), potassium (2R, 4R)-4-(4-methoxyphenyl)pentan-2-yl)-trifluoroborate (34.1 mg, 0.12
mmol, 1.2 equiv), precatalyst (5.53 mg, 5.0 μmol, 5 mol %), ligand (3.68 mg, 5.0 μmol, 5 mol
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%), and toluene/water (200 uL/200 uL). The reaction mixture was heated up to 100 ºC for 24 h.
A colorless oil (27.9 mg, 86% yield) was isolated following column chromatography (0.8-1%
ether in hexane), which showed a 33:1 (anti/syn) determined by 1H NMR. 1H NMR (300 MHz,
CDCl3): δ 7.78 (d, J = 8.3 Hz, 1H), 7.38 (d, J = 1.4 Hz, 1H), 7.15 (dd, J1 = 8.3 Hz, J2 = 1.6 Hz,
1H), 7.08-7.00 (m, 3H), 6.89-6.81 (m, 2H), 3.82 (s, 3H), 2.64 (sextet, J = 7.3 Hz, 1H), 2.50-2.36
(m, 1H), 2.43 (d, J = 1.1 Hz, 3H), 1.92 (t, J = 7.5 Hz, 2H), 1.24 (d, J = 7.0 Hz, 3H), 1.14 (d, J =
6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ 158.0, 143.4, 140.0, 139.6, 138.1, 132.2, 128.3,
124.0, 122.8, 121.8, 120.0, 113.9, 55.4, 47.4, 38.1, 37.1, 23.8, 14.2 ppm. HRMS: Calcd (M+Na+)
347.1446; Found 347.1444. Optical rotation of this product [α]25D (c 1.00, CHCl3) = -137.3 º.

Me

MeO

syn/anti = 4.5:1

5-((2S,4R)-4-(4-methoxyphenyl)pentan-2-yl)-3-

Me

methylbenzo[b]thiophene (17b). General procedure B was employed

S
Me

with 5-chloro-3- methylbenzo[b]thiophene (18.2 mg, 0.1 mmol, 1.0
equiv), potassium (2R, 4R)-4-(4-methoxyphenyl)pentan-2-yl)-trifluoroborate (34.1 mg, 0.12
mmol, 1.2 equiv), precatalyst (8.0 mg, 0.01 mmol, 10 mol %) and benzene/water (200 uL/200
uL). Schlenk tube was used in this reaction, which was heated up to 80 ºC for 48 h. A colorless
oil (21.2 mg, 65% yield) was isolated following column chromatography (0.8-1% ether in
hexane), which showed a 5:1 (syn/anti) determined by 1H NMR. 1H NMR (300 MHz, CDCl3): δ
7.77 (d, J = 8.3 Hz, 1H), 7.47 (d, J = 1.2 Hz, 1H), 7.18 (dd, J1 = 8.3 Hz, J2 = 1.4 Hz, 1H), 7.127.04 (m, 3H), 6.89-6.81 (m, 2H), 3.80 (s, 3H), 2.80 (sextet, J = 7.1 Hz, 1H), 2.64 (sextet, J = 7.1
Hz, 1H), 2.43 (s, 3H), 2.07-1.92 (m, 1H), 1.92-1.77 (m, 1H), 1.31 (d, J = 6.9 Hz, 3H), 1.24 (d, J
= 6.8 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 157.9, 143.9, 140.1, 140.0, 138.0, 132.2,

128.0, 123.8, 122.8, 121.8, 120.0, 114.0, 55.4, 47.6, 37.8, 36.8, 22.9, 22.6, 14.2 ppm. HRMS:
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Calcd (M+Na+) 347.1446; Found 347.1444. Optical rotation of this product [α]25D (c 1.00,
CHCl3) = +2.8 º.
((1R,
Me

Me or

2R)-2-methylcyclopentyl)benzene

and

((1S,

2S)-2-

methylcyclopentyl)benzene (18) (56). General procedure A2 was
employed with chlorobenzene (30.4 μL, 0.3 mmol, 1.0 equiv) and

potassium trans-2-methylcyclopent-1-yl trifluoroborate (85.5 mg, 0.45 mmol, 1.5 equiv). The
reaction mixture was heated to 100 ºC for 24 h. A colorless liquid (run 1: 34.4 mg, 72% yield;
run 2: 33.9 mg, 71% yield) was obtained by chromatography (100% hexane). 1H NMR (300
MHz, CDCl3): δ 7.39-7.32 (m, 2H), 7.32- 7.21 (m, 3H), 2.55-2.40 (m, 1H), 2.22-1.89 (m, 3H),
1.89-1.72 (m, 3H), 1.47-1.28 (m, 1H), 0.99 (d, J = 6.3 Hz, 3H). 13C NMR (75 MHz, CDCl3): δ
145.6, 128.4, 127.6, 125.9, 54.7, 43.2, 35.5, 34.9, 24.0, 18.7 ppm.

S

Racemic

S

Me

or

Me

or

(S)-3-(4-phenylbutan-2-yl)thiophene

(19a).

General procedure B was employed with 3- bromothiophene
(28.1 uL, 0.3 mmol, 1.0 equiv), potassium 4-phenylbut-2-yl

trifluoroborate or potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 96.3%
ee), and toluene/water (600 uL/600 uL). The vessel was heated to 80 ºC for 24 h (48 h for
reaction with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 36.2 mg, 56%
yield; run 2 (enantioenriched): 30.2 mg, 47% yield, 92% ee) was obtained by chromatography
(100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol scale afforded the
product with 90% ee. 1H NMR (300 MHz, CDCl3): δ 7.34- 7.24 (m, 3H), 7.23-7.14 (m, 3H),
7.03-6.99 (m, 1H), 6.99-6.96 (m, 1H), 2.90 (sextet, J = 7.0 Hz, 1H), 2.58 (t, J = 8.0 Hz, 2H),
2.04-1.82 (m, 2H), 1.31 (d, J = 6.9 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 148.3, 142.6,
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128.5, 128.4, 126.8, 125.8, 125.4, 119.2, 39.9, 34.8, 33.8, 22.1 ppm. HRMS: Calcd (M+H+)
217.1051; Found 217.1068. Optical rotation of this product [α]25D (c 1.00, CHCl3) = +18.7 º.

Racemic or (S)-3-(4-phenylbutan-2-yl)furan (19b). General
O

O

Me

Me

procedure B was employed with 3-bromofuran (27.0 uL, 0.3

or

mmol, 1.0 equiv), potassium 4-phenylbut-2-yl trifluoroborate or
potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol, 96.3% ee), and
toluene/water (600 uL/600 uL). The reaction mixture was heated to 100 ºC for 24 h (48 h for
reaction with enantioenriched nucleophile). A colorless liquid (run 1 (racemic): 26.8 mg, 45%
yield; run 2 (enantioenriched): 24.6 mg, 41% yield, 90% ee) was isolated following column
chromatography (100% hexane). A duplicate run of the enantioenriched variant on 0.05 mmol
scale afforded the product with 89% ee. 1H NMR (300 MHz, CDCl3): δ 7.42-7.39 (m, 1H), 7.357.25 (m, 3H), 7.25-7.16 (m, 3H), 6.35 (t, J = 0.8 Hz, 1H), 2.71 (sextet, J = 7.0 Hz, 1H), 2.62 (t, J
= 7.9 Hz, 1H), 1.96-1.77 (m, 2H), 1.26 (d, J = 6.9 Hz, 3H) ppm. 13C NMR (75 MHz, CDCl3): δ
143.0, 142.6, 138.3, 130.7, 128.5, 128.4, 125.8, 109.5, 39.4, 33.7, 29.8, 21.6 ppm. HRMS: Calcd
(M+H+) 201.1279; Found 201.1278. Optical rotation of this product [α] 25D (c 1.00, CHCl3) =
+8.7 º.

Racemic (or (S))-2-methyl-8-(4-phenylbutan- 2-yl)quinolone (19c) (18). General procedure B
was employed with 8- chloro-2-methylquinoline (53.3 mg, 0.3 mmol, potassium 4-phenylbut-2yl trifluoroborate or potassium (R)-4-phenylbut-2-yl trifluoroborate (108.0 mg, 0.45 mmol,
96.3% ee), and toluene/water (600 uL/ 600uL). A slightly yellow liquid (run 1 (racemic): 55.8
mg, 68% yield; run 2 (enantioenriched): 45.5 mg, 55% yield, 90% ee) was isolated following
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column chromatography (97:3 hexane/ether). A duplicate run of the enantioenriched variant on
0.05 mmol scale afforded the product with 89% ee. 1H NMR (300 MHz, CDCl3): δ 8.01 (d, J =
8.3 Hz, 1H), 7.61 (d, J = 8.0 Hz, 1H), 7.57 (d, J = 7.4 Hz, 1H), 7.44 (t, J = 7.7 Hz, 1H), 7.24 (t, J
= 8.3 Hz, 3H), 7.19-7.10 (m, 3H), 4.37 (sextet, J = 7.0 Hz, 1H), 2.73 (s, 3H), 2.69-2.47 (m, 2H),
2.23-2.07 (m, 1H), 2.07-1.91 (m, 1H), 1.40 (d, J = 7.0 Hz, 3H) ppm.

13

C NMR (75 MHz,

CDCl3): δ 157.6, 146.2, 145.7, 143.3, 136.4 128.6, 128.3, 126.6, 125.9, 125.6, 125.6, 125.4,
121.6, 40.1, 34.4, 32.1, 25.8, 21.9 ppm. Optical rotation of this product [α]25D (c 1.00, CHCl3) = 80.9 º.
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Chiral GC Data for Compounds of Figure 3
Chiral Gas Chromatography
Instrument: Shimadzu GC-2010 Gas Chromatograph
Column: Restek Rt®-bDEXsm (30 meter, 0.32 mm ID, 0.25 um df)
Carrier gas: Helium
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158

159

160

161

162

163

164

165

166

167

168

169

170

171

172

173

174

175

176

177

178

179

180

181

182

183

184

185

186

187

188

189

190

Chiral HPLC Data
Instrument: Shimadzu LC-20AB, with SPD-20A dual-channel UV detector
Column: Chiral PAK IA;
Mobile Phase: A: H2O; B: acetonitrile
Method: 1.5 mL/min, 25% B gradient to 35% B at 60 min
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Column: Chiral PAK IA;
Mobile Phase: A: H2O; B: acetonitrile
Method: 1.4 mL/min, isocratic 40% B for 5 minutes, gradient to 100%
B at 25 minutes, then gradient to 60% B at 35 minutes
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Column: Chiral PAK IA
Mobile Phase: A: H2O; B: Acetonitrile
Method: 1.0 ml/mL, isocratic 85% B
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Column: Chiral PAK IA
Mobile Phase: A: H2O; B: 95/5 (methanol/acetonitrile)
Method: 1.2 mL/min, isocratic 85% B

195

196

Column: Chiral PAK IA
Mobile Phase: A: H2O; B: 95/5 (methanol/acetonitrile)
Method: 2.0 mL/min, isocratic 85% B

197

Column: Chiral OJ-RH
Mobile Phase: A: H2O; B: Acetonitrile
Method: 1.0 mL/min, 70% B gradient to 95% B at 45 mins

198

Column: Chiral PAK IA
Mobile Phase: A: 2-propanol; B: 99/1 Hexane: 2-propanol
Method: 0.5 mL/min, 100 % B for 25 min, gradient to 40 % B at 27 min

199

200

201

202

203

204

205

206

207

208

209

210

211

NMR Spectra Data
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8. Supporting Information for Chapter 3

General Information
Commercially available reagents were purchased from Sigma-Aldrich, Alfa-Aesar, and Acros,
and used as received unless otherwise noted. Anhydrous THF (inhibitor-free), diethyl ether,
dichloromethane, and toluene were purified by passing through two packed columns of neutral
alumina. Water was distilled and degassed prior to use. Flash chromatography was performed
using Silicylcle silica gel (ultra pure grade). Solvents used for chromatography (ACS grade)
were purchased from Fisher, and used as received.
General Analytical Information
Compounds were characterized by 1H NMR,

13

C NMR and

11

B spectroscopy. Copies of the

NMR spectra for compounds can be found later in the Supporting Information. NMR spectra
were recorded on a Bruker 300 MHz or 800 MHz instrument. All 800 MHz NMR data presented
was collected at the City University of New York Advanced Science Research Center (CUNY
ASRC) Biomolecular NMR Facility. All 1H NMR experiments are reported in δ units, parts per
million (ppm), and were measured relative to the signals for residual chloroform (7.26 ppm),
DMSO (2.50 ppm), or acetone (2.05 ppm). All 13C NMR spectra are reported in ppm relative to
deuterochloroform (77.23 ppm) or DMSO (39.52 ppm), and were obtained with 1H decoupling.
All GC analyses were performed on a Shimadzu GC- 2010 gas chromatograph with an FID
detector using a 25 m x 0.20 mm capillary column with cross-linked methyl siloxane as the
stationary phase. All GC yields were calibrated using dodecane as an internal standard.
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Procedural Information

General Procedure for Deuteration of Alkenes by D2 gas and Pd/C:
Alkene (1.8 mmol) and Pd/C (0.04 g) is added to a Q-tube with MeCN (5.5 ml). This is then
back filled with D2 gas (x2) at 100 psi and stirred overnight. The solution is then filtered through
a syringe filter and concentrated.

General Procedure for Preparation of Potassium Alkyltrifluoroborates:
The pinacolboronate (10 mmol) was added to a 100 mL round bottom flask equipped with a
stirbar, and MeOH or MeCN (50 mL) was added via a syringe. Pre-prepared KHF2 aqueous
solution (10.0 mL, 4.5 M, 45 mmol) was added to the mixture via pipet. The mixture was
allowed to stirred at room temperature for 2 h, after which time no more boronate was detectable
by GC. The solvent was removed under reduced pressure. The solid residue was extracted with
acetone (20 mL x 3). The combined extracts were filtered through a cotton plug into another
round bottom flask. Acetone was removed under reduced pressure. The remaining residue was
dissolved in ether (0.5-1 mL) and precipitated by addition of hexane. The precipitate was
collected on a fritted filter funnel, and washed with hexane.

Synthesis of MOM-Based Nucleophile:

tert-butyldiphenyl(prop-2-yn-1-yloxy)silane (Precursor to 21). To a
dried round bottom flask, DMAP (1.47 g, 12 mmol) was added and the
flask was evacuated and backfilled with argon (x3). DCM (40 ml), TBDPS-Cl (33 ml, 120
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mmol) and Et3N (16.75 ml, 120 mmol) were added. The flask was cooled to 0 oC and propargyl
alcohol (5.82 ml, 100 mmol) was added dropwise. The reaction was allowed to warm to rt, while
stirring overnight. The reaction was then quenched with H2O (at 0 oC), the organic layer was
extracted with DCM (x3). The organic solution was then dried with sodium sulfate, concentrated
in vacuo and purified via column chromatography, yielding a white solid (26.25 g, 89 mmol,
89% yield). 1H NMR (300 MHz, CDCl3): δ 7.71 (m, 4H), 7.42 (m, 6H), 4.30 (d, J = 2.4 Hz, 2H),
2.38 (t, J = 2.4 Hz, 1H), 1.06 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 135.8, 133.2, 130.0,

127.9, 73.2, 52.7, 26.9, 19.3 ppm.

(E)-tert-butyldiphenyl((3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan2-yl)allyl)oxy)silane (21).74 A flask (backfilled with argon) is charged
with tert-butyldiphenyl(prop-2-yn-1-yloxy)silane (2.28 g, 7.75 mmol) and DCM (6 ml). This
flask is then cooled to 0 oC and pinacolborane (1.18 ml, 8.1 mmol) is added dropwise. This is
then slowly transferred by cannula to another flask (containing Schwartz reagent (0.21 g, 10 mol
%) and DCM (6.5 ml), under argon). This solution is allowed to rise to rt and stirred overnight.
The reaction is then quenched with H2O, extracted with E2O (x3), washed with water and then
dried with sodium sulfate. The solution was concentrated in vacuo and purified via column
chromatography, yielding a white solid (1.38 g, 3.25 mmol, 42% yield). 1H NMR (300 MHz,
CDCl3): δ 7.67 (m, 4H), 7.38 (m, 6H), 6.67 (dt, J1 = 17.9 Hz, J2 = 3.3 Hz, 1H), 5.94 (dt, J1 = 17.9
Hz, J2 = 2.2 Hz, 1H), 4.27 (t, J = 2.18, 1H), 4.26 (t, J = 2.23 Hz, 1H), 1.29 (s, 12H), 1.06 (s, 9H)
ppm.

13

C NMR (75 MHz, CDCl3): δ 151.8, 135.7, 133.7, 129.8, 127.9, 83.4, 65.2, 27.0, 25.0,

19.5 ppm. 11B NMR (96 MHz, CDCl3): δ 29.5 ppm.
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2-[3-(tert-Butyldiphenylsiloxy)-1,2-syn-dideuteriopropyl]-2-4,4,5,5tetramethyl-1,3,2-dioxaborolane

(22).

Prepared

via

General

Procedure for Deuteration of Alkenes by D2 gas and Pd/C. Yielding a clear oil (100% yield). 1H
NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.67 (m, 4H), 7.42-7.35 (m, 6H), 3.62 (d, J =
6.9 Hz, 2H), 1.68 (apparent quartet, J1 = 6.6 Hz, J2 = 6.4 Hz, 1H), 1.22 (s, 12H), 1.04 (s, 9H),
0.79 (d, J = 6.1 Hz) ppm. 13C NMR (75 MHz, CDCl3): δ 135.8, 134.4, 129.6, 127.7, 83.1, 65.9,
27.1, 25.0, 19.4 ppm. 11B NMR (96 MHz, CDCl3): δ 34.3 ppm.

2,3-syn-dideuterio-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2yl)propan-1-ol (23).76 Under argon, 2-[3-(tert-Butyldiphenylsiloxy)-1,2-syndideuteriopropyl]-2-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (22) (0.812 g, 1.9 mmol) and
MeOH (6 ml) were stirred at 0 oC. Acetyl chloride (0.02 ml, 0.28 mmol) was added dropwise.
The solution was allowed to warm to rt and stirred overnight. DCM (20 ml per 1 mmol of
substrate) was added and then aqueous NaHCO3 (1 ml per 1 mmol of substrate) was added. This
was then extracted with DCM and washed with H2O. The organic phase was dried with sodium
sulfate and concentrated in vacuo. Purification by column chromatography yielded an oil (0.2 g,
1.06 mmol, 56% yield). 1H NMR (300 MHz, deuterium decoupled, CDCl3): δ 4.01 (d, J = 7.0
Hz, 1H), 3.84 (d, J = 6.8 Hz, 1H), 3.61 (broad t, J = 5.3 Hz, 1 H), 1.68 (m, 1H), 1.25 (s, 12H),
0.80 (m, 1H) ppm.

13

C NMR (75 MHz, CDCl3): δ 83.4, 65.0, 26.9, 25.0 ppm.

11

B NMR (96

MHz, CDCl3): δ 34.0 ppm.

2-(1,2-syn-dideuterio-3-(methoxymethoxy)propyl)-4,4,5,5tetramethyl-1,3,2-dioxaborolane (24). In a dry flask (under argon),

252

containing 2,3-syn-dideuterio-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)propan-1-ol (23)
(0.91 g, 4.85 mmol), MOM-Cl (0.77 ml, 9.9 mmol) and DCM (30 ml), was cooled to 0 oC. iPr2NEt (6.87 ml, 39.4 mmol) was added dropwise, the solution was then allowed to warm to rt
while stirring overnight. This was quenched with H2O and extracted with DCM (x3). The
organic phase was then dried with sodium sulfate and concentrated in vacuo. Purification via
column chromatography yielded a yellow-ish oil (1.08 g, 4.6 mmol, 95% yield). 1H NMR (300
MHz, deuterium decoupled, CDCl3): δ 4.63 (s, 2H), 3.50 (d, J = 6.7 Hz, 2H), 3.37 (s, 3H), 1.70
(apparent quartet, J1 = 6.5 Hz, J2 = 6.6 Hz, 1H), 1.26 (s, 12H), 0.82 (m, 1H) ppm. 13C NMR (75
MHz, CDCl3): δ 113.8, 96.4, 83.1, 69.6, 55.2, 25.0 ppm.

11

B NMR (96 MHz, CDCl3): δ 34.1

ppm.

Potassium

(1,2-syn-dideuterio-3

(methoxymethoxy)propyl)trifluoroborate (25). Prepared via General
Procedure for Preparation of Potassium Alkyltrifluoroborates. Yielding a white solid (77%
yield). 1H NMR (300 MHz, deuterium decoupled, DMSO): δ 4.49 (s, 2H), 3.29 (d, J = 7.6 Hz,
2H), 3.21 (s, 3H), 1.34 (m, 1H), -0.16 (m, 1H) ppm. 13C NMR (75 MHz, CDCl3): δ 95.4, 71.0,
54.2, 30.6, 23.7 ppm. 11B NMR (96 MHz, CDCl3): δ 4.75 (d, J = 56.2 Hz) ppm.

Synthesis of t-Butyl-Based Nucleophiles:

(E)-2-(3,3-dimethylbut-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(26).74 A flask (backfilled with argon) is charged with 3,3-dimethylbut-1-yne
(3.7 ml, 30 mmol) and DCM (9 ml). This flask is then cooled to 0 oC and
pinacolborane (4.4 ml, 31 mmol) is added dropwise. This is then slowly transferred by cannula to
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another flask (containing Schwartz reagent (0.39 g, 5 mol %) and DCM (5 ml), under argon).
This solution is allowed to rise to rt and stirred overnight. The reaction is then quenched with
H2O, extracted with E2O (x3), washed with water and then dried with sodium sulfate. The
solution was concentrated in vacuo and purified via column chromatography, yielding a white
solid (3.67 g, 17.5 mmol, 58% yield). 1H NMR (300 MHz, CDCl3): δ 6.64 (d, J = 18.2 Hz, 1H),
5.35 (d, 18.2 Hz, 1H), 1.27, (s, 12H), 1.07 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 164.61,

83.19, 29.0, 25.0 ppm. 11B NMR (96 MHz, CDCl3): δ 30.0 ppm.

2-(1,2-syn-dideuterio-3,3-dimethylbutyl)-4,4,5,5-tetramethyl-1,3,2dioxaborolane (27). Prepared via General Procedure for Deuteration of
Alkenes by D2 gas and Pd/C. Yielding a clear oil (100% yield). 1H NMR (800
MHz, deuterium decoupled, CDCl3): δ 1.27 (d, J = 5.0 Hz, 1H), 1.24 (s, 12H), 0.84 (s, 9H), 0.68
(d, J = 5.0 Hz, 1H) ppm.

13

C NMR (75 MHz, CDCl3): δ 83.0, 37.4, 30.9, 29.0, 25.0 ppm.

11

B

NMR (96 MHz, CDCl3): δ 34.4 ppm.

Potassium (1,2- syn-dideuterio-3,3-dimethylbutyl)trifluoroborate (28).
Prepared

via

General

Procedure

for

Preparation

of

Potassium

Alkyltrifluoroborates. Yielding a white solid (71% yield). 1H NMR (300 MHz,
deuterium decoupled, DMSO): δ 0.98 (d, J = 4.2 Hz, 1H), 0.76 (s, 9H), -0.20 (m, 1H) ppm. 13C
NMR (75 MHz, CDCl3): δ 30.4, 29.4 ppm. 11B NMR (96 MHz, CDCl3): δ 5.1 ppm.

2-(3,3-dimethylbut-1-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(29).78 To a solution of 3,3-dimethylbut-1-yne (5.55 mL, 45 mmol) in
diethyl ether (100 mL) in a 500 mL flask (at -78 °C, under an Ar atmosphere) dropwise n-BuLi
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(45 mmol, in hexane solution) was added. The reaction mixture was stirred for 1 h at -78 °C. The
resulting reaction mixture was then added to a solution of 4,4,5,5-tetramethyl-2-(1methylethoxy)-1,3,2-dioxaborolane (7.65 mL, 37.5 mmol) in diethyl ether (100 mL) at -78 °C.
After being stirred for 2 h at -78 °C, the reaction mixture was quenched with 1.0 M HCl/Et2O
(57 mL, 57 mmol), and the mixture was warmed to room temperature with additional 1 h
stirring. Filtration, evaporation, then followed by column chromatography afforded a pale yellow
oil (6.27g, 30.4 mmol, 81%). 1H NMR (300 MHz, CDCl3): δ 1.27 (s, 12H), 1.24 (s, 9H) ppm.
13

C NMR (75 MHz, CDCl3): δ 84.2. 30.7, 28.1, 24.8 ppm.

11

B NMR (96 MHz, CDCl3): δ 23.8

ppm.

(Z)-2-(3,3-dimethylbut-1-en-1-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
(30).79 To a stirred mixture of Schwartz reagent (10.05 g, 38.6 mmol) in THF
(75 ml) (under argon) was added 2-(3,3-dimethylbut-1-yn-1-yl)-4,4,5,5-tetramethyl-1,3,2dioxaborolane (29) (6.7 g, 32.2 mmol, in 50 ml THF). The reaction was stirred for 30 min, then
H2O (100 ml) was added and the solution was stirred a further 30 min. THF was then removed in
vacuo, then product was then extracted with hexanes (x3). This was then concentrated in vacuo,
affording a clear oil (6.39 g, 30.4 mmol, 91% yield). 1H NMR (300 MHz, CDCl3): δ 6.26 (d, J =
15.0 Hz, 1H), 5.18 (d, J = 15.0 Hz, 1H), 1.28 (s, 12H), 1.09 (s, 9H) ppm.

13

C NMR (75 MHz,

CDCl3): δ 159.9, 83.5, 35.3, 31.1, 30.1, 25.0 ppm. 11B NMR (96 MHz, CDCl3): δ 30.5 ppm.

2-(1,2-anti-dideuterio-3,3-dimethylbutyl)-4,4,5,5-tetramethyl-1,3,2dioxaborolane (31). Prepared via General Procedure for Deuteration of
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Alkenes by D2 gas and Pd/C. Yielding a clear oil (100% yield). 1H NMR (800 MHz, deuterium
decoupled, CDCl3): δ 1.26 (d, J = 12.3 Hz, 1H), 1.25 (s, 12H), 0.84 (s, 9H), 0.68 (d, J = 12.3 Hz,
1H) ppm. 13C NMR (75 MHz, CDCl3): δ 83.0, 37.4, 30.9, 29.0, 25.0 ppm.

11

B NMR (96 MHz,

CDCl3): δ 34.4 ppm.

Potassium (1,2- anti-dideuterio-3,3-dimethylbutyl)trifluoroborate (32).
Prepared

via

General

Procedure

for

Preparation

of

Potassium

Alkyltrifluoroborates. Yielding a white solid (77% yield). 1H NMR (300 MHz,
deuterium decoupled, DMSO): δ 0.97 (d, J = 13.8Hz, 1H), 0.75 (s, 9H), -0.20 (m, 1H) ppm. 13C
NMR (75 MHz, CDCl3): δ 30.4, 29.4 ppm. 11B NMR (96 MHz, CDCl3): δ 5.1 ppm.

General Procedures for Suzuki Cross-Coupling Reactions in Figure 3.6:

Note: for characterization of ligands/catalysts please see SI for Chapter 2.

General procedure (conditions A):
On the bench top, K2CO3 (20 mg, 0.015 mmol), P(t-Bu3)-ligated 3rd generation Buchwald
palladium precatalyst (1.4 mg, 0.0025 mmol), potassium trifluoroborate (0.075 mmol) and aryl
halide (if solid) (0.05 mmol) were added to an oven-dried 16 mL screwtop glass culture tube
equipped with a stirbar. The test tube was sealed with a screw-top septum and electrical tape.
Using a needle attached to a vacuum manifold, the reaction vessel was evacuated (ca. 100 mtorr)
and backfilled with argon 3 times. Toluene (0.1 mL) and degassed water (0.05 mL) were then
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added via syringe. If the aryl halide were a liquid, it was added to the vessel via syringe at this
point. Then the septum was covered with electrical tape, and the vessel was heated to 100 ºC for
24 h. Following completion of the reaction, dodecane (10 l) was added (for GC yield
calculation) and the cooled reaction mixture was diluted with saturated NH4Cl solution. After
extraction with ethyl acetate (3 x 10 mL), the sample was shot on the GC. The remaining organic
layers were filtered through a syringe filter and concentrated for NMR/ further deprotection.

General procedure (conditions B):
On the bench top, K2CO3 (20 mg, 0.015 mmol), di(3,5-di-trifluoromethyl)phenyl XPhos (14)ligated 3rd generation Buchwald palladium precatalyst (2.8 mg, 0.0025 mmol), potassium
trifluoroborate (0.075 mmol) and aryl halide (if solid) (0.05 mmol) were added to an oven-dried
16 mL screwtop glass culture tube equipped with a stirbar. The test tube was sealed with a
screw-top septum and electrical tape. Using a needle attached to a vacuum manifold, the reaction
vessel was evacuated (ca. 100 mtorr) and backfilled with argon 3 times. Toluene (0.1 mL) and
degassed water (0.05 mL) were then added via syringe. If the aryl halide were a liquid, it was
added to the vessel via syringe at this point. Then the septum was covered with electrical tape,
and the vessel was heated to 100 ºC for 24 h. Following completion of the reaction, dodecane (10
l) was added (for GC yield calculation) and the cooled reaction mixture was diluted with
saturated NH4Cl solution. After extraction with ethyl acetate (3 x 10 mL), the sample was shot
on the GC. The remaining organic layers were filtered through a syringe filter and concentrated
for NMR/further deprotection.
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Compound Characterization (Figure 2.4):

Ethyl

4-(3-((tert-butyldiphenylsilyl)oxy)-1,2-syn-

dideuteriopropyl)benzoate (33). Prepared via General
procedure (conditions A) from potassium (1,2-syndideuterio-3 (methoxymethoxy)propyl)trifluoroborate (25). This was then placed in a bomb-flask
with excess TFA and stirred at 70 oC overnight. The solution was then diluted with H2O and
neutralized with aqueous NaHCO3 and extracted with DCM. This filtered through a small
amount of silica (1:9 ether:hex, to filter off undesired compounds, followed by 100% DCM to
retrieve semi-pure product). This was then reprotected following the same procedure to
synthesize tert-butyldiphenyl(prop-2-yn-1-yloxy)silane (above). Following this protection,
column chromatography afforded a clear oil (35% yield, based on 0.05 mmol of aryl chloride
electrophile). ). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.1 Hz, 2H),
7.66 (d, J = 6.9 Hz, 4H), 7.42 (t, J = 7.3 Hz, 2H), 7.38 (t, J = 7.3 Hz, 4H), 7.22 (d, J = 8.0 Hz,
2H), 4.37 (q, J = 7.1 Hz, 2H), 3.68 (d, J = 6.1 Hz, 2H), 2.75 (d, J = 6.3 Hz, 1H), 1.85 (apparent
quartet, J = 6.1 Hz, 1H), 1.39 (t, J = 7.1 Hz, 3H), 1.07 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3):
δ 186.8, 147.8, 135.7, 134.0, 129.8, 128.6, 128.2, 127.8, 62.9, 60.9, 33.7, 32.0, 27.1, 19.4, 14.5
ppm.

Ethyl

4-(3-((tert-butyldiphenylsilyl)oxy)-1,2-syn-

dideuteriopropyl)benzoate (34). Prepared via General
procedure (conditions B) from potassium (1,2-syndideuterio-3 (methoxymethoxy)propyl)trifluoroborate (25). This was then placed in a bomb-flask
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with excess TFA and stirred at 70 oC overnight. The solution was then diluted with H2O and
neutralized with aqueous NaHCO3 and extracted with DCM. This filtered through a small
amount of silica (1:9 ether:hex, to filter off undesired compounds, followed by 100% DCM to
retrieve semi-pure product). This was then reprotected following the same procedure to
synthesize tert-butyldiphenyl(prop-2-yn-1-yloxy)silane (above). Following this protection,
column chromatography afforded a clear oil (51% yield, based on 0.05 mmol of aryl chloride
electrophile). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.1 Hz, 2H), 7.66
(d, J = 6.9 Hz, 4H), 7.42 (t, J = 7.3 Hz, 2H), 7.38 (t, J = 7.3 Hz, 4H), 7.22 (d, J = 8.0 Hz, 2H),
4.37 (q, J = 7.1 Hz, 2H), 3.68 (d, J = 6.1 Hz, 2H), 2.75 (d, J = 6.3 Hz, 1H), 1.85 (apparent
quartet, J = 6.1 Hz, 1H), 1.39 (t, J = 7.1 Hz, 3H), 1.07 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3):
δ 186.8, 147.8, 135.7, 134.0, 129.8, 128.6, 128.2, 127.8, 62.9, 60.9, 33.7, 32.0, 27.1, 19.4, 14.5
ppm.

Ethyl 4-(1,2-syn-dideuterio-3,3-dimethylbutyl)benzoate (35).
Prepared via General procedure (conditions A) from potassium
(1,2-syn-dideuterio-3,3-dimethylbutyl)trifluoroborate

(28).

(70% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.0
Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H), 4.36 (q, J = 7.1 Hz, 2H), 2.60 (d, J = 4.7 Hz. 1H), 1.47 (d, J =
4.7 Hz. 1H), 1.38 (t, 7.1 Hz, 3H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.9, 149.3,
129.9, 128.5, 128.1, 60.9, 45.7, 31.3, 30.7, 29.5, 14.6 ppm.

Ethyl 4-(1,2-syn-dideuterio-3,3-dimethylbutyl)benzoate (36).
Prepared via General procedure (conditions B) from potassium
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(1,2-syn-dideuterio-3,3-dimethylbutyl)trifluoroborate (28). (80% GC calibrated yield). 1H NMR
(800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 8.0 Hz, 2H),
4.36 (q, J = 7.1 Hz, 2H), 2.60 (d, J = 4.7 Hz. 1H), 1.47 (d, J = 4.7 Hz. 1H), 1.38 (t, 7.1 Hz, 3H),
0.96 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 166.9, 149.3, 129.9, 128.5, 128.1, 60.9, 45.7,

31.3, 30.7, 29.5, 14.6 ppm.

4-(1,2-syn-dideuterio-3,3-dimethylbutyl)-1,1'-biphenyl (37).
Prepared via General procedure (conditions A) from potassium
(1,2-syn-dideuterio-3,3-dimethylbutyl)trifluoroborate

(28).

(90% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.58 (dd, J1 =
8.2 Hz, J2 = 1.2 Hz, 2H) 7.51 (dt, J1 = 8.2 Hz, J2 = 1.2 Hz, 2H), 7.43 (t, J = 8.1 Hz, 2H), 7.33 (tt,
J1 = 7.4 Hz, J2 = 1.2 Hz, 1H), 7.26 (d, J = 7.7 Hz, 2H), 2.59 (d, J = 4.7 Hz, 1H), 1.52 (d, J = 4.7
Hz, 1H), 0.98 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 142.9, 141.4, 138.7, 128.9, 128.8,

127.3, 127.2, 127.1, 30.7, 29.5 ppm.

4-(1,2-syn-dideuterio-3,3-dimethylbutyl)-1,1'-biphenyl (38).
Prepared via General procedure (conditions B) from potassium
(1,2-syn-dideuterio-3,3-dimethylbutyl)trifluoroborate

(28).

(97% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.58 (dd, J1 =
8.2 Hz, J2 = 1.2 Hz, 2H) 7.51 (dt, J1 = 8.2 Hz, J2 = 1.2 Hz, 2H), 7.43 (t, J = 8.1 Hz, 2H), 7.33 (tt,
J1 = 7.4 Hz, J2 = 1.2 Hz, 1H), 7.26 (d, J = 7.7 Hz, 2H), 2.59 (d, J = 4.7 Hz, 1H), 1.52 (d, J = 4.7
Hz, 1H), 0.98 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 142.9, 141.4, 138.7, 128.9, 128.8,

127.3, 127.2, 127.1, 30.7, 29.5 ppm.
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1-(1,2-syn-dideuterio-3,3-dimethylbutyl)-4-methoxybenzene
(39). Prepared via General procedure (conditions A) from
potassium

(1,2-syn-dideuterio-3,3-dimethylbutyl)trifluoroborate

(28). (90% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.11 (d, J
= 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H), 2.50 (d, J = 4.7 Hz, 1H), 1.45 (d, J = 4.7
Hz, 1H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ157.7, 135.8, 129.3, 113.9, 55.5, 46.3,
30.6, 30.1, 29.5 ppm.

1-(1,2-syn-dideuterio-3,3-dimethylbutyl)-4-methoxybenzene
(40). Prepared via General procedure (conditions B) from
potassium

(1,2-syn-dideuterio-3,3-dimethylbutyl)trifluoroborate

(28). (30% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.11 (d, J
= 8.6 Hz, 2H), 6.83 (d, J = 8.6 Hz, 2H), 3.80 (s, 3H), 2.50 (d, J = 4.7 Hz, 1H), 1.45 (d, J = 4.7
Hz, 1H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ157.7, 135.8, 129.3, 113.9, 55.5, 46.3,
30.6, 30.1, 29.5 ppm.

Ethyl 4-(1,2-anti-dideuterio-3,3-dimethylbutyl)benzoate (41).
Prepared via General procedure (conditions A) from potassium
(1,2-anti-dideuterio-3,3-dimethylbutyl)trifluoroborate (32). (88%
GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.2 Hz,
2H), 7.24 (d, J = 8.2 Hz, 2H), 4.36 (q, J = 7.2 Hz, 2H), 2.60 (d, J = 12.9 Hz, 1H), 1.47 (d, J =
12.9 Hz, 1H), 1.39 (t, J = 7.2 Hz, 3H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.9,
149.3, 129.9, 128.5, 128.1, 60.9, 45.7, 31.3, 30.7, 29.5, 14.6 ppm.
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Ethyl 4-(1,2-anti-dideuterio-3,3-dimethylbutyl)benzoate (42).
Prepared via General procedure (conditions B) from potassium
(1,2-anti-dideuterio-3,3-dimethylbutyl)trifluoroborate (32). (88%
GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.2 Hz,
2H), 7.24 (d, J = 8.2 Hz, 2H), 4.36 (q, J = 7.2 Hz, 2H), 2.60 (d, J = 12.9 Hz, 1H), 1.47 (d, J =
12.9 Hz, 1H), 1.39 (t, J = 7.2 Hz, 3H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ 166.9,
149.3, 129.9, 128.5, 128.1, 60.9, 45.7, 31.3, 30.7, 29.5, 14.6 ppm.

4-(1,2-anti-dideuterio-3,3-dimethylbutyl)-1,1'-biphenyl (43).
Prepared via General procedure (conditions A) from potassium
(1,2-anti-dideuterio-3,3-dimethylbutyl)trifluoroborate

(32).

(89% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.58 (dd, J1 =
8.2 Hz, J2 = 1.2 Hz, 2H) 7.51 (dt, J1 = 8.2 Hz, J2 = 1.2 Hz, 2H), 7.43 (t, J = 8.1 Hz, 2H), 7.32 (tt,
J1 = 7.3 Hz, J2 = 1.2 Hz, 1H), 7.26 (d, J = 7.7 Hz, 2H), 2.59 (d, J = 12.9 Hz, 1H), 1.51 (d, J =
12.9 Hz, 1H), 0.98 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 142.9, 141.4, 138.7, 128.9,

128.8, 127.3, 127.2, 127.1, 30.7, 29.5 ppm.

4-(1,2-anti-dideuterio-3,3-dimethylbutyl)-1,1'-biphenyl (44).
Prepared via General procedure (conditions B) from potassium
(1,2-anti-dideuterio-3,3-dimethylbutyl)trifluoroborate

(32).

(99% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.58 (dd, J1 =
8.2 Hz, J2 = 1.2 Hz, 2H) 7.51 (dt, J1 = 8.2 Hz, J2 = 1.2 Hz, 2H), 7.43 (t, J = 8.1 Hz, 2H), 7.32 (tt,
J1 = 7.3 Hz, J2 = 1.2 Hz, 1H), 7.26 (d, J = 7.7 Hz, 2H), 2.59 (d, J = 12.9 Hz, 1H), 1.51 (d, J =
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12.9 Hz, 1H), 0.98 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 142.9, 141.4, 138.7, 128.9,

128.8, 127.3, 127.2, 127.1, 30.7, 29.5 ppm.

1-(1,2-anti-dideuterio-3,3-dimethylbutyl)-4-methoxybenzene
(45). Prepared via General procedure (conditions A) from
potassium

(1,2-anti-dideuterio-3,3-dimethylbutyl)trifluoroborate

(32). (21% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.101 (d,
J = 8.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 3.79 (s, 3H), 2.49 (d, J = 4.7 Hz, 1H), 1.44 (d, J = 4.7
Hz, 1H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ157.7, 135.8, 129.3, 113.9, 55.5, 46.3,
30.6, 30.1, 29.5 ppm.

1-(1,2-anti-dideuterio-3,3-dimethylbutyl)-4-methoxybenzene
(46). Prepared via General procedure (conditions B) from
potassium

(1,2-anti-dideuterio-3,3-dimethylbutyl)trifluoroborate

(32). (58% GC calibrated yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.101 (d,
J = 8.4 Hz, 2H), 6.83 (d, J = 8.4 Hz, 2H), 3.79 (s, 3H), 2.49 (d, J = 4.7 Hz, 1H), 1.44 (d, J = 4.7
Hz, 1H), 0.96 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ157.7, 135.8, 129.3, 113.9, 55.5, 46.3,
30.6, 30.1, 29.5 ppm.
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Alternate Method of Synthesizing TBDPS-Based Products:

Ethyl 4-(3-hydroxyprop-1-yn-1-yl)benzoate (33A).9 A flask
was charged with Pd(PPh3)Cl2 (45.1 mg, 0.05 mmol) and CuI (19
mg, 0.1 mmol). After the flask was evacuated and refilled with
argon, NEt3 (10 mL) was added and the suspension was stirred at room temperature. A solution
of ethyl 4-iodobenzoate (0.84 ml, 5 mmol) and propargyl alcohol (0.32 ml, 5.5 mmol) in NEt3
(10 mL) was added to the suspension. After the reaction was complete (monitored by TLC), the
mixture was filtered through a plug of Celite and extracted with EtOAc (20 mL x 3). The
combined solution was washed with brine, dried with sodium sulfate and concentrated in vacuo,
(0.9 g, 4.4 mmol, 88%). This semi-crude product was then used for the following step. 1H NMR
(300 MHz, CDCl3): δ 7.99 (d, J = 8.4 Hz, 2H), 7.49 (d, J = 8.4 Hz, 2H), 4.52 (d, J = 5.2 Hz),
4.38 (q, J = 7.1 Hz, 2H), 1.39 (t, J = 7.1 Hz, 3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 166.2,

131.7, 130.4, 129.6, 127.3, 90.2, 85.2, 61.4, 51.8, 14.5 ppm.

Ethyl

4-(3-((tert-butyldiphenylsilyl)oxy)prop-1-yn-1-

yl)benzoate

(33B).

Ethyl

4-(3-hydroxyprop-1-yn-1-
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yl)benzoate (33A) (0.61g, 3 mmol) was then reprotected following the same procedure to
synthesize tert-butyldiphenyl(prop-2-yn-1-yloxy)silane (above), (1.13 g, 2.55 mmol, 85%). 1H
NMR (300 MHz, CDCl3): δ 7.97 (dt, J1 = 8.5 Hz, J2 = 1.8 Hz, 2H), 7.76 (m, 4H), 7.48-7.34 (m,
8H), 4.57 (s, 2H), 4.38 (q, J = 7.2 Hz, 2H), 1.40 (t, 7.2 Hz, 3H), 1.10 (s, 9H) ppm. 13C NMR (75
MHz, CDCl3): δ 166.3, 135.9, 133.3, 131.6, 130.0, 129.5, 127.9, 127.7, 90.8, 84.7, 61.3, 53.3,
26.9, 19.4, 14.5 ppm.

(Z)-ethyl
yl)benzoate

4-(3-((tert-butyldiphenylsilyl)oxy)prop-1-en-1(33C).

Ethyl

4-(3-((tert-

butyldiphenylsilyl)oxy)prop-1-yn-1-yl)benzoate (33B) (0.19 g,
0.44 mmol) was used in a reaction based off of the reaction to synthesize compound (30) but this
did not go to completion. (less than <70% yield based on GC ratio of product to starting
material). 1H NMR (300 MHz, CDCl3): δ 7.96 (d, J = 8.5, 2H), 7.75 (m, 4H), 7.48-7.31 (m, 8H),
6.49 (d, J = 11.9 Hz, 1H), 6.00 (dt, J1 = 11.9 Hz, J2 = 6.3 Hz, 1H), 4.47 (dd, J1 = 1.8 Hz, J2 = 6.3
Hz, 2H), 4.36 (m, 2H), 1.39 (m, 3H), 1.09 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 166.3,

135.8, 135.7, 133.3, 131.6, 130.0, 129.5, 127.9, 91.0, 61.3, 53.3, 26.9, 19.4, 14.5 ppm. Note, due
to the compound being mixed with unseperable starting material the NMR is difficult to interpret
fully.

Ethyl

4-(3-((tert-butyldiphenylsilyl)oxy)-1,2-anti-

dideuteriopropyl)benzoate (33D). Prepared via General
Procedure for Deuteration of Alkenes by D2 gas and Pd/C,
with the starting material being (Z)-ethyl 4-(3-((tert-butyldiphenylsilyl)oxy)prop-1-en-1-
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yl)benzoate (33C), following column chromatography (to remove impurities in starting material)
this yielded a clear oil (100% yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94
(d, J = 8.1 Hz, 2H), 7.66 (d, J = 6.9 Hz, 4H), 7.42 (t, J = 7.3 Hz, 2H), 7.38 (t, J = 7.3 Hz, 4H),
7.22 (d, J = 8.0 Hz, 2H), 4.37 (q, J = 7.1 Hz, 2H), 3.68 (d, J = 6.1 Hz, 2H), 2.75 (d, J = 9.7 Hz,
1H), 1.85 (dt, J1 = 6.1 Hz, J2 = 9.3, 1H), 1.39 (t, J = 7.1 Hz, 3H), 1.07 (s, 9H) ppm. 13C NMR (75
MHz, CDCl3): δ 186.8, 147.8, 135.7, 134.0, 129.8, 128.6, 128.2, 127.8, 62.9, 60.9, 33.7, 32.0,
27.1, 19.4, 14.5 ppm.

(E)-ethyl 4-(3-hydroxyprop-1-en-1-yl)benzoate (34A). A
flask (open to air) was charged with (E)-ethyl 4-(3-oxoprop-1en-1-yl)benzoate (0.33 g, 1.6 mmol) and then diluted with H2O
(3 ml) and MeOH (1 ml). NaBH4 (73 mg, 1.92 mmol) was added a little at a time and the
reaction was stirred till no strating material was detected (by TLC). MeOH was then removed in
vacuo and the product was extracted by Et2O (x3). This was then dried with sodium sulfate and
concentrated in vacuo, (0.22g, 1.07 mmol, 67%). This semi-crude product was then taken for the
following step. 1H NMR (300 MHz, CDCl3): δ 7.99 (m, 2H), 7.42 (d, J = 8.5 Hz, 2H), 6.66 (d, J
= 15.9 Hz, 1H), 6.47 (dt, J1 = 5.3 Hz, J2 = 15.9 Hz, 1H) 4.37 (q, J = 7.2 Hz, 2H), 1.39 (t, J = 7.2,
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3H) ppm.

13

C NMR (75 MHz, CDCl3): δ 166.6, 141.3, 131.4, 130.1, 130.0, 128.6, 63.6, 61.1,

14.5 ppm.
(E)-ethyl

4-(3-((tert-butyldiphenylsilyl)oxy)prop-1-en-

1-yl)benzoate (34B). (E)-ethyl 4-(3-hydroxyprop-1-en-1yl)benzoate (34A) (0.196g, 0.96 mmol) was then
reprotected following the same procedure to synthesize tert-butyldiphenyl(prop-2-yn-1yloxy)silane (above), (0.22 g, 0.49 mmol, 85%). 1H NMR (300 MHz, CDCl3): δ 8.03 (d, J = 8.4
Hz, 2H), 7.60 (m, 4H), 7.44 (m, 8H), 6.75 (d, J = 15.8, 1H), 6.42 (dt, J1 = 4.6 Hz, J2 = 15.8 Hz)
4.41 (m, 4H), 1.43 (t, J = 7.2 Hz, 3H), 1.15 (s, 9H) ppm.

13

C NMR (75 MHz, CDCl3): δ 166.6,

141.3, 131.4, 130.1, 130.0, 129.9, 129.6, 128.6, 126.4, 63.6, 62.2, 61.1, 61.0, 34.0, 32.2, 14.5
ppm.

Ethyl

4-(3-((tert-butyldiphenylsilyl)oxy)-1,2-syn-

dideuteriopropyl)benzoate (34C). Prepared via General
Procedure for Deuteration of Alkenes by D2 gas and Pd/C,
with the starting material (E)-ethyl 4-(3-((tert-butyldiphenylsilyl)oxy)prop-1-en-1-yl)benzoate
(34B), following column chromatography (to remove impurities in starting material) this yielded
a clear oil (100% yield). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 7.94 (d, J = 8.1
Hz, 2H), 7.66 (d, J = 6.9 Hz, 4H), 7.42 (t, J = 7.3 Hz, 2H), 7.38 (t, J = 7.3 Hz, 4H), 7.22 (d, J =
8.0 Hz, 2H), 4.37 (q, J = 7.1 Hz, 2H), 3.68 (d, J = 6.1 Hz, 2H), 2.75 (d, J = 6.3 Hz, 1H), 1.85
(apparent quartet, J = 6.1 Hz, 1H), 1.39 (t, J = 7.1 Hz, 3H), 1.07 (s, 9H) ppm.

13

C NMR (75

MHz, CDCl3): δ 186.8, 147.8, 135.7, 134.0, 129.8, 128.6, 128.2, 127.8, 62.9, 60.9, 33.7, 32.0,
27.1, 19.4, 14.5 ppm.
NMR Spectra Data
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Integrations for vicinal protons is low as this contains some doubley deuterated material
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Integrations for vicinal protons is low as this contains some doubley deuterated material
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Cross-Coupling Products
Cross-Coupling Products – From OTBDPS-Based Nucleophile
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9. Supporting Information for Chapter 4

General Information
Commercially available reagents were purchased from Sigma-Aldrich, Alfa-Aesar, and Ark
Pharm, and used as received unless otherwise noted. Anhydrous THF (inhibitor-free), diethyl
ether, dichloromethane, and toluene were purified by passing through two packed columns of
neutral alumina. Water distilled and degassed prior to use. Solvents used for recrystalization
(ACS grade) were purchased from Fisher, and used as received.
General Analytical Information
Compounds were characterized by 1H NMR and

31

P NMR spectroscopy. Copies of the 1H and

31

P spectra for compounds can be found at the end of this Supporting Information. NMR spectra

were recorded on a Bruker 300 MHz instrument. All 1H NMR experiments are reported in δ
units, parts per million (ppm), and were measured relative to the signals for residual chloroform
methylene chloride (5.32 ppm).
Procedural Information
(MeCN)2PdCl2. In a flask with a condensor, PdCl2 (2 g, 11.3 mmol)
was stirred in MeCN (35 ml) under reflux for 2.5 hours. This solution
was then decanted to remove the PdCl2 chunks, which were then ground to powder and re-added
to the reflux flask, to stir under reflux for a further 30mins. In the sole case where this reaction
was conducted, the stirred solution was immediately used for the synthesis of (TMEDA)PdCl 2,
by addition of TMEDA (following the procedure below), this gave a similar approximate yield
of the TMEDA product (95%).

361

(TMEDA)PdCl2. (MeCN)2PdCl2 (2 g, 7.7 mmol) was stirred under air, at room
temperature, with MeCN (70 ml). TMEDA (8.5 ml, 56.3 mmol) was added
dropwise and the reaction was left to stir for 1 hour. The solution was then filtered
over a glass frit and washed with MeCN, this afforded a yellow solid (2.1 g, 7.1 mmol, 93%
yield).

(TMEDA)PdMe2.105 In a dry flask (under argon) charged with (TMEDA)PdCl2 (1
g, 3.4 mmol) and MTBE (15 ml), MeLi (10mmol, 1.6 M in ether) was added
dropwise at -20 oC. The reaction was stirred and allowed to rise to rt over 2 hours.
The reaction was then cooled to 0 oC and quenched with H2O and extracted with MTBE. The
organic phase was then dried with sodium sulfate and concentrated in vacuo. This yieled a white
solid (0.75 g, 3 mmol, 87% yield). ). 1H NMR (800 MHz, deuterium decoupled, CDCl3): δ 2.49
(s, 4H), 2.42 (s, 12H), -0.32 (s, 6H) ppm.

Phenyl lithium amide.86 A dry flask (under argon), charged with aniline
(0.91 ml, 10 mmol) and hexane (15 ml) was cooled to 0 oC and n-BuLi (7
mmol, 2.5 M in hexane) was added dropwise. The reaction was stirred for 45 mins before being
taken into a nitrogen-filled glove box to be filtered through a glass frit and collected. (0.495 g, 5
mmol, 50% yield).

General Procedure for Synthesis of Oxidative Addition Complexes:
In a nitrogen filled glove box, a flask containing (TMEDA)PdMe2 (0.1 g, 0.4 mmol), BrettPhos
(0.24g, 1.01 equiv), THF (2 ml), and aryl halide (1.53 mmol) was sealed and then removed from

362

the glove box. This flask was then stirred at 55 oC for 2 hours, then left to stir at rt overnight.
Product were then recrystalized in a hexane/ethyl acetate mixture (with cooling in a freezer), this
was then filtered, washed with hexane and collected.

PhPdCl(BrettPhos). Was synthesized via the General Procedure for
Synthesis of Oxidative Addition Complexes. (28% yield).

31

P NMR (121

MHz, CDCl3): δ 43.88, 36.09 ppm.

(m-xylene)PdBr(BrettPhos). Was synthesized via the General Procedure
for Synthesis of Oxidative Addition Complexes. (39% yield). 31P NMR (121
MHz, CDCl3): δ 44.43, 36.76 ppm.
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